Document and Entity Information
Document and Entity Information - USD ($) | 12 Months Ended | ||
Dec. 31, 2017 | Feb. 14, 2018 | Jun. 30, 2017 | |
Document Documentand Entity Information [Abstract] | |||
Document Type | 10-K | ||
Amendment Flag | false | ||
Document Period End Date | Dec. 31, 2017 | ||
Document Fiscal Year Focus | 2,017 | ||
Document Fiscal Period Focus | FY | ||
Trading Symbol | IEX | ||
Entity Registrant Name | IDEX CORP /DE/ | ||
Entity Central Index Key | 832,101 | ||
Current Fiscal Year End Date | --12-31 | ||
Entity Well-known Seasoned Issuer | Yes | ||
Entity Current Reporting Status | Yes | ||
Entity Voluntary Filers | No | ||
Entity Filer Category | Large Accelerated Filer | ||
Entity Common Stock, Shares Outstanding | 76,535,263 | ||
Entity Public Float | $ 8,634,426,211 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 31, 2017 | Dec. 31, 2016 |
Current assets | ||
Cash and cash equivalents | $ 375,950 | $ 235,964 |
Receivables — net | 294,166 | 272,813 |
Inventories | 259,724 | 252,859 |
Other current assets | 74,203 | 61,085 |
Total current assets | 1,004,043 | 822,721 |
Property, plant and equipment — net | 258,350 | 247,816 |
Goodwill | 1,704,158 | 1,632,592 |
Intangible assets — net | 414,746 | 435,504 |
Other noncurrent assets | 18,331 | 16,311 |
Total assets | 3,399,628 | 3,154,944 |
Current liabilities | ||
Trade accounts payable | 147,067 | 128,933 |
Accrued expenses | 184,705 | 152,852 |
Short-term borrowings | 258 | 1,046 |
Dividends payable | 28,945 | 26,327 |
Total current liabilities | 360,975 | 309,158 |
Long-term borrowings | 858,788 | 1,014,235 |
Deferred income taxes | 137,638 | 166,427 |
Other noncurrent liabilities | 155,685 | 121,230 |
Total liabilities | 1,513,086 | 1,611,050 |
Commitments and contingencies (Note 8) | ||
Preferred stock: | ||
Authorized: 5,000,000 shares, $.01 per share par value; Issued: none | 0 | 0 |
Common stock: | ||
Authorized: 150,000,000 shares, $.01 per share par value; Issued: 90,162,211 shares at December 31, 2017 and 90,200,951 shares at December 31, 2016 | 902 | 902 |
Additional paid-in capital | 716,906 | 697,213 |
Retained earnings | 2,057,915 | 1,834,739 |
Treasury stock at cost: 13,468,675 shares at December 31, 2017 and 13,760,266 shares at December 31, 2016 | (799,674) | (787,307) |
Accumulated other comprehensive loss | (89,507) | (201,653) |
Total shareholders’ equity | 1,886,542 | 1,543,894 |
Total liabilities and shareholders’ equity | $ 3,399,628 | $ 3,154,944 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Dec. 31, 2017 | Dec. 31, 2016 |
Statement of Financial Position [Abstract] | ||
Preferred stock, shares authorized (in shares) | 5,000,000 | 5,000,000 |
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Preferred stock, shares issued (in shares) | 0 | 0 |
Common stock, shares authorized (in shares) | 150,000,000 | 150,000,000 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares issued (in shares) | 90,162,211 | 90,200,951 |
Treasury stock, shares (in shares) | 13,468,675 | 13,760,266 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Income Statement [Abstract] | |||
Net sales | $ 2,287,312 | $ 2,113,043 | $ 2,020,668 |
Cost of sales | 1,260,634 | 1,182,276 | 1,116,353 |
Gross profit | 1,026,678 | 930,767 | 904,315 |
Selling, general and administrative expenses | 524,940 | 492,398 | 474,156 |
Loss (gain) on sale of businesses - net | (9,273) | 22,298 | (18,070) |
Restructuring expenses | 8,455 | 3,674 | 11,239 |
Operating income | 502,556 | 412,397 | 436,990 |
Other (income) expense - net | 2,394 | (1,731) | 3,009 |
Interest expense | 44,889 | 45,616 | 41,636 |
Income before income taxes | 455,273 | 368,512 | 392,345 |
Provision for income taxes | 118,016 | 97,403 | 109,538 |
Net income | $ 337,257 | $ 271,109 | $ 282,807 |
Earnings per common share: | |||
Basic earnings per common share (in dollar per share) | $ 4.41 | $ 3.57 | $ 3.65 |
Diluted earnings per common share (in dollar per share) | $ 4.36 | $ 3.53 | $ 3.62 |
Share data: | |||
Basic weighted average common shares outstanding (in shares) | 76,232 | 75,803 | 77,126 |
Diluted weighted average common shares outstanding (in shares) | 77,333 | 76,758 | 77,972 |
CONSOLIDATED STATEMENTS OF COMP
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Statement of Comprehensive Income [Abstract] | |||
Net income | $ 337,257 | $ 271,109 | $ 282,807 |
Other comprehensive income (loss): | |||
Reclassification adjustments for derivatives, net of tax | 4,210 | 4,361 | 4,531 |
Pension and other postretirement adjustments, net of tax | (1,302) | 3,049 | 9,415 |
Cumulative translation adjustment | 110,421 | (76,822) | (63,441) |
Tax effect of reversal of indefinite assertion on certain intercompany loans | (3,932) | 0 | 0 |
Reclassification of foreign currency translation to earnings upon sale of businesses | 2,749 | 14,257 | (4,725) |
Other comprehensive income (loss) | 112,146 | (55,155) | (54,220) |
Comprehensive income | $ 449,403 | $ 215,954 | $ 228,587 |
CONSOLIDATED STATEMENTS OF SHAR
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($) $ in Thousands | Total | Common Stock and Additional Paid-In Capital | Retained Earnings | Cumulative Translation Adjustment | Retirement Benefits Adjustments | Cumulative Unrealized Gain (Loss) on Derivatives | Treasury Stock |
Balance at Dec. 31, 2014 | $ 1,486,451 | $ 648,451 | $ 1,483,821 | $ (24,813) | $ (40,316) | $ (27,149) | $ (553,543) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Net income | 282,807 | 282,807 | |||||
Cumulative translation adjustment | (68,166) | (68,166) | |||||
Net change in retirement obligations, net of tax | 9,415 | 9,415 | |||||
Net change on derivatives designated as cash flow hedges, net of tax | 4,531 | 4,531 | |||||
Issuance of shares of common stock from issuance of unvested shares, exercise of stock options and deferred compensation plans | 24,482 | 14,545 | 9,937 | ||||
Repurchase of common stock | (210,551) | (210,551) | |||||
Share-based compensation | 17,529 | 17,529 | |||||
Unvested shares surrendered for tax withholding | (3,259) | (3,259) | |||||
Cash dividends declared | (99,948) | (99,948) | |||||
Balance at Dec. 31, 2015 | 1,443,291 | 680,525 | 1,666,680 | (92,979) | (30,901) | (22,618) | (757,416) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Net income | 271,109 | 271,109 | |||||
Cumulative translation adjustment | (62,565) | (62,565) | |||||
Net change in retirement obligations, net of tax | 3,049 | 3,049 | |||||
Net change on derivatives designated as cash flow hedges, net of tax | 4,361 | 4,361 | |||||
Issuance of shares of common stock from issuance of unvested shares, exercise of stock options and deferred compensation plans | 30,240 | 253 | 29,987 | ||||
Repurchase of common stock | (54,950) | (54,950) | |||||
Share-based compensation | 17,337 | 17,337 | |||||
Unvested shares surrendered for tax withholding | (4,928) | (4,928) | |||||
Cash dividends declared | (103,050) | (103,050) | |||||
Balance at Dec. 31, 2016 | 1,543,894 | 698,115 | 1,834,739 | (155,544) | (27,852) | (18,257) | (787,307) |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||
Net income | 337,257 | 337,257 | |||||
Cumulative translation adjustment | 113,170 | 113,170 | |||||
Net change in retirement obligations, net of tax | (1,302) | (1,302) | |||||
Net change on derivatives designated as cash flow hedges, net of tax | 4,210 | 4,210 | |||||
Issuance of shares of common stock from issuance of unvested shares, exercise of stock options and deferred compensation plans | 22,935 | 22,935 | |||||
Repurchase of common stock | (29,074) | (29,074) | |||||
Share-based compensation | 19,693 | 19,693 | |||||
Unvested shares surrendered for tax withholding | (6,228) | (6,228) | |||||
Tax effect of reversal of indefinite assertion on certain intercompany loans | (3,932) | (3,932) | |||||
Cash dividends declared | (114,081) | (114,081) | |||||
Balance at Dec. 31, 2017 | $ 1,886,542 | $ 717,808 | $ 2,057,915 | $ (46,306) | $ (29,154) | $ (14,047) | $ (799,674) |
CONSOLIDATED STATEMENTS OF SHA7
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Parenthetical) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Statement of Stockholders' Equity [Abstract] | |||
Tax expense on change in retirement obligations, tax | $ 239 | $ 2,107 | $ 3,842 |
Tax from change on derivatives designated as cash flow hedges, tax | $ 2,445 | $ 2,490 | $ 2,499 |
Issuance of common stock from issuance of unvested shares, exercise of stock options and deferred compensation plans (in shares) | 557,591 | 594,919 | 685,501 |
Issuance of common stock from issuance of unvested shares, exercise of stock options and deferred compensation plans, tax | $ 6,027 | $ 5,305 | $ 3,794 |
Repurchase of common stock (in shares) | 266,000 | 738,593 | 2,811,002 |
Cash dividends declared, per common share outstanding (in dollars per share) | $ 1.48 | $ 1.36 | $ 1.28 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Cash flows from operating activities | |||
Net income | $ 337,257 | $ 271,109 | $ 282,807 |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Loss (gain) on sale of fixed assets - net | 315 | (28) | (114) |
Loss (gain) on sale of businesses - net | (9,273) | 22,298 | (18,070) |
Asset impairments | 0 | 205 | 795 |
Depreciation and amortization | 38,314 | 37,854 | 35,694 |
Amortization of intangible assets | 45,902 | 49,038 | 42,426 |
Amortization of debt issuance expenses | 1,320 | 1,295 | 1,612 |
Share-based compensation expense | 24,405 | 20,326 | 20,048 |
Deferred income taxes | (33,742) | (17,308) | (339) |
Excess tax benefit from share-based compensation | 0 | 0 | (5,265) |
Non-cash interest expense associated with forward starting swaps | 6,655 | 6,851 | 7,030 |
Pension settlement | 0 | 3,554 | 0 |
Changes in (net of the effect from acquisitions and divestitures): | |||
Receivables | (15,803) | 302 | 8,832 |
Inventories | 760 | 32,747 | 4,557 |
Other current assets | (20,031) | (22,006) | (2,728) |
Trade accounts payable | 12,556 | 73 | (2,828) |
Accrued expenses | 19,710 | (5,470) | (16,672) |
Other — net | 24,408 | (923) | 2,536 |
Net cash flows provided by operating activities | 432,753 | 399,917 | 360,321 |
Cash flows from investing activities | |||
Purchases of property, plant and equipment | (43,858) | (38,242) | (43,776) |
Acquisition of businesses, net of cash acquired | (38,161) | (510,001) | (195,013) |
Proceeds from fixed asset disposals | 6,011 | 49 | 894 |
Proceeds from sale of businesses, net of cash sold | 21,795 | 39,064 | 27,677 |
Other — net | (533) | (69) | (273) |
Net cash flows (used in) investing activities | (54,746) | (509,199) | (210,491) |
Cash flows from financing activities | |||
Borrowings under revolving credit facilities | 33,000 | 501,529 | 414,032 |
Payment of 2.58% Senior Euro Notes | 0 | 0 | (88,420) |
Payments under revolving credit facilities | (200,618) | (520,125) | (333,630) |
Debt issuance costs | 0 | (246) | (1,739) |
Dividends paid | (111,172) | (102,650) | (96,172) |
Proceeds from stock option exercises | 22,935 | 30,240 | 19,217 |
Excess tax benefit from share-based compensation | 0 | 0 | 5,265 |
Purchases of common stock | (29,074) | (57,272) | (210,822) |
Unvested shares surrendered for tax withholding | (6,228) | (4,928) | (3,259) |
Settlement of foreign exchange contracts | 13,736 | 0 | 0 |
Net cash flows provided by (used in) financing activities | (277,421) | 46,548 | (295,528) |
Effect of exchange rate changes on cash and cash equivalents | 39,400 | (29,320) | (35,421) |
Net increase (decrease) in cash | 139,986 | (92,054) | (181,119) |
Cash and cash equivalents at beginning of year | 235,964 | 328,018 | 509,137 |
Cash and cash equivalents at end of period | 375,950 | 235,964 | 328,018 |
Cash paid for: | |||
Interest | 36,818 | 37,067 | 33,502 |
Income taxes - net | 104,852 | 109,399 | 112,613 |
Significant non-cash activities: | |||
Contingent consideration for acquisition | $ 0 | 0 | 4,705 |
3.2% Senior Notes, due June 2023 | |||
Cash flows from financing activities | |||
Proceeds from issuance of Senior Notes | 100,000 | 0 | |
3.37% Senior Notes, due June 2025 | |||
Cash flows from financing activities | |||
Proceeds from issuance of Senior Notes | $ 100,000 | $ 0 |
CONSOLIDATED STATEMENTS OF CAS9
CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) | Dec. 31, 2017 |
3.2% Senior Notes, due June 2023 | |
Stated interest rate | 3.20% |
3.37% Senior Notes, due June 2025 | |
Stated interest rate | 3.37% |
2.58% Senior Euro Notes, due June 2015 | |
Stated interest rate | 2.58% |
Significant Accounting Policies
Significant Accounting Policies | 12 Months Ended |
Dec. 31, 2017 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies | Significant Accounting Policies Business IDEX is an applied solutions company specializing in fluid and metering technologies, health and science technologies, and fire, safety and other diversified products built to customers’ specifications. IDEX’s products are sold in niche markets to a wide range of industries throughout the world. The Company’s products include industrial pumps, compressors, flow meters, injectors and valves, and related controls for use in a wide variety of process applications; precision fluidics solutions, including pumps, valves, degassing equipment, corrective tubing, fittings, and complex manifolds, optical filters and specialty medical equipment and devices for use in life science applications; precision-engineered equipment for dispensing, metering and mixing paints; and engineered products for industrial and commercial markets, including fire and rescue, transportation equipment, oil & gas, electronics, and communications. These activities are grouped into three reportable segments: Fluid & Metering Technologies, Health & Science Technologies and Fire & Safety/Diversified Products. Principles of Consolidation The consolidated financial statements include the Company and its subsidiaries. All intercompany transactions and accounts have been eliminated. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The principal areas of estimation reflected in the financial statements are revenue recognition, sales returns and allowances, allowance for doubtful accounts, inventory valuation, recoverability of long-lived assets, income taxes, product warranties, contingencies and litigation, insurance-related items, defined benefit retirement plans and purchase accounting related to acquisitions. Revenue Recognition The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable, and collectability of the sales price is reasonably assured. For product sales, delivery does not occur until the products have been shipped and risk of loss has been transferred to the customer. Revenue from services is recognized when the services are provided or ratably over the contract term. Some arrangements with customers may include multiple deliverables, including the combination of products and services. In such cases, the Company has identified these as separate elements in accordance with Accounting Standards Codification (“ASC”) 605-25, Revenue Recognition-Multiple-Element Arrangements , and recognizes revenue consistent with the policy for each separate element based on the relative selling price method. Revenues from certain long-term contracts are recognized on the percentage-of-completion method. Percentage-of-completion is measured principally by the percentage of costs incurred to date for each contract to the estimated total costs for such contract at completion. Provisions for estimated losses on uncompleted long-term contracts are made in the period in which such losses are determined. Due to uncertainties inherent in the estimation process, it is reasonably possible that completion costs, including those arising from contract penalty provisions and final contract settlements, will be revised in the near-term. Such revisions to costs and income are recognized in the period in which the revisions are determined. The Company records allowances for discounts, product returns and customer incentives at the time of sale as a reduction of revenue as such allowances can be reliably estimated based on historical experience and known trends. The Company also offers product warranties and accrues its estimated exposure for warranty claims at the time of sale based upon the length of the warranty period, warranty costs incurred and any other related information known to the Company. Shipping and Handling Costs Shipping and handling costs are included in Cost of sales and are recognized as a period expense during the period in which they are incurred. Advertising Costs Advertising costs of $15.8 million , $15.3 million and $16.1 million for 2017 , 2016 and 2015 , respectively, are expensed as incurred within Selling, general and administrative expenses. Cash and Cash Equivalents The Company considers all highly liquid instruments purchased with an original maturity of 90 days or less to be cash and cash equivalents. Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are recorded at face amounts less an allowance for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses as a result of customers’ inability to make required payments. Management evaluates the aging of the accounts receivable balances, the financial condition of its customers, historical trends and the time outstanding of specific balances to estimate the amount of accounts receivable that may not be collected in the future and records the appropriate provision. Inventories The Company states inventories at the lower of cost or net realizable value. Cost, which includes material, labor, and factory overhead, is determined on a FIFO basis. We make adjustments to reduce the cost of inventory to its net realizable value, if required, for estimated excess, obsolescence or impaired balances. Factors influencing these adjustments include changes in market demand, product life cycle and engineering changes. Impairment of Long-Lived Assets Long-lived assets are reviewed for impairment if an event occurs or circumstances change that would more likely than not reduce the fair value of a long-lived asset below its carrying amount, as measured by comparing their net book value to the projected undiscounted future cash flows generated by their use. A long-lived asset impairment exists when the carrying amount of the asset exceeds its fair value. The amount and timing of impairment charges for these assets require the estimation of future cash flows to determine the fair value of the related assets. Impaired assets are recorded at their estimated fair value based on a discounted cash flow analysis. In 2017 , 2016 , and 2015 , the Company concluded that certain long-lived assets had a fair value that was less than the carrying value of the assets, resulting in zero , $0.2 million and $0.8 million , respectively, of long-lived asset impairment charges. Goodwill and Indefinite-Lived Intangible Assets In accordance with ASC 350, Goodwill and Other Intangible Assets , the Company reviews the carrying value of goodwill and indefinite-lived intangible assets annually on October 31, or if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The Company evaluates the recoverability of these assets based on the estimated fair value of each of the thirteen reporting units and the indefinite-lived intangible assets. See Note 4 for a further discussion on goodwill and intangible assets. Borrowing Expenses Expenses incurred in securing and issuing debt are capitalized and included as a reduction of Long-term borrowings. These amounts are amortized over the life of the related borrowing and the related amortization is included in Interest expense. Earnings per Common Share Earnings per common share (“EPS”) is computed by dividing net income by the weighted average number of shares of common stock (basic) plus common stock equivalents (diluted) outstanding during the year. Common stock equivalents consist of stock options, which have been included in the calculation of weighted average shares outstanding using the treasury stock method, restricted stock and performance share units. ASC 260, Earnings per Share , concludes that all outstanding unvested share-based payment awards that contain rights to nonforfeitable dividends participate in undistributed earnings with common shareholders. If awards are considered participating securities, the Company is required to apply the two-class method of computing basic and diluted earnings per share. The Company has determined that its outstanding shares of restricted stock are participating securities. Accordingly, EPS was computed using the two-class method prescribed by ASC 260. Basic weighted average shares outstanding reconciles to diluted weighted average shares outstanding as follows: 2017 2016 2015 (In thousands) Basic weighted average common shares outstanding 76,232 75,803 77,126 Dilutive effect of stock options, restricted stock and performance share units 1,101 955 846 Diluted weighted average common shares outstanding 77,333 76,758 77,972 Options to purchase approximately zero , 0.9 million and 0.9 million shares of common stock in 2017 , 2016 and 2015 , respectively, were not included in the computation of diluted EPS because the effect of their inclusion would have been antidilutive. Share-Based Compensation The Company accounts for share-based payments in accordance with ASC 718, Compensation-Stock Compensation . Accordingly, the Company expenses the fair value of awards made under its share-based compensation plans. That cost is recognized in the consolidated financial statements over the requisite service period of the grants. See Note 13 for further discussion on share-based compensation. Depreciation and Amortization Property and equipment are stated at cost, with depreciation and amortization provided using the straight-line method over the following estimated useful lives: Land improvements 8 to 12 years Buildings and improvements 8 to 30 years Machinery, equipment and other 3 to 12 years Office and transportation equipment 3 to 10 years Certain identifiable intangible assets are amortized over their estimated useful lives using the straight-line method. The estimated useful lives used in the computation of amortization of identifiable intangible assets are as follows: Patents 5 to 17 years Trade names 10 to 20 years Customer relationships 6 to 20 years Unpatented technology and other 6 to 20 years Research and Development Expenditures Costs associated with engineering activities, including research and development, are expensed in the period incurred and are included in Cost of sales. Total engineering expenses, which include research and development as well as application and support engineering, were $76.4 million , $68.8 million and $61.2 million in 2017 , 2016 and 2015 , respectively. Research and development expenses, which include costs associated with developing new products and major improvements to existing products, were $42.4 million , $39.4 million and $33.6 million in 2017 , 2016 and 2015 , respectively. Foreign Currency The functional currency of substantially all operations outside the United States is the respective local currency. Accordingly, those foreign currency balance sheet accounts have been translated using the exchange rates in effect as of the balance sheet date. Income statement amounts have been translated using the average exchange rate for the year. The gains and losses resulting from changes in exchange rates from year to year have been reported in Accumulated other comprehensive loss in the Consolidated Balance Sheets. The foreign currency transaction losses (gains) for the periods ending December 31, 2017 , 2016 and 2015 were $20.5 million , $(6.2) million , and $(0.1) million , respectively, and are reported within Other (income) expense - net on the Consolidated Statements of Operations. Of the $20.5 million reported as foreign currency transaction losses for the period ending December 31, 2017, $20.2 million was due to intercompany loans established in conjunction with the SFC Koenig acquisition. See Note 6 for further discussion. Income Taxes Income tax expense includes United States, state, local and international income taxes. Deferred tax assets and liabilities are recognized for the tax consequences of temporary differences between the financial reporting and the tax basis of existing assets and liabilities and for loss carryforwards. The tax rate used to determine the deferred tax assets and liabilities is the enacted tax rate for the year and manner in which the differences are expected to reverse. Valuation allowances are recorded to reduce deferred tax assets to the amount that will more likely than not be realized. Refer to Note 10 for further discussion on income taxes. Concentration of Credit Risk The Company is not dependent on a single customer as its largest customer accounted for less than 2% of net sales for all years presented. Recently Adopted Accounting Standards In March 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-07, Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost , which amends the requirements related to the income statement presentation of the components of net periodic benefit cost for a company’s sponsored defined benefit pension and other postretirement plans. Under this ASU, companies are required to disaggregate the current service cost component from the other components of net benefit cost and present it with other current compensation costs for related employees in the income statement and present the other components elsewhere in the income statement and outside of income from operations if such a subtotal is presented. This ASU also requires companies to disclose the income statement lines that contain the other components if they are not presented on appropriately described separate lines. In addition, only the service cost component of periodic net benefit cost is eligible for capitalization. The Company elected to early adopt this standard in the quarter ended March 31, 2017 as presenting the service cost within income from operations is more indicative of our current pension cost. The Company adopted this standard retrospectively and thus $6.6 million was reclassified from Selling, general and administrative expenses to Other (income) expense - net for the twelve months ended December 31, 2016, and $5.3 million was reclassified from Selling, general and administrative expenses to Other (income) expense - net for the twelve months ended December 31, 2015 to conform to current period presentation. The Company elected to apply the practical expedient that permits the use of previously disclosed service cost and other costs from the prior year’s pension and other postretirement benefit plan footnote in the comparative periods as appropriate estimates when retrospectively changing the presentation of these costs in the income statement. The Company included the required disclosures and the changes resulting from the adoption of this standard in Note 15. In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment , which eliminates Step 2 from the goodwill impairment test. Under this ASU, if the carrying amount of a reporting unit exceeds its fair value, an impairment loss will be recognized in an amount equal to the excess, limited to the total amount of goodwill allocated to the reporting unit. This ASU also eliminated the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform Step 2 of the goodwill impairment test. In addition, companies will be required to disclose the amount of goodwill allocated to each reporting unit with a zero or negative carrying amount of net assets. The Company early adopted this standard on January 1, 2017. The adoption of this standard did not have a material impact on our consolidated financial statements. In July 2015, the FASB issued ASU 2015-11, Simplifying the Measurement of Inventory . Under this guidance, entities utilizing the FIFO or average cost method should measure inventory at the lower of cost or net realizable value, where net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company adopted this guidance on January 1, 2017. The adoption of this standard did not have a material impact on our consolidated financial statements. New Accounting Pronouncements In January 2017, the FASB issued ASU 2017-01, Clarifying the Definition of a Business , which clarifies the definition of a business and assists entities with evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. Under this guidance, when substantially all of the fair value of gross assets acquired is concentrated in a single asset or group of similar assets, the assets acquired would not represent a business. In addition, in order to be considered a business, an acquisition would have to include at a minimum an input and a substantive process that together significantly contribute to the ability to create an output. The amended guidance also narrows the definition of outputs by more closely aligning it with how outputs are described in FASB guidance for revenue recognition. This guidance is effective for interim and annual periods for the Company on January 1, 2018, with early adoption permitted. The Company does not believe the guidance will have a material impact on its consolidated financial statements. In October 2016, the FASB issued ASU 2016-16, Intra-Entity Transfers of Assets Other Than Inventory , which amends ASC 740, Income Taxes . This ASU requires that the income tax consequences of an intra-entity asset transfer other than inventory are recognized at the time of the transfer. An entity will continue to recognize the income tax consequences of an intercompany transfer of inventory when the inventory is sold to a third party. The update is effective for financial statements issued for fiscal years beginning after December 15, 2017. The ASU requires adoption on a modified-retrospective basis through a cumulative adjustment to retained earnings at the beginning of the period of adoption. The Company is currently assessing the impact that adopting this new accounting standard will have on its consolidated financial statements and footnote disclosures. In August 2016, the FASB issued ASU 2016-15, Classification of Certain Cash Receipts and Cash Payments (a consensus of the FASB Emerging Issues Task Force). This ASU addresses the following eight specific cash flow issues: Debt prepayment or debt extinguishment costs; settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; contingent consideration payments made after a business combination; proceeds from the settlement of insurance claims; proceeds from the settlement of corporate-owned life insurance policies (including bank-owned life insurance policies); distributions received from equity method investees; beneficial interests in securitization transactions; and separately identifiable cash flows and application of the predominance principle. This standard is effective for fiscal years beginning after December 15, 2017. The Company does not believe the guidance will have a material impact on our consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, Leases , which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The standard introduces a new lessee model that will require most leases to be recorded on the balance sheet and eliminates the required use of bright line tests in current U.S. GAAP for determining lease classification. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. This standard is effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. Companies are permitted to adopt the standard early and a modified retrospective application is permitted. The new guidance requires adoption on a retrospective basis unless it is impracticable to apply, in which case the company would be required to apply the amendments prospectively as of the earliest date practicable. The Company is currently evaluating the impact of adopting the new guidance on our consolidated financial statements. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, which will replace numerous requirements in U.S. GAAP, including industry-specific requirements, and provide companies with a new five-step model for recognizing revenue from contracts with customers. Under ASU 2014-09, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires disclosures sufficient to enable users to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers, including qualitative and quantitative disclosures about contracts with customers, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract. This standard is effective for fiscal years beginning after December 15, 2017, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption. The FASB has also issued the following standards which clarify ASU 2014-09 and have the same effective date as the original standard: ASU 2016-08, Revenue from Contracts with Customers: Principal versus Agent Considerations (Reporting Revenue Gross versus Net) ; ASU 2016-10, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing ; ASU 2016-12 , Revenue from Contracts with Customers: Narrow-Scope Improvements and Practical Expedients ; and ASU 2016-20 , Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers. In 2016, we established an implementation team and analyzed the impact of the standard by surveying business units and reviewing contracts to identify potential differences that may result from applying the requirements of the new standard. We have completed our contract reviews. The contract reviews generally supported the recognition of revenue at a point in time, which is consistent with the current revenue recognition model used by most of our business units. As a result, we expect revenue recognition to remain substantially unchanged under the new standard. For our business units that currently recognize revenue under a percentage of completion model, we also expect revenue recognition to remain substantially unchanged as the contract reviews supported the recognition of revenue over time. The implementation team has reported these findings to the Audit Committee. The Company has implemented the appropriate changes to its processes, systems and controls to comply with the new guidance and is currently evaluating new disclosure requirements. The Company expects to adopt the standard in 2018 using the modified retrospective method and does not expect the adoption to have an impact on our consolidated financial statements. |
Acquisitions and Divestitures
Acquisitions and Divestitures | 12 Months Ended |
Dec. 31, 2017 | |
Business Combinations and Dispositions [Abstract] | |
Acquisitions and Divestitures | Acquisitions and Divestitures All of the Company’s acquisitions have been accounted for under ASC 805, Business Combinations . Accordingly, the accounts of the acquired companies, after adjustments to reflect fair values assigned to assets and liabilities, have been included in the Company’s consolidated financial statements from their respective dates of acquisition. The results of operations of the acquired companies have been included in the Company’s consolidated results since the date of each acquisition. Supplemental pro forma information has not been provided as the acquisitions did not have a material impact on the Company’s consolidated results of operations individually or in the aggregate. 2017 Acquisition On December 8, 2017, the Company acquired the stock of thinXXS Microtechnology AG (“thinXXS”), a leader in the design, manufacture, and sale of microfluidic components serving the point of care, veterinary, and life science markets. The business was acquired to complement our existing CiDRA Precision Services business and expand on our microfluidic and nanofluidic capabilities. Headquartered in Zweibrücken, Germany, thinXXS operates in our Health & Science Technologies segment. thinXXS was acquired for cash consideration of $38.2 million and the assumption of $1.2 million of debt. The purchase price was funded with cash on hand. Goodwill and intangible assets recognized as part of the transaction were $23.9 million and $11.8 million , respectively. The goodwill is not deductible for tax purposes. The Company made an initial allocation of the purchase price for the thinXXS acquisition as of the acquisition date based on its understanding of the fair value of the acquired assets and assumed liabilities. These nonrecurring fair value measurements are classified as Level 3 in the fair value hierarchy. As the Company obtains additional information about these assets and liabilities, including tangible and intangible asset appraisals, and learns more about the newly acquired business, we will refine the estimates of fair value and more accurately allocate the purchase price. Only items identified as of the acquisition date are considered for subsequent adjustment. The Company will make appropriate adjustments to the purchase price allocation prior to the completion of the measurement period, as required. The Company incurred $1.3 million of acquisition-related transaction costs in 2017. These costs were recorded in Selling, general and administrative expenses and were related to completed transactions, pending transactions and potential transactions, including transactions that ultimately were not completed. 2016 Acquisitions On March 16, 2016, the Company acquired the stock of Akron Brass Holding Corporation (“Akron Brass”), a producer of a large array of engineered life–safety products for the safety and emergency response markets, which includes apparatus valves, monitors, nozzles, specialty lighting, electronic vehicle–control systems and firefighting hand tools. The business was acquired to complement and create synergies with our existing Hale, Class 1, and Godiva businesses. Headquartered in Wooster, Ohio, Akron Brass operates in our Fire & Safety/Diversified Products segment. Akron Brass was acquired for cash consideration of $221.4 million . The purchase price was funded with borrowings under the Company’s revolving facilities. Goodwill and intangible assets recognized as part of the transaction were $124.6 million and $90.4 million , respectively. The goodwill is not deductible for tax purposes. On July 1, 2016, the Company acquired the stock of AWG Fittings GmbH (“AWG Fittings”), a producer of engineered products for the safety and emergency response markets, including valves, monitors and nozzles. The business was acquired to complement and create synergies with our existing Hale, Class 1, Godiva and Akron Brass businesses. Headquartered in Ballendorf, Germany, AWG Fittings operates in our Fire & Safety/Diversified Products segment. AWG Fittings was acquired for cash consideration of $47.5 million ( €42.8 million ). The purchase price was funded with cash on hand. Goodwill and intangible assets recognized as part of the transaction were $22.1 million and $10.3 million , respectively. The goodwill is not deductible for tax purposes. On August 31, 2016, the Company acquired the stock of SFC Koenig AG (“SFC Koenig”), a producer of highly engineered expanders and check valves for critical applications across the transportation, hydraulic, aviation and medical markets. Headquartered in Dietikon, Switzerland, SFC Koenig operates in our Health & Science Technologies segment. SFC Koenig was acquired for cash consideration of $241.1 million ( €215.9 million ). The purchase price was funded with cash on hand and borrowings under the Company’s revolving facilities. Goodwill and intangible assets recognized as part of the transaction were $141.3 million and $117.0 million , respectively. The goodwill is not deductible for tax purposes. The allocation of the acquisition costs to the assets acquired and liabilities assumed, based on their estimated fair values at their respective acquisition dates, is as follows: Akron Brass AWG Fittings SFC Koenig Total (In thousands) Accounts receivable $ 14,523 $ 5,867 $ 9,190 $ 29,580 Inventory 29,157 11,766 20,639 61,562 Other assets, net of cash acquired 446 565 4,501 5,512 Property, plant and equipment 12,195 6,595 4,637 23,427 Goodwill 124,643 22,055 141,298 287,996 Intangible assets 90,400 10,279 116,998 217,677 Deferred income taxes — 3,928 — 3,928 Total assets acquired 271,364 61,055 297,263 629,682 Current liabilities (7,081 ) (5,117 ) (11,704 ) (23,902 ) Deferred income taxes (36,439 ) — (36,168 ) (72,607 ) Other noncurrent liabilities (6,445 ) (8,444 ) (8,283 ) (23,172 ) Net assets acquired $ 221,399 $ 47,494 $ 241,108 $ 510,001 Acquired intangible assets consist of trade names, customer relationships and unpatented technology. The goodwill recorded for the acquisitions reflects the strategic fit, revenue and earnings growth potential of these businesses. Of the $217.7 million of acquired intangible assets, $28.8 million was assigned to the Akron Brass trade name and is not subject to amortization. The acquired intangible assets and weighted average amortization periods are as follows: (In thousands, except weighted average life) Total Weighted Average Life Trade names $ 14,078 15 Customer relationships 134,519 13 Unpatented technology 40,280 13 Amortized intangible assets 188,877 Indefinite lived - Akron Brass trade name 28,800 Total acquired intangible assets $ 217,677 The Company incurred $4.7 million of acquisition-related transaction costs in 2016. These costs were recorded in Selling, general and administrative expenses and were related to completed transactions, pending transactions and potential transactions, including transactions that ultimately were not completed. The Company also incurred $14.7 million of non-cash acquisition fair value inventory step-up charges associated with the completed 2016 acquisitions. These charges were recorded in Cost of sales. 2015 Acquisitions On May 29, 2015, the Company acquired the stock of Novotema, SpA (“Novotema”), a leader in the design, manufacture and sale of specialty sealing solutions for use in the building products, gas control, transportation, industrial and water markets. The business was acquired to complement and create synergies with our existing Sealing Solutions platform. Located in Villongo, Italy, Novotema operates in our Health & Science Technologies segment. Novotema was acquired for cash consideration of $61.1 million ( €56 million ). The entire purchase price was funded with cash on hand. Goodwill and intangible assets recognized as part of this transaction were $34.3 million and $20.0 million , respectively. The $34.3 million of goodwill is not deductible for tax purposes. On June 10, 2015, the Company acquired the stock of Alfa Valvole, S.r.l (“Alfa Valvole”), a leader in the design, manufacture and sale of specialty valve products for use in the chemical, petro-chemical, energy and sanitary markets. The business was acquired to expand our valve capabilities. Located in Casorezzo, Italy, Alfa Valvole operates in our Fluid & Metering Technologies segment. Alfa Valvole was acquired for cash consideration of $112.6 million ( €99.8 million ). The entire purchase price was funded with cash on hand. Goodwill and intangible assets recognized as part of this transaction were $69.6 million and $32.1 million , respectively. The $69.6 million of goodwill is not deductible for tax purposes. On July 1, 2015, the Company acquired the membership interests of CiDRA Precision Services, LLC (“CPS” or “CiDRA Precision Services”), a leader in the design, manufacture and sale of microfluidic components serving the life science, health and industrial markets. The business was acquired to provide a critical building block to our emerging microfluidic and nanofluidic capabilities. Located in Wallingford, Connecticut, CPS operates in our Health & Science Technologies segment. CPS was acquired for an aggregate purchase price of $24.2 million , consisting of $19.5 million in cash and contingent consideration valued at $4.7 million as of the opening balance sheet date. The contingent consideration was based on the achievement of financial objectives during the 12-month period following the close. Based on potential outcomes, the undiscounted amount of all the future payments that the Company could have been required to make under the contingent consideration arrangement was between $0 and $5.5 million . During the six months ended June 30, 2016, the Company re-evaluated the contingent consideration arrangement and fully reversed the $4.7 million liability based on CPS’s actual operating results from July 1, 2015 to June 30, 2016. The $4.7 million reversal was recognized as a benefit within Selling, general and administrative expenses, of which $3.7 million was recognized in March 2016 and the remaining $1.0 million was recognized in June 2016. The entire purchase price was funded with cash on hand. Goodwill and intangible assets recognized as part of this transaction were $9.7 million and $12.3 million , respectively. The $9.7 million of goodwill is deductible for tax purposes. On December 1, 2015, the Company acquired the assets of a complementary product line within our Fluid & Metering Technologies segment. The purchase price and goodwill associated with this transaction were $1.9 million and $0.7 million , respectively. The allocation of the acquisition costs to the assets acquired and liabilities assumed, based on their estimated fair values at their respective acquisition dates, is as follows: Novotema Alfa Valvole CPS Other Total (In thousands) Accounts receivable $ 8,029 $ 13,487 $ 945 $ — $ 22,461 Inventory 2,886 11,036 442 1,102 15,466 Other assets, net of cash acquired 1,866 3,367 79 — 5,312 Property, plant and equipment 11,844 8,395 1,105 — 21,344 Goodwill 34,316 69,568 9,739 748 114,371 Intangible assets 20,011 32,058 12,290 — 64,359 Total assets acquired 78,952 137,911 24,600 1,850 243,313 Current liabilities (7,760 ) (11,279 ) (420 ) — (19,459 ) Deferred income taxes (7,803 ) (12,622 ) — — (20,425 ) Other noncurrent liabilities (2,291 ) (1,420 ) — — (3,711 ) Net assets acquired $ 61,098 $ 112,590 $ 24,180 $ 1,850 $ 199,718 Acquired intangible assets consist of trade names, customer relationships and unpatented technology. The goodwill recorded for the acquisitions reflects the strategic fit, revenue and earnings growth potential of these businesses. The acquired intangible assets and weighted average amortization periods are as follows: (In thousands, except weighted average life) Total Weighted Average Life Trade names $ 9,247 15 Customer relationships 44,401 12 Unpatented technology 10,711 8 Total acquired intangible assets $ 64,359 The Company incurred $2.6 million of acquisition-related transaction costs in 2015. These costs were recorded in Selling, general and administrative expense and were related to completed transactions, pending transactions and potential transactions, including transactions that ultimately were not completed. The Company also incurred $3.4 million of non-cash acquisition fair value inventory charges in 2015. These charges were recorded in Cost of sales. Divestitures The Company periodically reviews its operations for businesses which may no longer be aligned with its strategic objectives and focuses on core business and customers. Any resulting gain or loss recognized due to divestitures is recorded within Loss (gain) on sale of businesses - net. The Company concluded that none of the divestitures that took place during the years ended December 31, 2017, 2016 and 2015 met the new criteria for reporting discontinued operations. On October 31, 2017, the Company completed the sale of its Faure Herman subsidiary for $21.8 million in cash, resulting in a pre-tax gain on the sale of $9.3 million . There was no income tax expense associated with this transaction. The results of Faure Herman were reported within the Fluid & Metering Technologies segment and generated $14.1 million of revenues in 2017 through the date of sale. On July 29, 2016, the Company completed the sale of its Hydra-Stop product line for $15.0 million in cash, resulting in a pre-tax gain on the sale of $5.8 million . In addition, the Company earned $1.0 million for the achievement of 2016 net sales objectives, which represents the maximum earn out for 2016, and the Company can earn an additional $1.0 million if 2017 net sales objectives are achieved. The Company recorded $2.8 million of income tax expense associated with this transaction during the year ended December 31, 2016. The results of Hydra-Stop were reported within the Fluid & Metering Technologies segment and generated $7.5 million of revenues in 2016 through the date of sale. On September 9, 2016, the Company completed the sale of its Melles Griot KK (“CVI Japan”) subsidiary for $17.5 million in cash, resulting in a pre-tax loss on the sale of $7.9 million . The Company recorded $3.4 million of income tax benefit associated with this transaction during the year ended December 31, 2016. The results of CVI Japan were reported within the Health & Science Technologies segment and generated $13.1 million of revenues in 2016 through the date of sale. On October 10, 2016, the Company completed the sale of its IETG and 40Seven subsidiaries for $2.7 million in cash, resulting in a pre-tax loss on the sale of $4.2 million . There was no income tax impact associated with this transaction. The results of IETG and 40Seven were reported within the Fluid & Metering Technologies segment and generated $8.3 million of revenues in 2016 through the date of sale. On December 30, 2016, the Company completed the sale of its Korea Electro-Optics Co., Ltd. (“CVI Korea”) subsidiary for $3.8 million in cash, resulting in a pre-tax loss on the sale of $16.0 million . The Company recorded $9.1 million of income tax benefit associated with this transaction during the year ended December 31, 2016. The results of CVI Korea were reported within the Health & Science Technologies segment and generated $11.7 million of revenues in 2016 through the date of sale. On July 31, 2015, the Company completed the sale of its Ismatec product line for $27.7 million in cash, resulting in a pre-tax gain on the sale of $18.1 million . The Company recorded $4.8 million of income tax expense associated with this transaction during the year ended December 31, 2015. The results of Ismatec were reported in the Health & Science Technologies segment and generated $5.3 million of revenues in 2015 through the date of sale. |
Balance Sheet Components
Balance Sheet Components | 12 Months Ended |
Dec. 31, 2017 | |
Additional Financial Information Disclosure [Abstract] | |
Balance Sheet Components | Balance Sheet Components December 31, 2017 2016 (In thousands) RECEIVABLES Customers $ 297,796 $ 275,250 Other 4,134 5,641 Total 301,930 280,891 Less allowance for doubtful accounts 7,764 8,078 Total receivables — net $ 294,166 $ 272,813 INVENTORIES Raw materials and components parts $ 169,676 $ 154,278 Work in process 33,668 34,832 Finished goods 56,380 63,749 Total $ 259,724 $ 252,859 PROPERTY, PLANT AND EQUIPMENT Land and improvements $ 32,984 $ 33,883 Buildings and improvements 175,467 169,261 Machinery, equipment and other 356,728 328,779 Office and transportation equipment 96,541 98,355 Construction in progress 14,715 10,373 Total 676,435 640,651 Less accumulated depreciation and amortization 418,085 392,835 Total property, plant and equipment — net $ 258,350 $ 247,816 ACCRUED EXPENSES Payroll and related items $ 75,869 $ 67,600 Management incentive compensation 24,320 16,339 Income taxes payable 28,033 8,808 Insurance 9,424 9,416 Warranty 6,281 5,628 Deferred revenue 11,031 12,607 Restructuring 4,180 3,893 Liability for uncertain tax positions 1,745 1,366 Accrued interest 1,759 1,663 Other 22,063 25,532 Total accrued expenses $ 184,705 $ 152,852 OTHER NONCURRENT LIABILITIES Pension and retiree medical obligations $ 99,646 $ 93,604 Transition tax payable 27,877 — Liability for uncertain tax positions 1,047 2,623 Deferred revenue 3,297 2,442 Other 23,818 22,561 Total other noncurrent liabilities $ 155,685 $ 121,230 The valuation and qualifying account activity for the years ended December 31, 2017 , 2016 and 2015 is as follows: 2017 2016 2015 (In thousands) ALLOWANCE FOR DOUBTFUL ACCOUNTS (1) Beginning balance January 1 $ 8,078 $ 7,812 $ 6,961 Charged to costs and expenses, net of recoveries 720 1,425 1,556 Utilization (1,418 ) (1,585 ) (1,009 ) Currency translation and other 384 426 304 Ending balance December 31 $ 7,764 $ 8,078 $ 7,812 (1) Includes provision for doubtful accounts, sales returns and sales discounts granted to customers. |
Goodwill and Intangible Assets
Goodwill and Intangible Assets | 12 Months Ended |
Dec. 31, 2017 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Goodwill and Intangible Assets | Goodwill and Intangible Assets The changes in the carrying amount of goodwill for 2017 and 2016 , by reportable business segment, were as follows: Fluid & Metering Technologies Health & Science Technologies Fire & Safety/ Diversified Products Total (In thousands) Goodwill $ 605,491 $ 740,425 $ 251,244 $ 1,597,160 Accumulated goodwill impairment losses (20,721 ) (149,820 ) (30,090 ) (200,631 ) Balance at January 1, 2016 584,770 590,605 221,154 1,396,529 Foreign currency translation (5,951 ) (23,559 ) (7,972 ) (37,482 ) Acquisitions — 143,719 146,674 290,393 Disposition of businesses (3,759 ) (12,013 ) — (15,772 ) Acquisition adjustments (1,623 ) 547 — (1,076 ) Balance at December 31, 2016 573,437 699,299 359,856 1,632,592 Foreign currency translation 15,748 19,225 18,206 53,179 Acquisitions — 23,929 — 23,929 Disposition of business (3,121 ) — — (3,121 ) Acquisition adjustments — (2,421 ) — (2,421 ) Balance at December 31, 2017 $ 586,064 $ 740,032 $ 378,062 $ 1,704,158 ASC 350 requires that goodwill be tested for impairment at the reporting unit level on an annual basis and between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. Goodwill represents the purchase price in excess of the net amount assigned to assets acquired and liabilities assumed. Goodwill and other acquired intangible assets with indefinite lives were tested for impairment as of October 31, 2017 , the Company’s annual impairment date. In assessing the fair value of the reporting units, the Company considers both the market approach and the income approach. Under the market approach, the fair value of the reporting unit is determined by the respective trailing twelve month EBITDA and the forward looking 2018 EBITDA (50% each), based on multiples of comparable public companies. The market approach is dependent on a number of significant management assumptions including forecasted EBITDA and selected market multiples. Under the income approach, the fair value of the reporting unit is determined based on the present value of estimated future cash flows. The income approach is dependent on a number of significant management assumptions including estimates of operating results, capital expenditures, net working capital requirements, long-term growth rates and discount rates. Weighting was equally attributed to both the market and the income approaches (50% each) in arriving at the fair value of the reporting units. In 2017 and 2016 , there were no events that occurred or circumstances that changed that would have required a review other than as of our annual test date. The following table provides the gross carrying value and accumulated amortization for each major class of intangible asset at December 31, 2017 and 2016 : At December 31, 2017 At December 31, 2016 Gross Carrying Amount Accumulated Amortization Net Weighted Average Life Gross Carrying Amount Accumulated Amortization Net (In thousands) (In thousands) Amortized intangible assets: Patents $ 9,633 $ (7,143 ) $ 2,490 11 $ 9,856 $ (6,635 ) $ 3,221 Trade names 117,206 (50,604 ) 66,602 16 113,428 (42,653 ) 70,775 Customer relationships 317,316 (124,566 ) 192,750 13 369,087 (161,065 ) 208,022 Unpatented technology 91,166 (29,428 ) 61,738 13 106,747 (44,516 ) 62,231 Other 839 (573 ) 266 10 6,527 (6,172 ) 355 Total amortized intangible assets 536,160 (212,314 ) 323,846 605,645 (261,041 ) 344,604 Indefinite-lived intangible assets: Banjo trade name 62,100 — 62,100 62,100 — 62,100 Akron Brass trade name 28,800 — 28,800 28,800 — 28,800 Total intangible assets $ 627,060 $ (212,314 ) $ 414,746 $ 696,545 $ (261,041 ) $ 435,504 The Banjo trade name and the Akron Brass trade name are indefinite-lived intangible assets which are tested for impairment on an annual basis in accordance with ASC 350 or more frequently if events or changes in circumstances indicate that the assets might be impaired. The Company uses the relief-from-royalty method, a form of the income approach, to determine the fair value of these trade names. The relief-from-royalty method is dependent on a number of significant management assumptions, including estimates of revenues, royalty rates and discount rates. In 2017 and 2016 , there were no events that occurred or circumstances that changed that would have required a review other than as of our annual test date. Amortization of intangible assets was $45.9 million , $49.0 million and $42.4 million in 2017 , 2016 and 2015 , respectively. Based on the intangible asset balances as of December 31, 2017 , amortization expense is expected to approximate $38.4 million in 2018 , $35.3 million in 2019 , $34.5 million in 2020 , $33.2 million in 2021 and $31.6 million in 2022 . |
Borrowings
Borrowings | 12 Months Ended |
Dec. 31, 2017 | |
Debt Disclosure [Abstract] | |
Borrowings | Borrowings Borrowings at December 31, 2017 and 2016 consisted of the following: 2017 2016 (In thousands) Revolving Facility $ 10,740 $ 169,579 4.5% Senior Notes, due December 2020 300,000 300,000 4.2% Senior Notes, due December 2021 350,000 350,000 3.2% Senior Notes, due June 2023 100,000 100,000 3.37% Senior Notes, due June 2025 100,000 100,000 Other borrowings 1,446 1,294 Total borrowings 862,186 1,020,873 Less current portion 258 1,046 Less deferred debt issuance costs 2,204 4,399 Less unaccreted debt discount 936 1,193 Total long-term borrowings $ 858,788 $ 1,014,235 On June 13, 2016, the Company completed a private placement of $100 million aggregate principal amount of 3.20% Senior Notes due June 13, 2023 and $100 million aggregate principal amount of 3.37% Senior Notes due June 13, 2025 (collectively, the “Notes”) pursuant to a Note Purchase Agreement, dated June 13, 2016 (the “Purchase Agreement”). Each series of Notes bears interest at the stated amount per annum, which is payable semi-annually in arrears on each June 13 th and December 13 th . The Notes are unsecured obligations of the Company and rank pari passu in right of payment with all of the Company’s other unsecured, unsubordinated debt. The Company may at any time prepay all, or any portion of the Notes; provided that such portion is greater than 5% of the aggregate principal amount of Notes then outstanding. In the event of a prepayment, the Company will pay an amount equal to par plus accrued interest plus a make-whole amount. In addition, the Company may repurchase the Notes by making an offer to all holders of the Notes, subject to certain conditions. The Purchase Agreement contains certain covenants that restrict the Company’s ability to, among other things, transfer or sell assets, incur indebtedness, create liens, transact with affiliates and engage in certain mergers or consolidations or other change of control transactions. In addition, the Company must comply with a leverage ratio and interest coverage ratio, as further described below, and the Purchase Agreement also limits the outstanding principal amount of priority debt that may be incurred by the Company to 15% of consolidated assets. The Purchase Agreement provides for customary events of default. In the case of an event of default arising from specified events of bankruptcy or insolvency, all of the outstanding Notes will become due and payable immediately without further action or notice. In the case of payment event of default, any holder of the Notes affected thereby may declare all the Notes held by it due and payable immediately. In the case of any other event of default, a majority of the holders of Notes may declare all of the Notes to be due and payable immediately. On June 23, 2015, the Company entered into a credit agreement (the “Credit Agreement”) along with certain of its subsidiaries, as borrowers (the “Borrowers”), Bank of America, N.A., as administrative agent, swing line lender and an issuer of letters of credit, with other agents party thereto. The Credit Agreement replaces the Company’s existing five -year $700 million credit agreement, dated as of June 27, 2011, which was due to expire on June 27, 2016. The Credit Agreement consists of a revolving credit facility (the “Revolving Facility”) in an aggregate principal amount of $700 million , with a final maturity date of June 23, 2020 . The maturity date may be extended under certain conditions for an additional one -year term. Up to $75 million of the Revolving Facility is available for the issuance of letters of credit. Additionally, up to $50 million of the Revolving Facility is available to the Company for swing line loans, available on a same-day basis. Proceeds of the Revolving Facility are available for use by the Borrowers for acquisitions, working capital and other general corporate purposes, including refinancing existing debt of the Company and its subsidiaries. The Company may request increases in the lending commitments under the Credit Agreement, but the aggregate lending commitments pursuant to such increases may not exceed $350 million . The Company has the right, subject to certain conditions set forth in the Credit Agreement, to designate certain foreign subsidiaries of the Company as borrowers under the Credit Agreement. In connection with any such designation, the Company is required to guarantee the obligations of any such subsidiaries. Borrowings under the Credit Agreement bear interest at either an alternate base rate or an adjusted LIBOR rate plus, in each case, an applicable margin. Such applicable margin is based on the Company’s senior, unsecured, long-term debt rating and can range from .005% to 1.50% . Based on the Company’s credit rating at December 31, 2017 , the applicable margin was 1.10% . Given the fact that LIBOR was negative at December 31, 2017, the default interest rate is equal to the applicable margin, resulting in a weighted average interest rate of 1.10% at December 31, 2017 . Interest is payable (a) in the case of base rate loans, quarterly, and (b) in the case of LIBOR rate loans, on the maturity date of the borrowing, or quarterly from the effective date for borrowings exceeding three months. The Credit Agreement requires payment to the lenders of a facility fee based upon (a) the amount of the lenders’ commitments under the credit facility from time to time and (b) the applicable corporate credit ratings of the Company. Voluntary prepayments of any loans and voluntary reductions of the unutilized portion of the commitments under the credit facility are permissible without penalty, subject to break funding payments and minimum notice and minimum reduction amount requirements. The negative covenants include, among other things, limitations (each of which is subject to customary exceptions for financings of this type) on our ability to grant liens; enter into transactions resulting in fundamental changes (such as mergers or sales of all or substantially all of the assets of the Company); restrict subsidiary dividends or other subsidiary distributions; enter into transactions with the Company’s affiliates; and incur certain additional subsidiary debt. The Credit Agreement also contains customary events of default (subject to grace periods, as appropriate) including among others: nonpayment of principal, interest or fees; breach of the representations or warranties in any material respect; breach of the financial, affirmative or negative covenants; payment default on, or acceleration of, other material indebtedness; bankruptcy or insolvency; material judgments entered against the Company or any of its subsidiaries; certain specified events under the Employee Retirement Income Security Act of 1974, as amended; certain changes in control of the Company; and the invalidity or unenforceability of the Credit Agreement or other documents associated with the Credit Agreement. At December 31, 2017 , $10.7 million was outstanding under the Revolving Facility, with $7.2 million of outstanding letters of credit, resulting in net available borrowing capacity under the Revolving Facility at December 31, 2017 of approximately $682.1 million . On December 9, 2011, the Company completed a public offering of $350.0 million 4.2% senior notes due December 15, 2021 (“4.2% Senior Notes”). The net proceeds from the offering of $346.2 million , after deducting a $0.9 million issuance discount, a $2.3 million underwriting commission and $0.6 million of offering expenses, were used to repay $306.0 million of outstanding bank indebtedness, with the balance used for general corporate purposes. The 4.2% Senior Notes bear interest at a rate of 4.2% per annum, which is payable semi-annually in arrears on each June 15th and December 15th. The Company may redeem all or a portion of the 4.2% Senior Notes at any time prior to maturity at the redemption prices set forth in the Note Indenture governing the 4.2% Senior Notes. The Company may issue additional debt from time to time pursuant to the Indenture. The Indenture and 4.2% Senior Notes contain covenants that limit the Company’s ability to, among other things, incur certain liens securing indebtedness, engage in certain sale-leaseback transactions, and enter into certain consolidations, mergers, conveyances, transfers or leases of all or substantially all the Company’s assets. The terms of the 4.2% Senior Notes also require the Company to make an offer to repurchase the 4.2% Senior Notes upon a change of control triggering event (as defined in the Indenture) at a price equal to 101% of their principal amount plus accrued and unpaid interest, if any. On December 6, 2010, the Company completed a public offering of $300.0 million 4.5% senior notes due December 15, 2020 (“ 4.5% Senior Notes”). The net proceeds from the offering of $295.7 million , after deducting a $1.6 million issuance discount, a $1.9 million underwriting commission and $0.8 million of offering expenses, were used to repay $250.0 million of outstanding bank indebtedness, with the balance used for general corporate purposes. The 4.5% Senior Notes bear interest at a rate of 4.5% per annum, which is payable semi-annually in arrears on each June 15th and December 15th. The Company may redeem all or a portion of the 4.5% Senior Notes at any time prior to maturity at the redemption prices set forth in the Note Indenture governing the 4.5% Senior Notes. The Company may issue additional debt from time to time pursuant to the Indenture. The Indenture and 4.5% Senior Notes contain covenants that limit the Company’s ability to, among other things, incur certain liens securing indebtedness, engage in certain sale-leaseback transactions, and enter into certain consolidations, mergers, conveyances, transfers or leases of all or substantially all the Company’s assets. The terms of the 4.5% Senior Notes also require the Company to make an offer to repurchase the 4.5% Senior Notes upon a change of control triggering event (as defined in the Indenture) at a price equal to 101% of their principal amount plus accrued and unpaid interest, if any. There are two key financial covenants that the Company is required to maintain in connection with the Revolving Facility and the Notes, a minimum interest coverage ratio of 3.0 to 1 and a maximum leverage ratio of 3.50 to 1 , which is the ratio of the Company’s consolidated total debt to its consolidated EBITDA. At December 31, 2017 , the Company was in compliance with both of these financial covenants. There are no financial covenants relating to the 4.5% Senior Notes or 4.2% Senior Notes; however, both are subject to cross-default provisions. Total borrowings at December 31, 2017 have scheduled maturities as follows: (In thousands) 2018 $ 1,436 2019 10 2020 310,740 2021 350,000 2022 — Thereafter 200,000 Total borrowings $ 862,186 |
Derivative Instruments
Derivative Instruments | 12 Months Ended |
Dec. 31, 2017 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Derivative Instruments | Derivative Instruments The type of cash flow hedges the Company has entered into includes interest rate exchange agreements that effectively convert a portion of floating-rate debt to fixed-rate debt and are designed to reduce the impact of interest rate changes on future interest expense as well as foreign currency exchange contracts designed to minimize the earnings impact on certain intercompany loans. The effective portion of gains or losses on interest rate exchange agreements is reported in accumulated other comprehensive income (loss) in shareholders’ equity and reclassified into net income in the same period or periods in which the hedged transaction affects net income. The remaining gain or loss in excess of the cumulative change in the present value of future cash flows or the hedged item, if any, is recognized into net income during the period of change. See Note 14 for the amount of loss reclassified into income for interest rate contracts for the years ended December 31, 2017 , 2016 and 2015 . Fair values relating to derivative financial instruments reflect the estimated amounts that the Company would receive or pay to sell or buy the contracts based on quoted market prices of comparable contracts at each balance sheet date. On April 15, 2010, the Company entered into a forward starting interest rate contract with a notional amount of $300.0 million with a settlement date in December 2010. This contract was entered into in anticipation of the issuance of the 4.5% Senior Notes and was designed to lock in the market interest rate as of April 15, 2010. In December 2010, the Company settled and paid this interest rate contract for $31.0 million . The $31.0 million is being amortized into interest expense over the 10 year term of the 4.5% Senior Notes, which results in an effective interest rate of 5.8% . On July 12, 2011, the Company entered into a forward starting interest rate contract with a notional amount of $350.0 million and a settlement date of September 30, 2011 . This contract was entered into in anticipation of the issuance of the 4.2% Senior Notes and was designed to lock in the market interest rate as of July 12, 2011. On September 29, 2011, the Company settled this interest rate contract for $34.7 million with a payment made on October 3, 2011. Simultaneously, the Company entered into a separate interest rate contract with a notional amount of $350.0 million and a settlement date of February 28, 2012 . The contract was entered into in anticipation of the expected issuance of the 4.2% Senior Notes and was designed to maintain the market rate as of July 12, 2011. In December 2011, the Company settled and paid the September interest rate contract for $4.0 million , resulting in a total settlement of $38.7 million . Of the $38.7 million , $0.8 million was recognized as other expense in 2011 and the balance of $37.9 million is being amortized into interest expense over the 10 year term of the 4.2% Senior Notes, which results in an effective interest rate of 5.3% . The amount of expense reclassified into interest expense for interest rate contracts for the years ended December 31, 2017 , 2016 and 2015 is $6.7 million , $6.9 million and $7.0 million , respectively. Approximately $6.5 million of the pre-tax amount included in accumulated other comprehensive loss in shareholders’ equity at December 31, 2017 will be recognized to net income over the next 12 months as the underlying hedged transactions are realized. At December 31, 2017 , the Company had outstanding foreign currency exchange contracts with a combined notional value of €180 million that have not been designated as hedges for accounting purposes. These contracts are used to minimize the economic impact and reduce the variability on earnings due to foreign currency fluctuations between the Swiss Franc and the Euro associated with certain intercompany loans that were established in conjunction with the SFC Koenig acquisition. The change in the fair value of the foreign currency exchange contracts and the corresponding foreign currency gain or loss on the revaluation of the intercompany loans are both recorded through earnings each period as incurred within Other (income) expense - net in the Consolidated Statements of Operations. During the year ended December 31, 2017 , the Company recorded a gain of $19.8 million within Other (income) expense - net related to these foreign currency exchange contracts. During year ended December 31, 2017 , the Company recorded a foreign currency transaction loss of $20.2 million within Other (income) expense - net related to these intercompany loans. The foreign currency exchange contracts are settled in cash approximately every 90 days, with the proceeds recorded within Financing Activities on the Consolidated Statement of Cash Flows. The non-cash impact associated with the change in the amount receivable from or payable to the counter parties is recorded within Operating Activities on the Statement of Cash Flows until such time as the foreign currency exchange contracts are settled in cash. For the year ended December 31, 2017 , the Company received $13.7 million in settlement of the foreign currency exchange contracts. The Company received $6.6 million on January 5, 2018 in settlement of the foreign currency exchange contracts outstanding as of December 31, 2017. Fair values relating to derivative financial instruments reflect the estimated amounts that the Company would receive or pay to sell or buy the contracts based on quoted market prices of comparable contracts at each balance sheet date. The following table sets forth the fair value amounts of derivative instruments held by the Company as of December 31, 2017 and 2016 : Fair Value Assets (Liabilities) December 31, 2017 December 31, 2016 Balance Sheet Caption (In thousands) Foreign currency exchange contracts $ 5,779 $ — Other current assets |
Fair Value Measurements
Fair Value Measurements | 12 Months Ended |
Dec. 31, 2017 | |
Fair Value Disclosures [Abstract] | |
Fair Value Measurements | Fair Value Measurements ASC 820, Fair Value Measurements and Disclosures, defines fair value, provides guidance for measuring fair value and requires certain disclosures. This standard discusses valuation techniques, such as the market approach (comparable market prices), the income approach (present value of future income or cash flow), and the cost approach (cost to replace the service capacity of an asset or replacement cost). The standard utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels: • Level 1: Observable inputs such as quoted prices (unadjusted) in active markets for identical assets or liabilities. • Level 2: Inputs, other than quoted prices that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and quoted prices for identical or similar assets or liabilities in markets that are not active. • Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions. The following table summarizes the basis used to measure the Company’s financial assets (liabilities) at fair value on a recurring basis in the balance sheets at December 31, 2017 and 2016 : Basis of Fair Value Measurements Balance at December 31, 2017 Level 1 Level 2 Level 3 (In thousands) Available for sale securities $ 6,742 $ 6,742 $ — $ — Foreign currency exchange contracts 5,779 — 5,779 — Basis of Fair Value Measurements Balance at December 31, 2016 Level 1 Level 2 Level 3 (In thousands) Available for sale securities $ 5,369 $ 5,369 $ — $ — There were no transfers of assets or liabilities between Level 1 and Level 2 in 2017 or 2016 . The carrying value of our cash and cash equivalents, accounts receivable, accounts payable and accrued expenses approximates their fair values because of the short term nature of these instruments. At December 31, 2017 , the fair value of the outstanding indebtedness under our Revolving Facility, 3.2% Senior Notes, 3.37% Senior Notes, 4.5% Senior Notes and 4.2% Senior Notes, based on quoted market prices and current market rates for debt with similar credit risk and maturity, was approximately $886.3 million compared to the carrying value of $861.0 million . This fair value measurement is classified as Level 2 within the fair value hierarchy since it is determined based upon significant inputs observable in the market, including interest rates on recent financing transactions to entities with a credit rating similar to ours. |
Commitments and Contingencies
Commitments and Contingencies | 12 Months Ended |
Dec. 31, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments and Contingencies | Commitments and Contingencies The Company leases certain office facilities, warehouses and data processing equipment under operating leases. Rental expense totaled $19.0 million , $18.6 million and $18.9 million in 2017 , 2016 and 2015 , respectively. The aggregate future minimum lease payments for operating and capital leases as of December 31, 2017 were as follows: Operating Capital (In thousands) 2018 $ 15,992 $ 258 2019 12,064 10 2020 9,465 — 2021 6,904 — 2022 4,999 — 2023 and thereafter 15,435 — $ 64,859 $ 268 Warranty costs are provided for at the time of sale. The warranty provision is based on historical costs and adjusted for specific known claims. A rollforward of the warranty reserve is as follows: 2017 2016 2015 (In thousands) Beginning balance January 1 $ 5,628 $ 7,936 $ 7,196 Provision for warranties 2,895 1,828 4,788 Claim settlements (2,317 ) (3,539 ) (3,864 ) Other adjustments, including acquisitions, divestitures and currency translation 75 (597 ) (184 ) Ending balance December 31 $ 6,281 $ 5,628 $ 7,936 The Company and certain of its subsidiaries are involved in pending and threatened legal, regulatory and other proceedings arising in the ordinary course of business. These proceedings may pertain to matters such as product liability or contract disputes, and may also involve governmental inquiries, inspections, audits or investigations relating to issues such as tax matters, intellectual property, environmental, health and safety issues, governmental regulations, employment and other matters. Although the results of such legal proceedings cannot be predicted with certainty, the Company believes that the ultimate disposition of these matters will not have a material adverse effect, individually or in the aggregate, on the Company’s business, financial condition, results of operations or cash flows. |
Common and Preferred Stock
Common and Preferred Stock | 12 Months Ended |
Dec. 31, 2017 | |
Equity [Abstract] | |
Common and Preferred Stock | Common and Preferred Stock On December 1, 2015 the Company’s Board of Directors approved a $300.0 million increase in the authorized level for repurchases of common stock. Repurchases under the program will be funded with future cash flow generation or borrowings available under the Revolving Facility. During 2017 , the Company purchased a total of 0.3 million shares at a cost of $29.1 million , compared to 0.7 million shares purchased at a cost of $55.0 million in 2016 . As of December 31, 2017 , there was $551 million of repurchase authorization remaining. At December 31, 2017 and 2016 , the Company had 150 million shares of authorized common stock, with a par value of $.01 per share, and five million shares of authorized preferred stock, with a par value of $.01 per share. No preferred stock was issued as of December 31, 2017 and 2016 . |
Income Taxes
Income Taxes | 12 Months Ended |
Dec. 31, 2017 | |
Income Tax Disclosure [Abstract] | |
Income Taxes | Income Taxes Pretax income for 2017 , 2016 and 2015 was taxed in the following jurisdictions: 2017 2016 2015 (In thousands) U.S. $ 302,515 $ 265,260 $ 285,399 Foreign 152,758 103,252 106,946 Total $ 455,273 $ 368,512 $ 392,345 The provision (benefit) for income taxes for 2017 , 2016 and 2015 , was as follows: 2017 2016 2015 (In thousands) Current U.S. $ 91,641 $ 67,668 $ 73,059 State and local 9,342 4,503 6,188 Foreign 50,775 42,540 30,630 Total current 151,758 114,711 109,877 Deferred U.S. (36,390 ) (6,249 ) 7,125 State and local 3,305 (331 ) (1,017 ) Foreign (657 ) (10,728 ) (6,447 ) Total deferred (33,742 ) (17,308 ) (339 ) Total provision for income taxes $ 118,016 $ 97,403 $ 109,538 Deferred tax assets (liabilities) at December 31, 2017 and 2016 were: 2017 2016 (In thousands) Employee and retiree benefit plans $ 31,804 $ 42,950 Capital loss carryforwards 12,853 18,668 Depreciation and amortization (176,592 ) (238,321 ) Inventories 8,548 11,519 Allowances and accruals 4,572 9,338 Interest rate exchange agreement 5,007 10,442 Other (8,019 ) (90 ) Total gross deferred tax (liabilities) (121,827 ) (145,494 ) Capital loss valuation allowance (12,853 ) (18,668 ) Total deferred tax (liabilities), net of valuation allowances $ (134,680 ) $ (164,162 ) The deferred tax assets and liabilities recognized in the Company’s Consolidated Balance Sheets as of December 31, 2017 and 2016 were: 2017 2016 (In thousands) Noncurrent deferred tax asset — Other noncurrent assets $ 2,958 $ 2,265 Noncurrent deferred tax liabilities — Deferred income taxes (137,638 ) (166,427 ) Net deferred tax liabilities $ (134,680 ) $ (164,162 ) The Company had prepaid income taxes, recorded within Other current assets on the Consolidated Balance Sheets, of $40.9 million and $42.2 million as of December 31, 2017 and 2016, respectively. The provision for income taxes differs from the amount computed by applying the statutory federal income tax rate to pretax income. The computed amount and the differences for 2017 , 2016 and 2015 are as follows: 2017 2016 2015 (In thousands) Pretax income $ 455,273 $ 368,512 $ 392,345 Provision for income taxes Computed amount at statutory rate of 35% $ 159,346 $ 128,979 $ 137,321 State and local income tax (net of federal tax benefit) 5,841 4,070 5,033 Taxes on non-U.S. earnings-net of foreign tax credits (24,914 ) (6,666 ) (11,663 ) Effect of flow-through entities 192 (8,735 ) (8,358 ) U.S. business tax credits (1,928 ) (1,665 ) (1,273 ) Domestic activities production deduction (8,516 ) (9,043 ) (6,521 ) Deferred tax effect of foreign tax rate change — — (2,636 ) Capital loss on divestitures (2,275 ) (23,444 ) — Share-based payments (6,844 ) (6,520 ) — Valuation allowance (361 ) 17,973 — Impact of Tax Act (100 ) — — Other (2,425 ) 2,454 (2,365 ) Total provision for income taxes $ 118,016 $ 97,403 $ 109,538 On December 22, 2017, the President of the United States signed into law the Tax Cuts and Jobs Act (the “Tax Act”). The Tax Act included significant changes to the existing tax law, including, but not limited to, a permanent reduction to the U.S. federal corporate income tax rate from 35% to 21%, effective January 1, 2018, and the creation of a modified territorial tax system with a one-time repatriation tax on certain deferred foreign income (“Transition Tax”). We have estimated our provision for income taxes in accordance with the Tax Act and guidance available as of the date of this filing and as a result have recorded a net $0.1 million tax benefit in the fourth quarter of 2017, the period in which the legislation was enacted. Although the net effect from the Tax Act was a $0.1 million tax benefit, there were several offsetting adjustments, including: a $40.6 million provisional tax benefit related to the remeasurement of certain deferred tax assets and liabilities, based on the rates at which they are expected to reverse in the future; $30.3 million of provisional tax expense related to the one-time Transition Tax on the mandatory deemed repatriation of foreign earnings based on cumulative foreign earnings of $779.0 million ; and an additional $10.2 million of tax expense primarily related to the removal of the permanent reinvestment representation with respect to certain of its subsidiaries in Canada, Italy, and Germany. The Company has $350 million and $670 million of permanently reinvested earnings of non-U.S. subsidiaries as of December 31, 2017 and 2016, respectively. The significant decrease in permanently reinvested earnings of non-U.S. subsidiaries was due to the Company’s removal of its permanently reinvested assertion on select entities in Canada, Germany and Italy, mainly in response to the deemed distribution and repatriation tax incurred in 2017 as a result of the Tax Act, further described within the footnote. No deferred U.S. income taxes have been provided on the $350 million of permanently reinvested earnings, as these earnings are provisionally considered to be reinvested for an indefinite period of time, pending further evaluation of the impacts of the Tax Act on the Company. It should also be noted that, pursuant to the Tax Act, the aforementioned earnings will not incur U.S. taxes when ultimately repatriated other than potentially U.S. state and local taxes and/or U.S. federal income taxes on foreign exchange gains or losses crystallized on the distribution of such earnings. Such distributions could also be subject to additional foreign withholding and foreign income taxes. The amount of unrecognized deferred income tax liabilities on currently permanently reinvested earnings is estimated to be $8.2 million as of December 31, 2017. During the years ended December 31, 2017, 2016 and 2015 the Company repatriated $3.3 million , $28.8 million and $14.3 million of foreign earnings, respectively, exclusive of the repatriation tax distributions deemed to have been made under the Tax Act. These actual distributions resulted in $6.4 million of incremental income tax benefit, $2.7 million of incremental income tax expense and $0.3 million of incremental income tax expense, in 2017, 2016, and 2015, respectively. These repatriations represent distributions of current year earnings and distributions from liquidating subsidiaries and did not impact our representation that the undistributed earnings were permanently invested. Because the changes included in the Tax Act are broad and complex, on December 22, 2017, the SEC issued Staff Accounting Bulletin No. 118, Income Tax Accounting Implications of the Tax Cuts and Jobs Act (“SAB 118”), which provides guidance on accounting for tax effects of the Tax Act. SAB 118 provides a measurement period that should not extend beyond one year from the Tax Act enactment date for companies to complete the accounting under ASC 740. In accordance with SAB 118, a company must reflect the income tax effects of those aspects of the Tax Act for which the accounting under ASC 740 is complete. To the extent that a company’s accounting for certain income tax effects of the Tax Act is incomplete but it is able to determine a reasonable estimate, it must record a provisional estimate to be included in the financial statements. If a company cannot determine a provisional estimate to be included in the financial statements, it should continue to apply ASC 740 on the basis of the provision of the tax laws that were in effect immediately before the enactment of the Tax Act. While the Company is able to make reasonable estimates of the impact of the reduction in corporate rate and the deemed repatriation transition tax, the final impact of the Tax Act may differ from these estimates, due to, among other things, changes in the Company’s interpretations and assumptions, additional guidance that may be issued by either the Internal Revenue Service or the U.S. Department of Treasury, and actions the Company may take. The Company is continuing to gather additional information to determine the final impact. While the Company was able to make reasonable estimates of certain impacts (and therefore, recorded provisional adjustments), the Company’s accounting for the following elements of the Tax Act is incomplete: Deemed Repatriation Transition Tax : The Transition Tax is a tax on previously untaxed accumulated and current earnings and profits of certain foreign subsidiaries. To determine the amount of the Transition Tax, the Company must determine, in addition to other factors, the amount of post-1986 earnings and profits of the relevant subsidiaries, as well as the amount of non-U.S. income taxes paid on such earnings. The Company is able to make a reasonable estimate of the Transition Tax and recorded a provisional Transition Tax obligation of $30.3 million . However, the Company is continuing to gather additional information to more precisely compute the amount of Transition Tax. As of December 31, 2017, the company recorded $2.4 million of the Transition tax within accrued liabilities and the remaining $27.9 million within other noncurrent liabilities on the consolidated balance sheets based on the Company’s intention to pay these liabilities. The amount recorded within other noncurrent liabilities is included as a source of cash in Other-net within the operating activities of the Consolidated Statements of Cash Flows. Reduction of U.S. federal corporate tax rate : The Tax Act reduces the corporate tax rate to 21%, effective January 1, 2018. The Company recorded a provisional deferred income tax benefit of $40.6 million for the year ended December 31, 2017 in connection with the remeasurement of certain deferred tax assets and liabilities. While the Company is able to make a reasonable estimate of the impact of the reduction in corporate rate, it may be affected by other analyses related to the Tax Act which are still ongoing, including, but not limited to, the state tax effect of adjustments made to federal temporary differences. Removal of permanent reinvestment representation on certain undistributed foreign earnings : As a result of the enactment of the Tax Act, the Company has decided to remove the permanent reinvestment representation with respect to certain of its subsidiaries in Canada, Italy, and Germany, as of December 31, 2017. Under the mandatory repatriation provisions of the Tax Act, post-1986 undistributed earnings were taxed in the U.S. as if they were distributed before December 31, 2017. However, with the removal of the permanent reinvestment representation with respect to select subsidiaries in Canada, Italy, and Germany, the non-creditable withholding taxes and any local country taxes associated with future dividends from these subsidiaries are required to be recorded as deferred tax liabilities as of the end of 2017. The Company recorded a provisional increase in its deferred tax liability of $9.2 million , with a corresponding adjustment to deferred income tax expense of $9.2 million for the year ending December 31, 2017. The Company is considering removal of the permanent reinvestment representation with respect to its remaining subsidiaries, which it estimates would result in an additional $8.2 million increase in its deferred tax liability. Global intangible low taxed income (“GILTI”) : The Tax Act creates a new requirement that certain income (i.e. GILTI) earned by controlled foreign corporations (“CFCs”) must be included currently in the gross income of the CFC’s U.S. shareholder. GILTI is the excess of the U.S. shareholder’s “net CFC tested income” over the net deemed intangible income return, which is currently defined as the excess of (1) 10% of the aggregate of the U.S. shareholder’s pro rata share of the qualified business asset investment of each CFC with respect to which it is a U.S. shareholder over (2) the amount of certain interest expense taken into account in the determination of net CFC-tested income. In January 2018, FASB released guidance on the accounting for the GILTI tax. The guidance indicates that either accounting for deferred taxes related to GILTI tax inclusions or treating the GILTI tax as a period cost are both acceptable methods subject to an accounting policy election. Because of the complexity of the new GILTI tax rules, the Company is continuing to evaluate this provision of the Tax Act and the application of ASC 740. Therefore, the Company has not made any adjustments related to potential GILTI tax in the Company’s financial statements and has not made a policy decision regarding whether to record deferred taxes on GILTI. As a result of the enactment of the Tax Act, the Company has decided to remove the ASC 830 representation with respect to certain intercompany loans between the Company’s foreign subsidiaries. Under ASC 830, functional currency assets and liabilities are translated into U.S. dollars generally using current rates of exchange prevailing at the balance sheet date of each respective subsidiary and the related translation adjustments are recorded as a separate component of other comprehensive income. The Company has decided to remove the ASC 830 representation with respect to certain intercompany loans between the Company’s foreign subsidiaries. As a result, the Company recorded an increase in income tax expense of $1.0 million . A reconciliation of the beginning and ending amount of unrecognized tax benefits for 2017 , 2016 and 2015 is as follows: 2017 2016 2015 (In thousands) Beginning balance January 1 $ 3,775 $ 7,228 $ 3,619 Gross increase due to non-U.S. acquisitions — — 3,772 Gross increases for tax positions of prior years 537 201 1,256 Gross decreases for tax positions of prior years (587 ) (93 ) — Settlements (604 ) (2,014 ) (667 ) Lapse of statute of limitations (399 ) (1,547 ) (752 ) Ending balance December 31 $ 2,722 $ 3,775 $ 7,228 We recognize interest and penalties related to uncertain tax positions in income tax expense. As of December 31, 2017 , 2016 and 2015 , we had approximately $0.1 million , $0.1 million and $0.2 million , respectively, of accrued interest related to uncertain tax positions. As of December 31, 2017 , 2016 and 2015 , we had approximately zero , $0.1 million and $0.3 million , respectively, of accrued penalties related to uncertain tax positions. The total amount of unrecognized tax benefits that would affect our effective tax rate if recognized is $0.9 million , $1.8 million and $3.0 million as of December 31, 2017 , 2016 and 2015 , respectively. The tax years 2011-2016 remain open to examination by major taxing jurisdictions. Due to the potential for resolution of federal, state and foreign examinations, and the expiration of various statutes of limitation, it is reasonably possible that the Company’s gross unrecognized tax benefits balance may change within the next 12 months by a range of zero to $1.7 million . The Company had net operating loss and credit carryforwards related to prior acquisitions for U.S. federal purposes at December 31, 2017 and 2016 of $2.4 million and $3.5 million , respectively. The U.S. federal net operating loss and credit carryforwards are available for use against the Company’s consolidated U.S. federal taxable income and expire between 2021 and 2028. For non-U.S. purposes, the Company had net operating loss carryforwards at December 31, 2017 and 2016 of $24.5 million and $25.6 million , respectively, the majority of which relates to acquisitions. The entire balance of the non-U.S. net operating losses is available to be carried forward. At December 31, 2017 and 2016 , the Company had U.S. state net operating loss carryforwards of approximately $6.7 million and $33.1 million , respectively. If unutilized, the U.S. state net operating loss will expire between 2019 and 2037. At December 31, 2017 and 2016 , the Company recorded a valuation allowance against the deferred tax asset attributable to the U.S. state net operating loss of $0.1 million and $1.3 million , respectively. The Company had a capital loss carryover for U.S. federal purposes at December 31, 2017 and 2016 of approximately $46.0 million and $70.1 million , respectively. U.S. federal capital loss carryovers can be carried back three years and forward five years, thus, if unutilized, the U.S. federal capital loss carryover will expire in 2021. At December 31, 2017 and 2016 , the Company recorded a valuation allowance against the deferred tax asset attributable to the U.S. federal capital loss carryover of $9.7 million and $18.7 million , respectively. At December 31, 2017 and 2016 , the Company had U.S. state capital loss carryovers of approximately $62.7 million and $70.1 million , respectively. If unutilized, the U.S. state capital loss carryovers will expire between 2021 and 2031. At December 31, 2017 and 2016 , the Company recorded a valuation allowance against the deferred tax assets attributable to the U.S. state capital loss carryovers of $0.8 million and $0.7 million , respectively. At December 31, 2017 and 2016 , the Company had a foreign capital loss carryforward of approximately $14.2 million and $0.7 million , respectively. The foreign capital loss can be carried forward indefinitely. At both December 31, 2017 and 2016 , the Company has a full valuation allowance against the deferred tax asset attributable to the foreign capital loss. |
Business Segments and Geographi
Business Segments and Geographic Information | 12 Months Ended |
Dec. 31, 2017 | |
Segment Reporting [Abstract] | |
Business Segments and Geographic Information | Business Segments and Geographic Information IDEX has three reportable business segments: Fluid & Metering Technologies, Health & Science Technologies and Fire & Safety/Diversified Products. The Fluid & Metering Technologies segment designs, produces and distributes positive displacement pumps, flow meters, injectors, and other fluid-handling pump modules and systems and provides flow monitoring and other services for the food, chemical, general industrial, water & wastewater, agriculture and energy industries. The Health & Science Technologies segment designs, produces and distributes a wide range of precision fluidics, rotary lobe pumps, centrifugal and positive displacement pumps, roll compaction and drying systems used in beverage, food processing, pharmaceutical and cosmetics, pneumatic components and sealing solutions, including very high precision, low-flow rate pumping solutions required in analytical instrumentation, clinical diagnostics and drug discovery, high performance molded and extruded sealing components, biocompatible medical devices and implantables, air compressors used in medical, dental and industrial applications, optical components and coatings for applications in the fields of scientific research, defense, biotechnology, aerospace, telecommunications and electronics manufacturing, laboratory and commercial equipment used in the production of micro and nano scale materials, precision photonic solutions used in life sciences, research and defense markets, and precision gear and peristaltic pump technologies that meet exacting original equipment manufacturer specifications. The Fire & Safety/Diversified Products segment produces firefighting pumps, valves and controls, rescue tools, lifting bags and other components and systems for the fire and rescue industry, engineered stainless steel banding and clamping devices used in a variety of industrial and commercial applications, and precision equipment for dispensing, metering and mixing colorants and paints used in a variety of retail and commercial businesses around the world. Information on the Company’s business segments is presented below based on the nature of products and services offered. The Company evaluates performance based on several factors, of which sales and operating income are the primary financial measures. Intersegment sales are accounted for at fair value as if the sales were to third parties. 2017 2016 (4) 2015 (4) (In thousands) NET SALES Fluid & Metering Technologies External customers $ 880,648 $ 848,708 $ 859,945 Intersegment sales 309 393 847 Total segment sales 880,957 849,101 860,792 Health & Science Technologies External customers 819,719 744,380 737,011 Intersegment sales 412 429 1,985 Total segment sales 820,131 744,809 738,996 Fire & Safety/Diversified Products External customers 586,945 519,955 423,712 Intersegment sales 588 54 203 Total segment sales 587,533 520,009 423,915 Intersegment eliminations (1,309 ) (876 ) (3,035 ) Total net sales $ 2,287,312 $ 2,113,043 $ 2,020,668 OPERATING INCOME (LOSS) (1) Fluid & Metering Technologies $ 241,030 $ 217,500 $ 206,419 Health & Science Technologies 179,567 153,691 158,364 Fire & Safety/Diversified Products 147,028 123,605 117,346 Corporate office (2) (65,069 ) (82,399 ) (45,139 ) Total operating income 502,556 412,397 436,990 Interest expense 44,889 45,616 41,636 Other (income) expense - net 2,394 (1,731 ) 3,009 Income before taxes $ 455,273 $ 368,512 $ 392,345 2017 2016 (4) 2015 (4) (In thousands) ASSETS Fluid & Metering Technologies $ 1,101,580 $ 1,065,670 $ 1,125,266 Health & Science Technologies 1,323,373 1,266,036 1,108,302 Fire & Safety/Diversified Products 744,515 705,735 448,867 Corporate office 230,160 117,503 123,008 Total assets $ 3,399,628 $ 3,154,944 $ 2,805,443 DEPRECIATION AND AMORTIZATION (3) Fluid & Metering Technologies $ 23,587 $ 28,458 $ 27,662 Health & Science Technologies 45,287 45,298 42,827 Fire & Safety/Diversified Products 14,541 11,956 6,051 Corporate office and other 801 1,180 1,580 Total depreciation and amortization $ 84,216 $ 86,892 $ 78,120 CAPITAL EXPENDITURES Fluid & Metering Technologies $ 18,218 $ 16,389 $ 22,846 Health & Science Technologies 16,340 15,665 13,104 Fire & Safety/Diversified Products 6,363 5,945 5,804 Corporate office and other 2,937 243 2,022 Total capital expenditures $ 43,858 $ 38,242 $ 43,776 (1) Segment operating income (loss) excludes net unallocated corporate operating expenses. (2) 2017 includes a $9.3 million gain on the sale of a business, 2016 includes a $22.3 million loss on the sale of businesses - net and 2015 includes an $18.1 million gain on the sale of a business. (3) Excludes amortization of debt issuance expenses. (4) Certain amounts in the prior year income statements have been reclassified to conform with the current presentation due to the early adoption of ASU 2017-07. Information about the Company’s operations in different geographical regions for the years ended December 31, 2017 , 2016 and 2015 is shown below. Net sales were attributed to geographic areas based on location of the customer and no country outside the U.S. was greater than 10% of total revenues. 2017 2016 2015 (In thousands) NET SALES U.S. $ 1,158,889 $ 1,067,333 $ 1,015,277 North America, excluding U.S. 93,419 84,836 85,852 Europe 567,282 517,179 490,435 Asia 366,577 340,624 325,507 Other 101,145 103,071 103,597 Total net sales $ 2,287,312 $ 2,113,043 $ 2,020,668 LONG-LIVED ASSETS — PROPERTY, PLANT AND EQUIPMENT U.S. $ 145,808 $ 152,504 $ 144,508 North America, excluding U.S. 3,627 1,533 643 Europe 85,932 71,681 69,082 Asia 22,613 21,793 26,498 Other 370 305 214 Total long-lived assets — net $ 258,350 $ 247,816 $ 240,945 |
Restructuring
Restructuring | 12 Months Ended |
Dec. 31, 2017 | |
Restructuring and Related Activities [Abstract] | |
Restructuring | Restructuring During the first and fourth quarters of 2017, the fourth quarter of 2016 and the third and fourth quarters of 2015, the Company recorded restructuring costs as a part of restructuring initiatives that support the implementation of key strategic efforts designed to facilitate long-term, sustainable growth through cost reduction actions, primarily consisting of employee reductions and facility rationalization. The costs incurred related to these initiatives were included in Restructuring expenses in the Consolidated Statements of Operations while the related accruals were included in Accrued expenses in the Consolidated Balance Sheets. Severance costs primarily consisted of severance benefits through payroll continuation, COBRA subsidies, outplacement services, conditional separation costs and employer tax liabilities, while exit costs primarily consisted of asset disposals or impairments and lease exit and contract termination costs. 2017 Initiative During the fourth quarter of 2017, the Company recorded pre-tax restructuring expenses totaling $3.7 million related to the 2017 restructuring initiative. These expenses consisted of employee severance related to employee reductions across various functional areas as well as facility rationalization and contract termination costs. The 2017 restructuring initiative included severance benefits for 92 employees. Severance payments will be substantially paid by the end of 2018 using cash from operations. Pre-tax restructuring expenses by segment for the 2017 initiative were as follows: Severance Exit Costs Total (In thousands) Fluid & Metering Technologies $ 1,375 $ 433 $ 1,808 Health & Science Technologies 1,510 158 1,668 Fire & Safety/Diversified Products 182 — 182 Corporate/Other — — — Total restructuring costs $ 3,067 $ 591 $ 3,658 2016 Initiative During the first quarter of 2017, the Company recorded pre-tax restructuring expenses totaling $4.8 million related to the 2016 restructuring initiative. During the fourth quarter of 2016, the Company recorded pre-tax restructuring expenses totaling $3.7 million related to the 2016 restructuring initiative. These expenses consisted of employee severance related to employee reductions across various functional areas as well as facility rationalization costs. The 2016 restructuring initiative included severance benefits for 226 employees. Severance payments were substantially paid by the end of 2017 using cash from operations. Pre-tax restructuring expenses by segment for the 2016 initiative were as follows: 2017 2016 Severance Costs Exit Costs Total Restructuring Costs Total Restructuring Costs (In thousands) Fluid & Metering Technologies $ 1,566 $ — $ 1,566 $ 932 Health & Science Technologies 2,470 558 3,028 1,117 Fire & Safety/Diversified Products 73 — 73 1,425 Corporate/Other 130 — 130 200 Total restructuring costs $ 4,239 $ 558 $ 4,797 $ 3,674 2015 Initiative During 2015, the Company recorded pre-tax restructuring expenses totaling $11.2 million related to the 2015 restructuring initiative. These expenses consisted of employee severance related to employee reductions across various functional areas. The 2015 restructuring initiative included severance benefits for 208 employees. Severance payments were fully paid by the end of 2017 using cash from operations. Pre-tax restructuring expenses, comprised solely of severance costs, by segment for the 2015 initiative were as follows: Total Restructuring Costs (In thousands) Fluid & Metering Technologies $ 7,090 Health & Science Technologies 3,408 Fire & Safety/Diversified Products 576 Corporate/Other 165 Total restructuring costs $ 11,239 Restructuring accruals of $4.2 million and $3.9 million at December 31, 2017 and 2016 , respectively, are reflected in Accrued expenses in our Consolidated Balance Sheets as follows: Restructuring (In thousands) Balance at January 1, 2016 $ 6,636 Restructuring expenses 3,674 Payments, utilization and other (6,417 ) Balance at December 31, 2016 3,893 Restructuring expenses 8,455 Payments, utilization and other (8,168 ) Balance at December 31, 2017 $ 4,180 |
Share-Based Compensation
Share-Based Compensation | 12 Months Ended |
Dec. 31, 2017 | |
Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
Share-Based Compensation | Share-Based Compensation The Company maintains two share-based compensation plans for executives, non-employee directors and certain key employees that authorize the granting of stock options, restricted stock, performance share units, and other types of awards consistent with the purpose of the plans. The number of shares authorized for issuance under the Company’s plans as of December 31, 2017 totaled 15.6 million , of which 4.9 million shares were available for future issuance. The Company’s policy is to recognize compensation cost on a straight-line basis, assuming forfeitures, over the requisite service period for the entire award. Stock Options Stock options granted under the Company’s plans are generally non-qualified and are granted with an exercise price equal to the market price of the Company’s stock at the date of grant. The majority of the options issued to employees become exercisable in four equal installments, beginning one year from the date of grant, and generally expire 10 years from the date of grant. Stock options granted to non-employee directors cliff vest after one year . Weighted average option fair values and assumptions for the period are as follows: Years Ended December 31, 2017 2016 2015 Weighted average fair value of grants $24.19 $18.56 $20.32 Dividend yield 1.45% 1.69% 1.45% Volatility 29.41% 29.70% 29.90% Risk-free interest rate 0.83% - 3.04% 0.53% - 2.49% 0.24% - 2.82% Expected life (in years) 5.83 5.91 5.93 The assumptions are as follows: • The Company estimated volatility using its historical share price performance over the contractual term of the option. • The Company uses historical data to estimate the expected life of the option. The expected life assumption for the years ended December 31, 2017 , 2016 and 2015 is an output of the Binomial lattice option-pricing model, which incorporates vesting provisions, rate of voluntary exercise and rate of post-vesting termination over the contractual life of the option to define expected employee behavior. • The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant for periods within the contractual life of the option. For the years ended December 31, 2017 , 2016 and 2015 , we present the range of risk-free one-year forward rates, derived from the U.S. treasury yield curve, utilized in the Binomial lattice option-pricing model. • The expected dividend yield is based on the Company’s current dividend yield as the best estimate of projected dividend yield for periods within the contractual life of the option. A summary of the Company’s stock option activity as of December 31, 2017 , and changes during the year ended December 31, 2017 is presented as follows: Stock Options Shares Weighted Weighted-Average Aggregate Outstanding at January 1, 2017 1,987,946 $ 61.83 6.84 $ 56,144,876 Granted 441,990 93.48 Exercised (448,189 ) 51.17 Forfeited/Expired (57,064 ) 79.14 Outstanding at December 31, 2017 1,924,683 $ 71.07 6.87 $ 117,209,218 Vested and expected to vest at December 31, 2017 1,823,279 $ 70.26 6.77 $ 112,521,086 Exercisable at December 31, 2017 898,003 $ 57.21 5.27 $ 67,130,223 The intrinsic value for stock options outstanding and exercisable is defined as the difference between the market value of the Company’s common stock as of the end of the period and the grant price. The total intrinsic value of options exercised in 2017 , 2016 and 2015 was $26.1 million , $26.5 million and $16.9 million , respectively. In 2017 , 2016 and 2015 , cash received from options exercised was $22.9 million , $30.2 million and $19.2 million , respectively, while the actual tax benefit realized for the tax deductions from stock options exercised totaled $9.5 million , $9.6 million and $6.1 million , respectively. Total compensation cost for stock options is recorded in the Consolidated Statements of Operations as follows: Years Ended December 31, 2017 2016 2015 (In thousands) Cost of goods sold $ 428 $ 427 $ 543 Selling, general and administrative expenses 7,347 6,561 6,488 Total expense before income taxes 7,775 6,988 7,031 Income tax benefit (2,485 ) (2,213 ) (2,208 ) Total expense after income taxes $ 5,290 $ 4,775 $ 4,823 As of December 31, 2017 , there was $12.3 million of total unrecognized compensation cost related to stock options that is expected to be recognized over a weighted-average period of 1.4 years . Restricted Stock Restricted stock awards generally cliff vest after three years for employees and non-employee directors. Unvested restricted stock carries dividend and voting rights and the sale of the shares is restricted prior to the date of vesting. Dividends are paid on restricted stock awards and their fair value is equal to the market price of the Company’s stock at the date of the grant. A summary of the Company’s restricted stock activity as of December 31, 2017 , and changes during the year ending December 31, 2017 is as follows: Restricted Stock Shares Weighted-Average Unvested at January 1, 2017 217,898 $ 76.19 Granted 59,315 93.75 Vested (82,420 ) 72.42 Forfeited (12,770 ) 79.80 Unvested at December 31, 2017 182,023 $ 83.37 Total compensation cost for restricted stock is recorded in the Consolidated Statements of Operations as follows: Years Ended December 31, 2017 2016 2015 (In thousands) Cost of goods sold $ 335 $ 390 $ 341 Selling, general and administrative expenses 4,772 4,401 5,213 Total expense before income taxes 5,107 4,791 5,554 Income tax benefit (1,654 ) (1,410 ) (1,604 ) Total expense after income taxes $ 3,453 $ 3,381 $ 3,950 As of December 31, 2017 , there was $4.9 million of total unrecognized compensation cost related to restricted stock that is expected to be recognized over a weighted-average period of 1.0 year . Cash-Settled Restricted Stock The Company also maintains a cash-settled share based compensation plan for certain employees. Cash-settled restricted stock awards generally cliff vest after three years . Dividend equivalents are paid on certain cash-settled restricted stock awards. A summary of the Company’s unvested cash-settled restricted stock activity as of December 31, 2017 , and changes during the year ending December 31, 2017 is as follows: Cash-Settled Restricted Stock Shares Weighted-Average Unvested at January 1, 2017 103,790 $ 90.06 Granted 34,530 93.92 Vested (27,050 ) 92.44 Forfeited (16,540 ) 122.31 Unvested at December 31, 2017 94,730 $ 131.97 Total compensation cost for cash-settled restricted stock is recorded in the Consolidated Statements of Operations as follows: Years Ended December 31, 2017 2016 2015 (In thousands) Cost of goods sold $ 1,357 $ 764 $ 753 Selling, general and administrative expenses 3,241 2,224 1,765 Total expense before income taxes 4,598 2,988 2,518 Income tax benefit (808 ) (419 ) (355 ) Total expense after income taxes $ 3,790 $ 2,569 $ 2,163 At December 31, 2017 and 2016 , the Company has $4.5 million and $3.0 million , respectively, included in Accrued expenses in the Consolidated Balance Sheets and $3.0 million and $2.4 million , respectively, included in Other non-current liabilities. Performance Share Units Beginning in 2013 the Company granted performance share units to selected key employees that may be earned based on IDEX total shareholder return over the three-year period following the date of grant. Performance share units are expected to be made annually and are paid out at the end of a three -year period based on the Company’s performance. Performance is measured by determining the percentile rank of the total shareholder return of IDEX common stock in relation to the total shareholder return of the S&P Midcap 400 Industrial Group (for awards granted prior to 2016) or the Russell Midcap Index (for awards granted in 2016 and 2017) for the three-year period following the date of grant. The payment of awards following the three-year award period will be based on performance achieved in accordance with the scale set forth in the plan agreement and may range from 0 percent to 250 percent of the initial grant. A target payout of 100 percent is earned if total shareholder return is equal to the 50 th percentile of the peer group. Performance share units earn dividend equivalents for the award period, which will be paid to participants with the award payout at the end of the period based on the actual number of performance share units that are earned. Payments made at the end of the award period will be in the form of stock for performance share units and will be in cash for dividend equivalents. The Company’s performance share awards are considered performance condition awards and the grant date fair value of the awards, based on a Monte Carlo simulation model, is expensed ratably over the three-year term of the awards. The Company granted approximately 0.1 million of performance share units in each of 2017 , 2016 and 2015 . Weighted average performance share unit fair values and assumptions for the period specified are as follows: Years Ended December 31, 2017 2016 2015 Weighted average fair value of grants $115.74 $111.42 $95.07 Dividend yield —% —% —% Volatility 17.36% 17.99% 19.14% Risk-free interest rate 1.45% 0.89% 1.01% Expected life (in years) 2.85 2.86 2.86 The assumptions are as follows: • The Company estimated volatility using its historical share price performance over the remaining performance period as of the grant date. • The Company uses a Monte Carlo simulation model that uses an expected life commensurate with the performance period. As a result, the expected life of the performance share units was assumed to be the period from the grant date to the end of the performance period. • The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of grant with a term commensurate with the remaining performance period. • Total Shareholder Return is determined assuming that dividends are reinvested in the issuing entity over the performance period, which is mathematically equivalent to utilizing a 0% dividend yield. A summary of the Company’s performance share unit activity as of December 31, 2017 , and changes during the year ending December 31, 2017 , is as follows: Performance Share Units Shares Weighted-Average Unvested at January 1, 2017 137,055 $ 104.18 Granted 65,530 115.74 Vested (62,755 ) 95.81 Forfeited (2,960 ) 109.75 Unvested at December 31, 2017 136,870 $ 113.81 Awards that vested in 2017 will result in 143,897 shares being issued in 2018 . Total compensation cost for performance share units is as follows: Years Ended December 31, 2017 2016 2015 (In thousands) Cost of goods sold $ — $ — $ — Selling, general and administrative expenses 6,925 5,559 4,946 Total expense before income taxes 6,925 5,559 4,946 Income tax benefit (2,342 ) (1,859 ) (1,670 ) Total expense after income taxes $ 4,583 $ 3,700 $ 3,276 As of December 31, 2017 , there was $6.6 million of total unrecognized compensation cost related to performance shares that is expected to be recognized over a weighted-average period of 0.9 years . |
Other Comprehensive Income (Los
Other Comprehensive Income (Loss) | 12 Months Ended |
Dec. 31, 2017 | |
Equity [Abstract] | |
Other Comprehensive Income (Loss) | Other Comprehensive Income (Loss) The components of Other comprehensive income (loss) are as follows: For the Year Ended December 31, 2017 For the Year Ended December 31, 2016 Pre-tax Tax Net of tax Pre-tax Tax Net of tax (In thousands) Foreign currency translation adjustments Cumulative translation adjustment $ 110,421 $ — $ 110,421 $ (76,822 ) $ — $ (76,822 ) Reclassification of foreign currency translation to earnings upon sale of business 2,749 — 2,749 14,257 — 14,257 Tax effect of reversal of indefinite assertion on certain intercompany loans (3,932 ) — (3,932 ) — — — Foreign currency translation adjustments 109,238 — 109,238 (62,565 ) — (62,565 ) Pension and other postretirement adjustments Net gain (loss) arising during the year (5,355 ) 828 (4,527 ) (1,927 ) 789 (1,138 ) Amortization/recognition of settlement loss 3,814 (589 ) 3,225 7,083 (2,896 ) 4,187 Pension and other postretirement adjustments (1,541 ) 239 (1,302 ) 5,156 (2,107 ) 3,049 Reclassification adjustments for derivatives 6,655 (2,445 ) 4,210 6,851 (2,490 ) 4,361 Total other comprehensive income (loss) $ 114,352 $ (2,206 ) $ 112,146 $ (50,558 ) $ (4,597 ) $ (55,155 ) For the Year Ended December 31, 2015 Pre-tax Tax Net of tax (In thousands) Foreign currency translation adjustments Cumulative translation adjustment $ (63,441 ) $ — $ (63,441 ) Reclassification of foreign currency translation to earnings upon sale of business (4,725 ) — (4,725 ) Pension and other postretirement adjustments Net gain (loss) arising during the year 8,318 (2,411 ) 5,907 Amortization/recognition of settlement loss 4,939 (1,431 ) 3,508 Pension and other postretirement adjustments, net 13,257 (3,842 ) 9,415 Reclassification adjustments for derivatives 7,030 (2,499 ) 4,531 Total other comprehensive income (loss) $ (47,879 ) $ (6,341 ) $ (54,220 ) Amounts reclassified from accumulated other comprehensive income (loss) to net income are summarized as follows: For the Year Ended December 31, 2017 2016 2015 Income Statement Caption Foreign currency translation: Reclassification upon sale of business $ 2,749 $ 14,257 $ (4,725 ) Loss (gain) on sale of businesses - net Total before tax 2,749 14,257 (4,725 ) Provision for income taxes — — — Total net of tax $ 2,749 $ 14,257 $ (4,725 ) Pension and other postretirement plans: Amortization of service cost $ 3,580 $ 3,529 $ 4,939 Other (income) expense - net Recognition of settlement loss 234 3,554 — Other (income) expense - net Total before tax 3,814 7,083 4,939 Provision for income taxes (589 ) (2,896 ) (1,431 ) Total net of tax $ 3,225 $ 4,187 $ 3,508 Derivatives: Reclassification adjustments $ 6,655 $ 6,851 $ 7,030 Interest expense Total before tax 6,655 6,851 7,030 Provision for income taxes (2,445 ) (2,490 ) (2,499 ) Total net of tax $ 4,210 $ 4,361 $ 4,531 |
Retirement Benefits
Retirement Benefits | 12 Months Ended |
Dec. 31, 2017 | |
Retirement Benefits [Abstract] | |
Retirement Benefits | Retirement Benefits The Company sponsors several qualified and nonqualified pension plans and other postretirement plans for its employees. The Company uses a measurement date of December 31 for its defined benefit pension plans and post retirement medical plans. The Company employs the measurement date provisions of ASC 715, Compensation-Retirement Benefits , which require the measurement date of plan assets and liabilities to coincide with the sponsor’s year end. During 2016, the Company offered a voluntary lump-sum pension payment opportunity to certain terminated vested U.S. pension plan participants. Total lump-sum payments of $11.0 million were made for those participants electing to receive lump sums using pension plan assets. The Company recognized pretax settlement losses of $3.5 million in the fourth quarter of 2016 for those plans where the settlement payment exceeded the sum of the plans’ service and interest costs. The following table provides a reconciliation of the changes in the benefit obligations and fair value of plan assets over the two-year period ended December 31, 2017 , and a statement of the funded status at December 31 for both years. Pension Benefits Other Benefits 2017 2016 2017 2016 U.S. Non-U.S. U.S. Non-U.S. (In thousands) CHANGE IN BENEFIT OBLIGATION Obligation at January 1 $ 90,256 $ 87,764 $ 98,476 $ 58,063 $ 24,636 $ 20,400 Service cost 976 1,975 1,016 1,627 610 601 Interest cost 2,677 1,283 3,043 1,429 818 811 Plan amendments — — — — — — Benefits paid (6,258 ) (1,942 ) (3,140 ) (2,023 ) (738 ) (718 ) Actuarial loss (gain) 3,684 (15 ) 1,987 6,844 592 (1,990 ) Currency translation — 9,323 — (6,988 ) 150 52 Settlements — (2,452 ) (11,126 ) (819 ) — — Acquisition/Divestiture — (482 ) — 29,491 — 5,480 Other — 1,997 — 140 — — Obligation at December 31 $ 91,335 $ 97,451 $ 90,256 $ 87,764 $ 26,068 $ 24,636 CHANGE IN PLAN ASSETS Fair value of plan assets at January 1 $ 73,688 $ 32,586 $ 77,575 $ 20,645 $ — $ — Actual return on plan assets 5,046 1,792 6,740 2,470 — — Employer contributions 3,565 2,702 3,639 1,974 738 718 Benefits paid (6,258 ) (1,942 ) (3,140 ) (2,023 ) (738 ) (718 ) Currency translation — 2,446 — (4,108 ) — — Settlements — (2,452 ) (11,126 ) (819 ) — — Acquisition/Divestiture — — — 14,307 — — Other — 1,184 — 140 — — Fair value of plan assets at December 31 $ 76,041 $ 36,316 $ 73,688 $ 32,586 $ — $ — Funded status at December 31 $ (15,294 ) $ (61,135 ) $ (16,568 ) $ (55,178 ) $ (26,068 ) $ (24,636 ) COMPONENTS ON THE CONSOLIDATED BALANCE SHEETS Current liabilities $ (658 ) $ (1,159 ) $ (729 ) $ (1,005 ) $ (1,034 ) $ (1,044 ) Other noncurrent liabilities (14,636 ) (59,976 ) (15,839 ) (54,173 ) (25,034 ) (23,592 ) Net liability at December 31 $ (15,294 ) $ (61,135 ) $ (16,568 ) $ (55,178 ) $ (26,068 ) $ (24,636 ) The accumulated benefit obligation (“ABO”) for all defined benefit pension plans was $182.7 million and $176.7 million at December 31, 2017 and 2016 , respectively. The weighted average assumptions used in the measurement of the Company’s benefit obligation at December 31, 2017 and 2016 were as follows: U.S. Plans Non-U.S. Plans 2017 2016 2017 2016 Discount rate 3.46 % 3.91 % 1.82 % 1.76 % Rate of compensation increase 4.00 % 4.00 % 2.37 % 2.29 % The pretax amounts recognized in Accumulated other comprehensive income (loss) on the Consolidated Balance Sheets as of December 31, 2017 and 2016 were as follows: Pension Benefits Other Benefits 2017 2016 2017 2016 U.S. Non-U.S. U.S. Non-U.S. (In thousands) Prior service cost (credit) $ 86 $ 18 $ 110 $ 77 $ (483 ) $ (849 ) Net loss 27,789 17,986 27,860 17,643 (2,866 ) (3,852 ) Total $ 27,875 $ 18,004 $ 27,970 $ 17,720 $ (3,349 ) $ (4,701 ) The amounts in Accumulated other comprehensive income (loss) on the Consolidated Balance Sheet as of December 31, 2017 , that are expected to be recognized as components of net periodic benefit cost during 2018 are as follows: U.S. Pension Benefit Plans Non-U.S. Pension Benefit Plans Other Benefit Plans Total (In thousands) Prior service cost (credit) $ 24 $ 3 $ (366 ) $ (339 ) Net loss 2,716 1,282 (371 ) 3,627 Total $ 2,740 $ 1,285 $ (737 ) $ 3,288 The components of, and the weighted average assumptions used to determine, the net periodic benefit cost for the plans in 2017 , 2016 and 2015 are as follows: Pension Benefits 2017 2016 2015 U.S. Non-U.S. U.S. Non-U.S. U.S. Non-U.S. (In thousands) Service cost $ 976 $ 1,975 $ 1,016 $ 1,627 $ 1,279 $ 1,506 Interest cost 2,677 1,283 3,043 1,429 3,770 1,734 Expected return on plan assets (3,832 ) (1,088 ) (4,777 ) (993 ) (4,910 ) (1,114 ) Settlement loss recognized — 234 3,339 215 — — Net amortization 2,566 1,809 3,226 1,008 3,422 1,931 Net periodic benefit cost $ 2,387 $ 4,213 $ 5,847 $ 3,286 $ 3,561 $ 4,057 Other Benefits 2017 2016 2015 (In thousands) Service cost $ 610 $ 601 $ 673 Interest cost 818 811 833 Net amortization (795 ) (705 ) (414 ) Net periodic benefit cost $ 633 $ 707 $ 1,092 U.S. Plans Non-U.S. Plans 2017 2016 2015 2017 2016 2015 Discount rate 3.91 % 4.12 % 3.78 % 1.76 % 2.99 % 2.66 % Expected return on plan assets 5.50 % 6.50 % 6.50 % 3.20 % 4.58 % 5.19 % Rate of compensation increase 4.00 % 4.00 % 4.00 % 2.29 % 2.98 % 3.00 % The pretax change recognized in Accumulated other comprehensive income (loss) on the Consolidated Balance Sheet in 2017 is as follows: Pension Benefits Other U.S. Non-U.S. (In thousands) Net gain (loss) in current year $ (2,471 ) $ 318 $ (592 ) Amortization of prior service cost (credit) 24 3 (366 ) Amortization of net loss (gain) 2,542 2,040 (429 ) Exchange rate effect on amounts in OCI — (2,645 ) 35 Total $ 95 $ (284 ) $ (1,352 ) The discount rates for our plans are derived by matching the plan’s cash flows to a yield curve that provides the equivalent yields on zero-coupon bonds for each maturity. The discount rate selected is the rate that produces the same present value of cash flows. In selecting the expected rate of return on plan assets, the Company considers the historical returns and expected returns on plan assets. The expected returns are evaluated using asset return class, variance and correlation assumptions based on the plan’s target asset allocation and current market conditions. Prior service costs are amortized on a straight-line basis over the average remaining service period of active participants. Gains and losses in excess of 10% of the greater of the benefit obligation or the market value of assets are amortized over the average remaining service period of active participants. Costs of defined contribution plans were $10.2 million , $10.1 million and $10.3 million for 2017 , 2016 and 2015 , respectively. The Company, through its subsidiaries, participates in certain multi-employer pension plans covering approximately 355 participants under U.S. collective bargaining agreements. None of these plans are considered individually significant to the Company as contributions to these plans totaled $1.0 million , $1.3 million , and $1.0 million for 2017 , 2016 and 2015 , respectively. For measurement purposes, a 6.21% weighted average annual rate of increase in the per capita cost of covered health care benefits was assumed for 2017 . The rate was assumed to decrease gradually each year to a rate of 4.50% for 2038 , and remain at that level thereafter. Assumed health care cost trend rates have an effect on the amounts reported for the health care plans. A 1% increase in the assumed health care cost trend rates would increase the service and interest cost components of the net periodic benefit cost by $0.2 million and the health care component of the accumulated postretirement benefit obligation by $2.3 million . A 1% decrease in the assumed health care cost trend rate would decrease the service and interest cost components of the net periodic benefit cost by $0.1 million and the health care component of the accumulated postretirement benefit obligation by $2.0 million . Plan Assets The Company’s pension plan weighted average asset allocations at December 31, 2017 and 2016 , by asset category, were as follows: U.S. Plans Non-U.S. Plans 2017 2016 2017 2016 Equity securities 47 % 44 % 14 % 24 % Fixed income securities 51 % 43 % 30 % 26 % Cash/Commingled Funds/Other (1) 2 % 13 % 56 % 50 % Total 100 % 100 % 100 % 100 % The basis used to measure the defined benefit plans’ assets at fair value at December 31, 2017 and 2016 is summarized as follows: Basis of Fair Value Measurement Outstanding Balances Level 1 Level 2 Level 3 As of December 31, 2017 (In thousands) Equity U.S. Large Cap $ 16,402 $ 16,402 $ — $ — U.S. Small / Mid Cap 7,966 7,051 915 — International 16,844 13,205 3,639 — Fixed Income U.S. Intermediate 13,568 13,483 85 — U.S. Short Duration 13,362 13,362 — — U.S. High Yield 9,529 8,462 1,067 — International 13,311 3,767 9,544 — Other Commingled Funds (1) 16,059 — — 16,059 Cash and Equivalents 2,613 1,346 1,267 — Other 2,851 — 2,851 — $ 112,505 $ 77,078 $ 19,368 $ 16,059 (1) Other commingled funds represent pooled institutional investments in non-U.S. plans. Basis of Fair Value Measurement Outstanding Level 1 Level 2 Level 3 As of December 31, 2016 (In thousands) Equity U.S. Large Cap $ 15,345 $ 15,345 $ — $ — U.S. Small / Mid Cap 8,920 7,111 1,809 — International 16,282 10,647 5,635 — Fixed Income U.S. Intermediate 10,014 9,943 71 — U.S. Short Duration 10,160 10,160 — — U.S. High Yield 9,343 7,924 1,419 — International 10,310 3,627 6,683 — Other Commingled Funds (1) 14,180 — — 14,180 Cash and Equivalents 10,382 9,660 722 — Other 1,338 — 1,338 — $ 106,274 $ 74,417 $ 17,677 $ 14,180 Equities that are valued using quoted prices are valued at the published market prices. Equities in a common collective trust or a registered investment company that are valued using significant other observable inputs are valued at the net asset value (“NAV”) provided by the fund administrator. The NAV is based on the value of the underlying assets owned by the fund minus its liabilities. Fixed income securities that are valued using significant other observable inputs are valued at prices obtained from independent financial service industry-recognized vendors. Investment Policies and Strategies The investment objective of the plan, consistent with prudent standards for preservation of capital and maintenance of liquidity, is to earn the highest possible total rate of return consistent with the plan’s tolerance for risk. The general asset allocation guidelines for plan assets are that “equities” will constitute from 40% to 60% of the market value of total fund assets with a target of 44% , and “fixed income” obligations, including cash, will constitute from 40% to 60% with a target of 56% . The term “equities” includes common stock, convertible bonds and convertible stock. The term “fixed income” includes preferred stock and/or contractual payments with a specific maturity date. The Company strives to maintain asset allocations within the designated ranges by conducting periodic reviews of fund allocations and plan liquidity needs and rebalancing the portfolio accordingly. Diversification of assets is employed to ensure that adverse performance of one security or security class does not have an undue detrimental impact on the portfolio as a whole. Diversification is interpreted to include diversification by type, characteristic and number of investments as well as by investment style of designated investment fund managers. No restrictions are placed on the selection of individual investments by the investment fund managers. The total fund performance and the performance of the investment fund managers is reviewed on a regular basis using appointed professional independent advisors. As of December 31, 2017 and 2016 , there were no shares of the Company’s stock held in plan assets. Cash Flows The Company expects to contribute approximately $5.5 million to its defined benefit plans and $0.1 million to its other postretirement benefit plans in 2018 . The Company also expects to contribute approximately $11.0 million to its defined contribution plan and $8.5 million to its 401(k) savings plan in 2018 . Estimated Future Benefit Payments The future estimated benefit payments for the next five years and the five years thereafter are as follows: 2018 — $13.6 million ; 2019 — $11.0 million ; 2020 — $11.3 million ; 2021 — $11.0 million ; 2022 — $11.0 million ; 2022 to 2026 — $54.7 million . |
Quarterly Results of Operations
Quarterly Results of Operations (Unaudited) | 12 Months Ended |
Dec. 31, 2017 | |
Quarterly Financial Information Disclosure [Abstract] | |
Quarterly Results of Operations (Unaudited) | Quarterly Results of Operations (Unaudited) The unaudited quarterly results of operations for the years ended December 31, 2017 and 2016 are as follows: 2017 Quarters 2016 Quarters First Second Third Fourth First Second Third Fourth (In thousands, except per share amounts) Net sales $ 553,552 $ 573,366 $ 574,490 $ 585,904 $ 502,572 $ 549,696 $ 530,356 $ 530,419 Gross profit 250,941 256,925 257,930 260,882 223,335 244,058 230,889 232,485 Operating income 115,671 125,133 126,504 135,248 103,345 113,823 109,708 85,521 Net income 75,899 83,844 83,768 93,746 68,130 75,759 69,873 57,347 Basic EPS $ 0.99 $ 1.10 $ 1.09 $ 1.23 $ 0.90 $ 1.00 $ 0.92 $ 0.75 Diluted EPS $ 0.99 $ 1.08 $ 1.08 $ 1.21 $ 0.89 $ 0.99 $ 0.91 $ 0.75 Basic weighted average shares outstanding 76,115 76,220 76,309 76,283 75,749 75,690 75,819 75,955 Diluted weighted average shares outstanding 76,894 77,320 77,523 77,597 76,699 76,674 76,880 76,806 (1) Quarterly data includes acquisition of Akron Brass (March 2016), AWG Fittings (July 2016), SFC Koenig (September 2016) and thinXXS (December 2017) from the date of acquisition. Quarterly data also includes the gain/(loss) on the sale of Hydra-Stop (July 2016), CVI Japan (September 2016), IETG (October 2016), CVI Korea (December 2016) and Faure Herman (October 2017) and also the results of each divested business through the date of disposition. |
Significant Accounting Polici26
Significant Accounting Policies (Policies) | 12 Months Ended |
Dec. 31, 2017 | |
Accounting Policies [Abstract] | |
Business | Business IDEX is an applied solutions company specializing in fluid and metering technologies, health and science technologies, and fire, safety and other diversified products built to customers’ specifications. IDEX’s products are sold in niche markets to a wide range of industries throughout the world. The Company’s products include industrial pumps, compressors, flow meters, injectors and valves, and related controls for use in a wide variety of process applications; precision fluidics solutions, including pumps, valves, degassing equipment, corrective tubing, fittings, and complex manifolds, optical filters and specialty medical equipment and devices for use in life science applications; precision-engineered equipment for dispensing, metering and mixing paints; and engineered products for industrial and commercial markets, including fire and rescue, transportation equipment, oil & gas, electronics, and communications. These activities are grouped into three reportable segments: Fluid & Metering Technologies, Health & Science Technologies and Fire & Safety/Diversified Products. |
Principles of Consolidation | Principles of Consolidation The consolidated financial statements include the Company and its subsidiaries. All intercompany transactions and accounts have been eliminated. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The principal areas of estimation reflected in the financial statements are revenue recognition, sales returns and allowances, allowance for doubtful accounts, inventory valuation, recoverability of long-lived assets, income taxes, product warranties, contingencies and litigation, insurance-related items, defined benefit retirement plans and purchase accounting related to acquisitions. |
Revenue Recognition | Revenue Recognition The Company recognizes revenue when persuasive evidence of an arrangement exists, delivery has occurred, the sales price is fixed or determinable, and collectability of the sales price is reasonably assured. For product sales, delivery does not occur until the products have been shipped and risk of loss has been transferred to the customer. Revenue from services is recognized when the services are provided or ratably over the contract term. Some arrangements with customers may include multiple deliverables, including the combination of products and services. In such cases, the Company has identified these as separate elements in accordance with Accounting Standards Codification (“ASC”) 605-25, Revenue Recognition-Multiple-Element Arrangements , and recognizes revenue consistent with the policy for each separate element based on the relative selling price method. Revenues from certain long-term contracts are recognized on the percentage-of-completion method. Percentage-of-completion is measured principally by the percentage of costs incurred to date for each contract to the estimated total costs for such contract at completion. Provisions for estimated losses on uncompleted long-term contracts are made in the period in which such losses are determined. Due to uncertainties inherent in the estimation process, it is reasonably possible that completion costs, including those arising from contract penalty provisions and final contract settlements, will be revised in the near-term. Such revisions to costs and income are recognized in the period in which the revisions are determined. The Company records allowances for discounts, product returns and customer incentives at the time of sale as a reduction of revenue as such allowances can be reliably estimated based on historical experience and known trends. The Company also offers product warranties and accrues its estimated exposure for warranty claims at the time of sale based upon the length of the warranty period, warranty costs incurred and any other related information known to the Company. |
Shipping and Handling Costs | Shipping and Handling Costs Shipping and handling costs are included in Cost of sales and are recognized as a period expense during the period in which they are incurred. |
Advertising Costs | Advertising Costs Advertising costs of $15.8 million , $15.3 million and $16.1 million for 2017 , 2016 and 2015 , respectively, are expensed as incurred within Selling, general and administrative expenses. |
Cash and Cash Equivalents | Cash and Cash Equivalents The Company considers all highly liquid instruments purchased with an original maturity of 90 days or less to be cash and cash equivalents. |
Accounts Receivable and Allowance for Doubtful Accounts | Accounts Receivable and Allowance for Doubtful Accounts Accounts receivable are recorded at face amounts less an allowance for doubtful accounts. The Company maintains allowances for doubtful accounts for estimated losses as a result of customers’ inability to make required payments. Management evaluates the aging of the accounts receivable balances, the financial condition of its customers, historical trends and the time outstanding of specific balances to estimate the amount of accounts receivable that may not be collected in the future and records the appropriate provision. |
Inventories | Inventories The Company states inventories at the lower of cost or net realizable value. Cost, which includes material, labor, and factory overhead, is determined on a FIFO basis. We make adjustments to reduce the cost of inventory to its net realizable value, if required, for estimated excess, obsolescence or impaired balances. Factors influencing these adjustments include changes in market demand, product life cycle and engineering changes. |
Impairment of Long-Lived Assets | Impairment of Long-Lived Assets Long-lived assets are reviewed for impairment if an event occurs or circumstances change that would more likely than not reduce the fair value of a long-lived asset below its carrying amount, as measured by comparing their net book value to the projected undiscounted future cash flows generated by their use. A long-lived asset impairment exists when the carrying amount of the asset exceeds its fair value. The amount and timing of impairment charges for these assets require the estimation of future cash flows to determine the fair value of the related assets. Impaired assets are recorded at their estimated fair value based on a discounted cash flow analysis. |
Goodwill and Indefinite-Lived Intangible Assets | Goodwill and Indefinite-Lived Intangible Assets In accordance with ASC 350, Goodwill and Other Intangible Assets , the Company reviews the carrying value of goodwill and indefinite-lived intangible assets annually on October 31, or if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The Company evaluates the recoverability of these assets based on the estimated fair value of each of the thirteen reporting units and the indefinite-lived intangible assets. See Note 4 for a further discussion on goodwill and intangible assets. |
Borrowing Expenses | Borrowing Expenses Expenses incurred in securing and issuing debt are capitalized and included as a reduction of Long-term borrowings. These amounts are amortized over the life of the related borrowing and the related amortization is included in Interest expense. |
Earnings per Common Share | Earnings per Common Share Earnings per common share (“EPS”) is computed by dividing net income by the weighted average number of shares of common stock (basic) plus common stock equivalents (diluted) outstanding during the year. Common stock equivalents consist of stock options, which have been included in the calculation of weighted average shares outstanding using the treasury stock method, restricted stock and performance share units. ASC 260, Earnings per Share , concludes that all outstanding unvested share-based payment awards that contain rights to nonforfeitable dividends participate in undistributed earnings with common shareholders. If awards are considered participating securities, the Company is required to apply the two-class method of computing basic and diluted earnings per share. The Company has determined that its outstanding shares of restricted stock are participating securities. Accordingly, EPS was computed using the two-class method prescribed by ASC 260. |
Share-Based Compensation | Share-Based Compensation The Company accounts for share-based payments in accordance with ASC 718, Compensation-Stock Compensation . Accordingly, the Company expenses the fair value of awards made under its share-based compensation plans. That cost is recognized in the consolidated financial statements over the requisite service period of the grants. See Note 13 for further discussion on share-based compensation. |
Depreciation and Amortization | Depreciation and Amortization Property and equipment are stated at cost, with depreciation and amortization provided using the straight-line method over the following estimated useful lives: Land improvements 8 to 12 years Buildings and improvements 8 to 30 years Machinery, equipment and other 3 to 12 years Office and transportation equipment 3 to 10 years Certain identifiable intangible assets are amortized over their estimated useful lives using the straight-line method. The estimated useful lives used in the computation of amortization of identifiable intangible assets are as follows: Patents 5 to 17 years Trade names 10 to 20 years Customer relationships 6 to 20 years Unpatented technology and other 6 to 20 years |
Research and Development Expenditures | Research and Development Expenditures Costs associated with engineering activities, including research and development, are expensed in the period incurred and are included in Cost of sales. |
Foreign Currency | Foreign Currency The functional currency of substantially all operations outside the United States is the respective local currency. Accordingly, those foreign currency balance sheet accounts have been translated using the exchange rates in effect as of the balance sheet date. Income statement amounts have been translated using the average exchange rate for the year. The gains and losses resulting from changes in exchange rates from year to year have been reported in Accumulated other comprehensive loss in the Consolidated Balance Sheets. |
Income Taxes | Income Taxes Income tax expense includes United States, state, local and international income taxes. Deferred tax assets and liabilities are recognized for the tax consequences of temporary differences between the financial reporting and the tax basis of existing assets and liabilities and for loss carryforwards. The tax rate used to determine the deferred tax assets and liabilities is the enacted tax rate for the year and manner in which the differences are expected to reverse. Valuation allowances are recorded to reduce deferred tax assets to the amount that will more likely than not be realized. |
Concentration of Credit Risk | Concentration of Credit Risk The Company is not dependent on a single customer as its largest customer accounted for less than 2% of net sales for all years presented. |
New Accounting Pronouncements | Recently Adopted Accounting Standards In March 2017, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2017-07, Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost , which amends the requirements related to the income statement presentation of the components of net periodic benefit cost for a company’s sponsored defined benefit pension and other postretirement plans. Under this ASU, companies are required to disaggregate the current service cost component from the other components of net benefit cost and present it with other current compensation costs for related employees in the income statement and present the other components elsewhere in the income statement and outside of income from operations if such a subtotal is presented. This ASU also requires companies to disclose the income statement lines that contain the other components if they are not presented on appropriately described separate lines. In addition, only the service cost component of periodic net benefit cost is eligible for capitalization. The Company elected to early adopt this standard in the quarter ended March 31, 2017 as presenting the service cost within income from operations is more indicative of our current pension cost. The Company adopted this standard retrospectively and thus $6.6 million was reclassified from Selling, general and administrative expenses to Other (income) expense - net for the twelve months ended December 31, 2016, and $5.3 million was reclassified from Selling, general and administrative expenses to Other (income) expense - net for the twelve months ended December 31, 2015 to conform to current period presentation. The Company elected to apply the practical expedient that permits the use of previously disclosed service cost and other costs from the prior year’s pension and other postretirement benefit plan footnote in the comparative periods as appropriate estimates when retrospectively changing the presentation of these costs in the income statement. The Company included the required disclosures and the changes resulting from the adoption of this standard in Note 15. In January 2017, the FASB issued ASU 2017-04, Simplifying the Test for Goodwill Impairment , which eliminates Step 2 from the goodwill impairment test. Under this ASU, if the carrying amount of a reporting unit exceeds its fair value, an impairment loss will be recognized in an amount equal to the excess, limited to the total amount of goodwill allocated to the reporting unit. This ASU also eliminated the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform Step 2 of the goodwill impairment test. In addition, companies will be required to disclose the amount of goodwill allocated to each reporting unit with a zero or negative carrying amount of net assets. The Company early adopted this standard on January 1, 2017. The adoption of this standard did not have a material impact on our consolidated financial statements. In July 2015, the FASB issued ASU 2015-11, Simplifying the Measurement of Inventory . Under this guidance, entities utilizing the FIFO or average cost method should measure inventory at the lower of cost or net realizable value, where net realizable value is defined as the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The Company adopted this guidance on January 1, 2017. The adoption of this standard did not have a material impact on our consolidated financial statements. New Accounting Pronouncements In January 2017, the FASB issued ASU 2017-01, Clarifying the Definition of a Business , which clarifies the definition of a business and assists entities with evaluating whether transactions should be accounted for as acquisitions or disposals of assets or businesses. Under this guidance, when substantially all of the fair value of gross assets acquired is concentrated in a single asset or group of similar assets, the assets acquired would not represent a business. In addition, in order to be considered a business, an acquisition would have to include at a minimum an input and a substantive process that together significantly contribute to the ability to create an output. The amended guidance also narrows the definition of outputs by more closely aligning it with how outputs are described in FASB guidance for revenue recognition. This guidance is effective for interim and annual periods for the Company on January 1, 2018, with early adoption permitted. The Company does not believe the guidance will have a material impact on its consolidated financial statements. In October 2016, the FASB issued ASU 2016-16, Intra-Entity Transfers of Assets Other Than Inventory , which amends ASC 740, Income Taxes . This ASU requires that the income tax consequences of an intra-entity asset transfer other than inventory are recognized at the time of the transfer. An entity will continue to recognize the income tax consequences of an intercompany transfer of inventory when the inventory is sold to a third party. The update is effective for financial statements issued for fiscal years beginning after December 15, 2017. The ASU requires adoption on a modified-retrospective basis through a cumulative adjustment to retained earnings at the beginning of the period of adoption. The Company is currently assessing the impact that adopting this new accounting standard will have on its consolidated financial statements and footnote disclosures. In August 2016, the FASB issued ASU 2016-15, Classification of Certain Cash Receipts and Cash Payments (a consensus of the FASB Emerging Issues Task Force). This ASU addresses the following eight specific cash flow issues: Debt prepayment or debt extinguishment costs; settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing; contingent consideration payments made after a business combination; proceeds from the settlement of insurance claims; proceeds from the settlement of corporate-owned life insurance policies (including bank-owned life insurance policies); distributions received from equity method investees; beneficial interests in securitization transactions; and separately identifiable cash flows and application of the predominance principle. This standard is effective for fiscal years beginning after December 15, 2017. The Company does not believe the guidance will have a material impact on our consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, Leases , which sets out the principles for the recognition, measurement, presentation and disclosure of leases for both parties to a contract (i.e. lessees and lessors). The standard introduces a new lessee model that will require most leases to be recorded on the balance sheet and eliminates the required use of bright line tests in current U.S. GAAP for determining lease classification. The new standard requires lessors to account for leases using an approach that is substantially equivalent to existing guidance for sales-type leases, direct financing leases and operating leases. This standard is effective for fiscal years beginning after December 15, 2018 and interim periods within those fiscal years. Companies are permitted to adopt the standard early and a modified retrospective application is permitted. The new guidance requires adoption on a retrospective basis unless it is impracticable to apply, in which case the company would be required to apply the amendments prospectively as of the earliest date practicable. The Company is currently evaluating the impact of adopting the new guidance on our consolidated financial statements. In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers, which will replace numerous requirements in U.S. GAAP, including industry-specific requirements, and provide companies with a new five-step model for recognizing revenue from contracts with customers. Under ASU 2014-09, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. This ASU also requires disclosures sufficient to enable users to understand the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers, including qualitative and quantitative disclosures about contracts with customers, significant judgments and changes in judgments, and assets recognized from the costs to obtain or fulfill a contract. This standard is effective for fiscal years beginning after December 15, 2017, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption. The FASB has also issued the following standards which clarify ASU 2014-09 and have the same effective date as the original standard: ASU 2016-08, Revenue from Contracts with Customers: Principal versus Agent Considerations (Reporting Revenue Gross versus Net) ; ASU 2016-10, Revenue from Contracts with Customers: Identifying Performance Obligations and Licensing ; ASU 2016-12 , Revenue from Contracts with Customers: Narrow-Scope Improvements and Practical Expedients ; and ASU 2016-20 , Technical Corrections and Improvements to Topic 606, Revenue from Contracts with Customers. In 2016, we established an implementation team and analyzed the impact of the standard by surveying business units and reviewing contracts to identify potential differences that may result from applying the requirements of the new standard. We have completed our contract reviews. The contract reviews generally supported the recognition of revenue at a point in time, which is consistent with the current revenue recognition model used by most of our business units. As a result, we expect revenue recognition to remain substantially unchanged under the new standard. For our business units that currently recognize revenue under a percentage of completion model, we also expect revenue recognition to remain substantially unchanged as the contract reviews supported the recognition of revenue over time. The implementation team has reported these findings to the Audit Committee. The Company has implemented the appropriate changes to its processes, systems and controls to comply with the new guidance and is currently evaluating new disclosure requirements. The Company expects to adopt the standard in 2018 using the modified retrospective method and does not expect the adoption to have an impact on our consolidated financial statements. |
Significant Accounting Polici27
Significant Accounting Policies (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Accounting Policies [Abstract] | |
Schedule Of Basic Weighted Average Shares Reconciles To Diluted Weighted Average Shares | Basic weighted average shares outstanding reconciles to diluted weighted average shares outstanding as follows: 2017 2016 2015 (In thousands) Basic weighted average common shares outstanding 76,232 75,803 77,126 Dilutive effect of stock options, restricted stock and performance share units 1,101 955 846 Diluted weighted average common shares outstanding 77,333 76,758 77,972 |
Property And Equipment At Cost, Depreciation And Amortization Estimated Useful Lives | Property and equipment are stated at cost, with depreciation and amortization provided using the straight-line method over the following estimated useful lives: Land improvements 8 to 12 years Buildings and improvements 8 to 30 years Machinery, equipment and other 3 to 12 years Office and transportation equipment 3 to 10 years |
Schedule of Identifiable Intangible Assets, Useful Lives | Certain identifiable intangible assets are amortized over their estimated useful lives using the straight-line method. The estimated useful lives used in the computation of amortization of identifiable intangible assets are as follows: Patents 5 to 17 years Trade names 10 to 20 years Customer relationships 6 to 20 years Unpatented technology and other 6 to 20 years |
Acquisitions and Divestitures (
Acquisitions and Divestitures (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Business Combinations and Dispositions [Abstract] | |
Schedule of Allocation of Acquisition Costs To Assets Acquired and Liabilities Assumed | The allocation of the acquisition costs to the assets acquired and liabilities assumed, based on their estimated fair values at their respective acquisition dates, is as follows: Novotema Alfa Valvole CPS Other Total (In thousands) Accounts receivable $ 8,029 $ 13,487 $ 945 $ — $ 22,461 Inventory 2,886 11,036 442 1,102 15,466 Other assets, net of cash acquired 1,866 3,367 79 — 5,312 Property, plant and equipment 11,844 8,395 1,105 — 21,344 Goodwill 34,316 69,568 9,739 748 114,371 Intangible assets 20,011 32,058 12,290 — 64,359 Total assets acquired 78,952 137,911 24,600 1,850 243,313 Current liabilities (7,760 ) (11,279 ) (420 ) — (19,459 ) Deferred income taxes (7,803 ) (12,622 ) — — (20,425 ) Other noncurrent liabilities (2,291 ) (1,420 ) — — (3,711 ) Net assets acquired $ 61,098 $ 112,590 $ 24,180 $ 1,850 $ 199,718 The allocation of the acquisition costs to the assets acquired and liabilities assumed, based on their estimated fair values at their respective acquisition dates, is as follows: Akron Brass AWG Fittings SFC Koenig Total (In thousands) Accounts receivable $ 14,523 $ 5,867 $ 9,190 $ 29,580 Inventory 29,157 11,766 20,639 61,562 Other assets, net of cash acquired 446 565 4,501 5,512 Property, plant and equipment 12,195 6,595 4,637 23,427 Goodwill 124,643 22,055 141,298 287,996 Intangible assets 90,400 10,279 116,998 217,677 Deferred income taxes — 3,928 — 3,928 Total assets acquired 271,364 61,055 297,263 629,682 Current liabilities (7,081 ) (5,117 ) (11,704 ) (23,902 ) Deferred income taxes (36,439 ) — (36,168 ) (72,607 ) Other noncurrent liabilities (6,445 ) (8,444 ) (8,283 ) (23,172 ) Net assets acquired $ 221,399 $ 47,494 $ 241,108 $ 510,001 |
Acquired Intangible Assets and Weighted Average Amortization Periods | The acquired intangible assets and weighted average amortization periods are as follows: (In thousands, except weighted average life) Total Weighted Average Life Trade names $ 14,078 15 Customer relationships 134,519 13 Unpatented technology 40,280 13 Amortized intangible assets 188,877 Indefinite lived - Akron Brass trade name 28,800 Total acquired intangible assets $ 217,677 The acquired intangible assets and weighted average amortization periods are as follows: (In thousands, except weighted average life) Total Weighted Average Life Trade names $ 9,247 15 Customer relationships 44,401 12 Unpatented technology 10,711 8 Total acquired intangible assets $ 64,359 |
Balance Sheet Components (Table
Balance Sheet Components (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Additional Financial Information Disclosure [Abstract] | |
Balance Sheet Components | December 31, 2017 2016 (In thousands) RECEIVABLES Customers $ 297,796 $ 275,250 Other 4,134 5,641 Total 301,930 280,891 Less allowance for doubtful accounts 7,764 8,078 Total receivables — net $ 294,166 $ 272,813 INVENTORIES Raw materials and components parts $ 169,676 $ 154,278 Work in process 33,668 34,832 Finished goods 56,380 63,749 Total $ 259,724 $ 252,859 PROPERTY, PLANT AND EQUIPMENT Land and improvements $ 32,984 $ 33,883 Buildings and improvements 175,467 169,261 Machinery, equipment and other 356,728 328,779 Office and transportation equipment 96,541 98,355 Construction in progress 14,715 10,373 Total 676,435 640,651 Less accumulated depreciation and amortization 418,085 392,835 Total property, plant and equipment — net $ 258,350 $ 247,816 ACCRUED EXPENSES Payroll and related items $ 75,869 $ 67,600 Management incentive compensation 24,320 16,339 Income taxes payable 28,033 8,808 Insurance 9,424 9,416 Warranty 6,281 5,628 Deferred revenue 11,031 12,607 Restructuring 4,180 3,893 Liability for uncertain tax positions 1,745 1,366 Accrued interest 1,759 1,663 Other 22,063 25,532 Total accrued expenses $ 184,705 $ 152,852 OTHER NONCURRENT LIABILITIES Pension and retiree medical obligations $ 99,646 $ 93,604 Transition tax payable 27,877 — Liability for uncertain tax positions 1,047 2,623 Deferred revenue 3,297 2,442 Other 23,818 22,561 Total other noncurrent liabilities $ 155,685 $ 121,230 |
Valuation and Qualifying Accounts | The valuation and qualifying account activity for the years ended December 31, 2017 , 2016 and 2015 is as follows: 2017 2016 2015 (In thousands) ALLOWANCE FOR DOUBTFUL ACCOUNTS (1) Beginning balance January 1 $ 8,078 $ 7,812 $ 6,961 Charged to costs and expenses, net of recoveries 720 1,425 1,556 Utilization (1,418 ) (1,585 ) (1,009 ) Currency translation and other 384 426 304 Ending balance December 31 $ 7,764 $ 8,078 $ 7,812 (1) Includes provision for doubtful accounts, sales returns and sales discounts granted to customers. |
Goodwill and Intangible Assets
Goodwill and Intangible Assets (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |
Schedule of Changes in the Carrying Amount of Goodwill | The changes in the carrying amount of goodwill for 2017 and 2016 , by reportable business segment, were as follows: Fluid & Metering Technologies Health & Science Technologies Fire & Safety/ Diversified Products Total (In thousands) Goodwill $ 605,491 $ 740,425 $ 251,244 $ 1,597,160 Accumulated goodwill impairment losses (20,721 ) (149,820 ) (30,090 ) (200,631 ) Balance at January 1, 2016 584,770 590,605 221,154 1,396,529 Foreign currency translation (5,951 ) (23,559 ) (7,972 ) (37,482 ) Acquisitions — 143,719 146,674 290,393 Disposition of businesses (3,759 ) (12,013 ) — (15,772 ) Acquisition adjustments (1,623 ) 547 — (1,076 ) Balance at December 31, 2016 573,437 699,299 359,856 1,632,592 Foreign currency translation 15,748 19,225 18,206 53,179 Acquisitions — 23,929 — 23,929 Disposition of business (3,121 ) — — (3,121 ) Acquisition adjustments — (2,421 ) — (2,421 ) Balance at December 31, 2017 $ 586,064 $ 740,032 $ 378,062 $ 1,704,158 |
Schedule of Gross Carrying Value and Accumulated Amortization For Each Major Class of Intangible Asset | The following table provides the gross carrying value and accumulated amortization for each major class of intangible asset at December 31, 2017 and 2016 : At December 31, 2017 At December 31, 2016 Gross Carrying Amount Accumulated Amortization Net Weighted Average Life Gross Carrying Amount Accumulated Amortization Net (In thousands) (In thousands) Amortized intangible assets: Patents $ 9,633 $ (7,143 ) $ 2,490 11 $ 9,856 $ (6,635 ) $ 3,221 Trade names 117,206 (50,604 ) 66,602 16 113,428 (42,653 ) 70,775 Customer relationships 317,316 (124,566 ) 192,750 13 369,087 (161,065 ) 208,022 Unpatented technology 91,166 (29,428 ) 61,738 13 106,747 (44,516 ) 62,231 Other 839 (573 ) 266 10 6,527 (6,172 ) 355 Total amortized intangible assets 536,160 (212,314 ) 323,846 605,645 (261,041 ) 344,604 Indefinite-lived intangible assets: Banjo trade name 62,100 — 62,100 62,100 — 62,100 Akron Brass trade name 28,800 — 28,800 28,800 — 28,800 Total intangible assets $ 627,060 $ (212,314 ) $ 414,746 $ 696,545 $ (261,041 ) $ 435,504 |
Borrowings (Tables)
Borrowings (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Debt Disclosure [Abstract] | |
Schedule of Borrowings | Borrowings at December 31, 2017 and 2016 consisted of the following: 2017 2016 (In thousands) Revolving Facility $ 10,740 $ 169,579 4.5% Senior Notes, due December 2020 300,000 300,000 4.2% Senior Notes, due December 2021 350,000 350,000 3.2% Senior Notes, due June 2023 100,000 100,000 3.37% Senior Notes, due June 2025 100,000 100,000 Other borrowings 1,446 1,294 Total borrowings 862,186 1,020,873 Less current portion 258 1,046 Less deferred debt issuance costs 2,204 4,399 Less unaccreted debt discount 936 1,193 Total long-term borrowings $ 858,788 $ 1,014,235 |
Schedule of Maturities of Borrowings | Total borrowings at December 31, 2017 have scheduled maturities as follows: (In thousands) 2018 $ 1,436 2019 10 2020 310,740 2021 350,000 2022 — Thereafter 200,000 Total borrowings $ 862,186 |
Derivative Instruments (Tables)
Derivative Instruments (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |
Schedule of Derivative Instruments | The following table sets forth the fair value amounts of derivative instruments held by the Company as of December 31, 2017 and 2016 : Fair Value Assets (Liabilities) December 31, 2017 December 31, 2016 Balance Sheet Caption (In thousands) Foreign currency exchange contracts $ 5,779 $ — Other current assets |
Fair Value Measurements (Tables
Fair Value Measurements (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Fair Value Disclosures [Abstract] | |
Schedule of Company's Financial Assets and (Liabilities) at Fair Value on Recurring Basis | The following table summarizes the basis used to measure the Company’s financial assets (liabilities) at fair value on a recurring basis in the balance sheets at December 31, 2017 and 2016 : Basis of Fair Value Measurements Balance at December 31, 2017 Level 1 Level 2 Level 3 (In thousands) Available for sale securities $ 6,742 $ 6,742 $ — $ — Foreign currency exchange contracts 5,779 — 5,779 — Basis of Fair Value Measurements Balance at December 31, 2016 Level 1 Level 2 Level 3 (In thousands) Available for sale securities $ 5,369 $ 5,369 $ — $ — |
Commitments and Contingencies (
Commitments and Contingencies (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Commitments and Contingencies Disclosure [Abstract] | |
Future Minimum Lease Payments For Operating and Capital Leases | The aggregate future minimum lease payments for operating and capital leases as of December 31, 2017 were as follows: Operating Capital (In thousands) 2018 $ 15,992 $ 258 2019 12,064 10 2020 9,465 — 2021 6,904 — 2022 4,999 — 2023 and thereafter 15,435 — $ 64,859 $ 268 |
Roll Forward of the Warranty Reserve | A rollforward of the warranty reserve is as follows: 2017 2016 2015 (In thousands) Beginning balance January 1 $ 5,628 $ 7,936 $ 7,196 Provision for warranties 2,895 1,828 4,788 Claim settlements (2,317 ) (3,539 ) (3,864 ) Other adjustments, including acquisitions, divestitures and currency translation 75 (597 ) (184 ) Ending balance December 31 $ 6,281 $ 5,628 $ 7,936 |
Income Taxes (Tables)
Income Taxes (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Income Tax Disclosure [Abstract] | |
Schedule of Income Before Income Tax | Pretax income for 2017 , 2016 and 2015 was taxed in the following jurisdictions: 2017 2016 2015 (In thousands) U.S. $ 302,515 $ 265,260 $ 285,399 Foreign 152,758 103,252 106,946 Total $ 455,273 $ 368,512 $ 392,345 |
Schedule of Components of Income Tax | The provision (benefit) for income taxes for 2017 , 2016 and 2015 , was as follows: 2017 2016 2015 (In thousands) Current U.S. $ 91,641 $ 67,668 $ 73,059 State and local 9,342 4,503 6,188 Foreign 50,775 42,540 30,630 Total current 151,758 114,711 109,877 Deferred U.S. (36,390 ) (6,249 ) 7,125 State and local 3,305 (331 ) (1,017 ) Foreign (657 ) (10,728 ) (6,447 ) Total deferred (33,742 ) (17,308 ) (339 ) Total provision for income taxes $ 118,016 $ 97,403 $ 109,538 |
Schedule of Deferred Tax Assets and Liabilities | Deferred tax assets (liabilities) at December 31, 2017 and 2016 were: 2017 2016 (In thousands) Employee and retiree benefit plans $ 31,804 $ 42,950 Capital loss carryforwards 12,853 18,668 Depreciation and amortization (176,592 ) (238,321 ) Inventories 8,548 11,519 Allowances and accruals 4,572 9,338 Interest rate exchange agreement 5,007 10,442 Other (8,019 ) (90 ) Total gross deferred tax (liabilities) (121,827 ) (145,494 ) Capital loss valuation allowance (12,853 ) (18,668 ) Total deferred tax (liabilities), net of valuation allowances $ (134,680 ) $ (164,162 ) |
Schedule of Deferred Tax Assets (Liabilities) Recognized In Balance Sheets | The deferred tax assets and liabilities recognized in the Company’s Consolidated Balance Sheets as of December 31, 2017 and 2016 were: 2017 2016 (In thousands) Noncurrent deferred tax asset — Other noncurrent assets $ 2,958 $ 2,265 Noncurrent deferred tax liabilities — Deferred income taxes (137,638 ) (166,427 ) Net deferred tax liabilities $ (134,680 ) $ (164,162 ) |
Schedule of Effective Income Tax Rate Reconciliation | The provision for income taxes differs from the amount computed by applying the statutory federal income tax rate to pretax income. The computed amount and the differences for 2017 , 2016 and 2015 are as follows: 2017 2016 2015 (In thousands) Pretax income $ 455,273 $ 368,512 $ 392,345 Provision for income taxes Computed amount at statutory rate of 35% $ 159,346 $ 128,979 $ 137,321 State and local income tax (net of federal tax benefit) 5,841 4,070 5,033 Taxes on non-U.S. earnings-net of foreign tax credits (24,914 ) (6,666 ) (11,663 ) Effect of flow-through entities 192 (8,735 ) (8,358 ) U.S. business tax credits (1,928 ) (1,665 ) (1,273 ) Domestic activities production deduction (8,516 ) (9,043 ) (6,521 ) Deferred tax effect of foreign tax rate change — — (2,636 ) Capital loss on divestitures (2,275 ) (23,444 ) — Share-based payments (6,844 ) (6,520 ) — Valuation allowance (361 ) 17,973 — Impact of Tax Act (100 ) — — Other (2,425 ) 2,454 (2,365 ) Total provision for income taxes $ 118,016 $ 97,403 $ 109,538 |
Schedule of Unrecognized Tax Benefits | A reconciliation of the beginning and ending amount of unrecognized tax benefits for 2017 , 2016 and 2015 is as follows: 2017 2016 2015 (In thousands) Beginning balance January 1 $ 3,775 $ 7,228 $ 3,619 Gross increase due to non-U.S. acquisitions — — 3,772 Gross increases for tax positions of prior years 537 201 1,256 Gross decreases for tax positions of prior years (587 ) (93 ) — Settlements (604 ) (2,014 ) (667 ) Lapse of statute of limitations (399 ) (1,547 ) (752 ) Ending balance December 31 $ 2,722 $ 3,775 $ 7,228 |
Business Segments and Geograp36
Business Segments and Geographic Information (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Segment Reporting [Abstract] | |
Schedule of Information On Company's Business Segments | Information on the Company’s business segments is presented below based on the nature of products and services offered. The Company evaluates performance based on several factors, of which sales and operating income are the primary financial measures. Intersegment sales are accounted for at fair value as if the sales were to third parties. 2017 2016 (4) 2015 (4) (In thousands) NET SALES Fluid & Metering Technologies External customers $ 880,648 $ 848,708 $ 859,945 Intersegment sales 309 393 847 Total segment sales 880,957 849,101 860,792 Health & Science Technologies External customers 819,719 744,380 737,011 Intersegment sales 412 429 1,985 Total segment sales 820,131 744,809 738,996 Fire & Safety/Diversified Products External customers 586,945 519,955 423,712 Intersegment sales 588 54 203 Total segment sales 587,533 520,009 423,915 Intersegment eliminations (1,309 ) (876 ) (3,035 ) Total net sales $ 2,287,312 $ 2,113,043 $ 2,020,668 OPERATING INCOME (LOSS) (1) Fluid & Metering Technologies $ 241,030 $ 217,500 $ 206,419 Health & Science Technologies 179,567 153,691 158,364 Fire & Safety/Diversified Products 147,028 123,605 117,346 Corporate office (2) (65,069 ) (82,399 ) (45,139 ) Total operating income 502,556 412,397 436,990 Interest expense 44,889 45,616 41,636 Other (income) expense - net 2,394 (1,731 ) 3,009 Income before taxes $ 455,273 $ 368,512 $ 392,345 2017 2016 (4) 2015 (4) (In thousands) ASSETS Fluid & Metering Technologies $ 1,101,580 $ 1,065,670 $ 1,125,266 Health & Science Technologies 1,323,373 1,266,036 1,108,302 Fire & Safety/Diversified Products 744,515 705,735 448,867 Corporate office 230,160 117,503 123,008 Total assets $ 3,399,628 $ 3,154,944 $ 2,805,443 DEPRECIATION AND AMORTIZATION (3) Fluid & Metering Technologies $ 23,587 $ 28,458 $ 27,662 Health & Science Technologies 45,287 45,298 42,827 Fire & Safety/Diversified Products 14,541 11,956 6,051 Corporate office and other 801 1,180 1,580 Total depreciation and amortization $ 84,216 $ 86,892 $ 78,120 CAPITAL EXPENDITURES Fluid & Metering Technologies $ 18,218 $ 16,389 $ 22,846 Health & Science Technologies 16,340 15,665 13,104 Fire & Safety/Diversified Products 6,363 5,945 5,804 Corporate office and other 2,937 243 2,022 Total capital expenditures $ 43,858 $ 38,242 $ 43,776 (1) Segment operating income (loss) excludes net unallocated corporate operating expenses. (2) 2017 includes a $9.3 million gain on the sale of a business, 2016 includes a $22.3 million loss on the sale of businesses - net and 2015 includes an $18.1 million gain on the sale of a business. (3) Excludes amortization of debt issuance expenses. (4) Certain amounts in the prior year income statements have been reclassified to conform with the current presentation due to the early adoption of ASU 2017-07. |
Schedule of Sales From External Customers and Long-Lived Assets | Information about the Company’s operations in different geographical regions for the years ended December 31, 2017 , 2016 and 2015 is shown below. Net sales were attributed to geographic areas based on location of the customer and no country outside the U.S. was greater than 10% of total revenues. 2017 2016 2015 (In thousands) NET SALES U.S. $ 1,158,889 $ 1,067,333 $ 1,015,277 North America, excluding U.S. 93,419 84,836 85,852 Europe 567,282 517,179 490,435 Asia 366,577 340,624 325,507 Other 101,145 103,071 103,597 Total net sales $ 2,287,312 $ 2,113,043 $ 2,020,668 LONG-LIVED ASSETS — PROPERTY, PLANT AND EQUIPMENT U.S. $ 145,808 $ 152,504 $ 144,508 North America, excluding U.S. 3,627 1,533 643 Europe 85,932 71,681 69,082 Asia 22,613 21,793 26,498 Other 370 305 214 Total long-lived assets — net $ 258,350 $ 247,816 $ 240,945 |
Restructuring (Tables)
Restructuring (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Restructuring and Related Activities [Abstract] | |
Schedule of Pre-Tax Restructuring Expenses By Segment | Pre-tax restructuring expenses by segment for the 2017 initiative were as follows: Severance Exit Costs Total (In thousands) Fluid & Metering Technologies $ 1,375 $ 433 $ 1,808 Health & Science Technologies 1,510 158 1,668 Fire & Safety/Diversified Products 182 — 182 Corporate/Other — — — Total restructuring costs $ 3,067 $ 591 $ 3,658 Pre-tax restructuring expenses, comprised solely of severance costs, by segment for the 2015 initiative were as follows: Total Restructuring Costs (In thousands) Fluid & Metering Technologies $ 7,090 Health & Science Technologies 3,408 Fire & Safety/Diversified Products 576 Corporate/Other 165 Total restructuring costs $ 11,239 Pre-tax restructuring expenses by segment for the 2016 initiative were as follows: 2017 2016 Severance Costs Exit Costs Total Restructuring Costs Total Restructuring Costs (In thousands) Fluid & Metering Technologies $ 1,566 $ — $ 1,566 $ 932 Health & Science Technologies 2,470 558 3,028 1,117 Fire & Safety/Diversified Products 73 — 73 1,425 Corporate/Other 130 — 130 200 Total restructuring costs $ 4,239 $ 558 $ 4,797 $ 3,674 |
Schedule of Restructuring Accruals Expenses | Restructuring accruals of $4.2 million and $3.9 million at December 31, 2017 and 2016 , respectively, are reflected in Accrued expenses in our Consolidated Balance Sheets as follows: Restructuring (In thousands) Balance at January 1, 2016 $ 6,636 Restructuring expenses 3,674 Payments, utilization and other (6,417 ) Balance at December 31, 2016 3,893 Restructuring expenses 8,455 Payments, utilization and other (8,168 ) Balance at December 31, 2017 $ 4,180 |
Share-Based Compensation (Table
Share-Based Compensation (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Schedule of Weighted Average Option Fair Values and Assumptions | Weighted average option fair values and assumptions for the period are as follows: Years Ended December 31, 2017 2016 2015 Weighted average fair value of grants $24.19 $18.56 $20.32 Dividend yield 1.45% 1.69% 1.45% Volatility 29.41% 29.70% 29.90% Risk-free interest rate 0.83% - 3.04% 0.53% - 2.49% 0.24% - 2.82% Expected life (in years) 5.83 5.91 5.93 |
Schedule of Stock Option Activity | A summary of the Company’s stock option activity as of December 31, 2017 , and changes during the year ended December 31, 2017 is presented as follows: Stock Options Shares Weighted Weighted-Average Aggregate Outstanding at January 1, 2017 1,987,946 $ 61.83 6.84 $ 56,144,876 Granted 441,990 93.48 Exercised (448,189 ) 51.17 Forfeited/Expired (57,064 ) 79.14 Outstanding at December 31, 2017 1,924,683 $ 71.07 6.87 $ 117,209,218 Vested and expected to vest at December 31, 2017 1,823,279 $ 70.26 6.77 $ 112,521,086 Exercisable at December 31, 2017 898,003 $ 57.21 5.27 $ 67,130,223 |
Schedule of Compensation Cost for Stock Options | Total compensation cost for stock options is recorded in the Consolidated Statements of Operations as follows: Years Ended December 31, 2017 2016 2015 (In thousands) Cost of goods sold $ 428 $ 427 $ 543 Selling, general and administrative expenses 7,347 6,561 6,488 Total expense before income taxes 7,775 6,988 7,031 Income tax benefit (2,485 ) (2,213 ) (2,208 ) Total expense after income taxes $ 5,290 $ 4,775 $ 4,823 |
Schedule of Restricted Stock Activity | A summary of the Company’s restricted stock activity as of December 31, 2017 , and changes during the year ending December 31, 2017 is as follows: Restricted Stock Shares Weighted-Average Unvested at January 1, 2017 217,898 $ 76.19 Granted 59,315 93.75 Vested (82,420 ) 72.42 Forfeited (12,770 ) 79.80 Unvested at December 31, 2017 182,023 $ 83.37 |
Schedule of Compensation Cost for Restricted Stock | Total compensation cost for restricted stock is recorded in the Consolidated Statements of Operations as follows: Years Ended December 31, 2017 2016 2015 (In thousands) Cost of goods sold $ 335 $ 390 $ 341 Selling, general and administrative expenses 4,772 4,401 5,213 Total expense before income taxes 5,107 4,791 5,554 Income tax benefit (1,654 ) (1,410 ) (1,604 ) Total expense after income taxes $ 3,453 $ 3,381 $ 3,950 |
Schedule of Unvested Cash-settled Restricted Stock Activity | A summary of the Company’s unvested cash-settled restricted stock activity as of December 31, 2017 , and changes during the year ending December 31, 2017 is as follows: Cash-Settled Restricted Stock Shares Weighted-Average Unvested at January 1, 2017 103,790 $ 90.06 Granted 34,530 93.92 Vested (27,050 ) 92.44 Forfeited (16,540 ) 122.31 Unvested at December 31, 2017 94,730 $ 131.97 |
Schedule of Compensation Cost for Unvested Cash-settled Restricted Stock | Total compensation cost for cash-settled restricted stock is recorded in the Consolidated Statements of Operations as follows: Years Ended December 31, 2017 2016 2015 (In thousands) Cost of goods sold $ 1,357 $ 764 $ 753 Selling, general and administrative expenses 3,241 2,224 1,765 Total expense before income taxes 4,598 2,988 2,518 Income tax benefit (808 ) (419 ) (355 ) Total expense after income taxes $ 3,790 $ 2,569 $ 2,163 |
Schedule of Weighted Average Performance Share Units Fair Values and Assumptions | Weighted average performance share unit fair values and assumptions for the period specified are as follows: Years Ended December 31, 2017 2016 2015 Weighted average fair value of grants $115.74 $111.42 $95.07 Dividend yield —% —% —% Volatility 17.36% 17.99% 19.14% Risk-free interest rate 1.45% 0.89% 1.01% Expected life (in years) 2.85 2.86 2.86 |
Schedule of Performance Shares Units Activity | A summary of the Company’s performance share unit activity as of December 31, 2017 , and changes during the year ending December 31, 2017 , is as follows: Performance Share Units Shares Weighted-Average Unvested at January 1, 2017 137,055 $ 104.18 Granted 65,530 115.74 Vested (62,755 ) 95.81 Forfeited (2,960 ) 109.75 Unvested at December 31, 2017 136,870 $ 113.81 |
Performance Shares Units | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs | Total compensation cost for performance share units is as follows: Years Ended December 31, 2017 2016 2015 (In thousands) Cost of goods sold $ — $ — $ — Selling, general and administrative expenses 6,925 5,559 4,946 Total expense before income taxes 6,925 5,559 4,946 Income tax benefit (2,342 ) (1,859 ) (1,670 ) Total expense after income taxes $ 4,583 $ 3,700 $ 3,276 |
Other Comprehensive Income (L39
Other Comprehensive Income (Loss) (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Equity [Abstract] | |
Schedule of Accumulated Other Comprehensive Income (Loss) | The components of Other comprehensive income (loss) are as follows: For the Year Ended December 31, 2017 For the Year Ended December 31, 2016 Pre-tax Tax Net of tax Pre-tax Tax Net of tax (In thousands) Foreign currency translation adjustments Cumulative translation adjustment $ 110,421 $ — $ 110,421 $ (76,822 ) $ — $ (76,822 ) Reclassification of foreign currency translation to earnings upon sale of business 2,749 — 2,749 14,257 — 14,257 Tax effect of reversal of indefinite assertion on certain intercompany loans (3,932 ) — (3,932 ) — — — Foreign currency translation adjustments 109,238 — 109,238 (62,565 ) — (62,565 ) Pension and other postretirement adjustments Net gain (loss) arising during the year (5,355 ) 828 (4,527 ) (1,927 ) 789 (1,138 ) Amortization/recognition of settlement loss 3,814 (589 ) 3,225 7,083 (2,896 ) 4,187 Pension and other postretirement adjustments (1,541 ) 239 (1,302 ) 5,156 (2,107 ) 3,049 Reclassification adjustments for derivatives 6,655 (2,445 ) 4,210 6,851 (2,490 ) 4,361 Total other comprehensive income (loss) $ 114,352 $ (2,206 ) $ 112,146 $ (50,558 ) $ (4,597 ) $ (55,155 ) For the Year Ended December 31, 2015 Pre-tax Tax Net of tax (In thousands) Foreign currency translation adjustments Cumulative translation adjustment $ (63,441 ) $ — $ (63,441 ) Reclassification of foreign currency translation to earnings upon sale of business (4,725 ) — (4,725 ) Pension and other postretirement adjustments Net gain (loss) arising during the year 8,318 (2,411 ) 5,907 Amortization/recognition of settlement loss 4,939 (1,431 ) 3,508 Pension and other postretirement adjustments, net 13,257 (3,842 ) 9,415 Reclassification adjustments for derivatives 7,030 (2,499 ) 4,531 Total other comprehensive income (loss) $ (47,879 ) $ (6,341 ) $ (54,220 ) |
Reclassification out of Accumulated Other Comprehensive Income | Amounts reclassified from accumulated other comprehensive income (loss) to net income are summarized as follows: For the Year Ended December 31, 2017 2016 2015 Income Statement Caption Foreign currency translation: Reclassification upon sale of business $ 2,749 $ 14,257 $ (4,725 ) Loss (gain) on sale of businesses - net Total before tax 2,749 14,257 (4,725 ) Provision for income taxes — — — Total net of tax $ 2,749 $ 14,257 $ (4,725 ) Pension and other postretirement plans: Amortization of service cost $ 3,580 $ 3,529 $ 4,939 Other (income) expense - net Recognition of settlement loss 234 3,554 — Other (income) expense - net Total before tax 3,814 7,083 4,939 Provision for income taxes (589 ) (2,896 ) (1,431 ) Total net of tax $ 3,225 $ 4,187 $ 3,508 Derivatives: Reclassification adjustments $ 6,655 $ 6,851 $ 7,030 Interest expense Total before tax 6,655 6,851 7,030 Provision for income taxes (2,445 ) (2,490 ) (2,499 ) Total net of tax $ 4,210 $ 4,361 $ 4,531 |
Retirement Benefits (Tables)
Retirement Benefits (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Defined Benefit Plan Disclosure [Line Items] | |
Reconciliation of Changes in Benefit Obligations and Fair Value of Plan Assets | The following table provides a reconciliation of the changes in the benefit obligations and fair value of plan assets over the two-year period ended December 31, 2017 , and a statement of the funded status at December 31 for both years. Pension Benefits Other Benefits 2017 2016 2017 2016 U.S. Non-U.S. U.S. Non-U.S. (In thousands) CHANGE IN BENEFIT OBLIGATION Obligation at January 1 $ 90,256 $ 87,764 $ 98,476 $ 58,063 $ 24,636 $ 20,400 Service cost 976 1,975 1,016 1,627 610 601 Interest cost 2,677 1,283 3,043 1,429 818 811 Plan amendments — — — — — — Benefits paid (6,258 ) (1,942 ) (3,140 ) (2,023 ) (738 ) (718 ) Actuarial loss (gain) 3,684 (15 ) 1,987 6,844 592 (1,990 ) Currency translation — 9,323 — (6,988 ) 150 52 Settlements — (2,452 ) (11,126 ) (819 ) — — Acquisition/Divestiture — (482 ) — 29,491 — 5,480 Other — 1,997 — 140 — — Obligation at December 31 $ 91,335 $ 97,451 $ 90,256 $ 87,764 $ 26,068 $ 24,636 CHANGE IN PLAN ASSETS Fair value of plan assets at January 1 $ 73,688 $ 32,586 $ 77,575 $ 20,645 $ — $ — Actual return on plan assets 5,046 1,792 6,740 2,470 — — Employer contributions 3,565 2,702 3,639 1,974 738 718 Benefits paid (6,258 ) (1,942 ) (3,140 ) (2,023 ) (738 ) (718 ) Currency translation — 2,446 — (4,108 ) — — Settlements — (2,452 ) (11,126 ) (819 ) — — Acquisition/Divestiture — — — 14,307 — — Other — 1,184 — 140 — — Fair value of plan assets at December 31 $ 76,041 $ 36,316 $ 73,688 $ 32,586 $ — $ — Funded status at December 31 $ (15,294 ) $ (61,135 ) $ (16,568 ) $ (55,178 ) $ (26,068 ) $ (24,636 ) COMPONENTS ON THE CONSOLIDATED BALANCE SHEETS Current liabilities $ (658 ) $ (1,159 ) $ (729 ) $ (1,005 ) $ (1,034 ) $ (1,044 ) Other noncurrent liabilities (14,636 ) (59,976 ) (15,839 ) (54,173 ) (25,034 ) (23,592 ) Net liability at December 31 $ (15,294 ) $ (61,135 ) $ (16,568 ) $ (55,178 ) $ (26,068 ) $ (24,636 ) |
Weighted Average Assumptions Used in Measurement of Benefit Obligation | The weighted average assumptions used in the measurement of the Company’s benefit obligation at December 31, 2017 and 2016 were as follows: U.S. Plans Non-U.S. Plans 2017 2016 2017 2016 Discount rate 3.46 % 3.91 % 1.82 % 1.76 % Rate of compensation increase 4.00 % 4.00 % 2.37 % 2.29 % |
Pretax Amounts Recognized in Accumulated Other Comprehensive Income (Loss) | The pretax amounts recognized in Accumulated other comprehensive income (loss) on the Consolidated Balance Sheets as of December 31, 2017 and 2016 were as follows: Pension Benefits Other Benefits 2017 2016 2017 2016 U.S. Non-U.S. U.S. Non-U.S. (In thousands) Prior service cost (credit) $ 86 $ 18 $ 110 $ 77 $ (483 ) $ (849 ) Net loss 27,789 17,986 27,860 17,643 (2,866 ) (3,852 ) Total $ 27,875 $ 18,004 $ 27,970 $ 17,720 $ (3,349 ) $ (4,701 ) |
Amounts in Accumulated Other Comprehensive Income (Loss) Expected to Be Recognized as Components of Net Periodic Benefit Cost During 2012 | The amounts in Accumulated other comprehensive income (loss) on the Consolidated Balance Sheet as of December 31, 2017 , that are expected to be recognized as components of net periodic benefit cost during 2018 are as follows: U.S. Pension Benefit Plans Non-U.S. Pension Benefit Plans Other Benefit Plans Total (In thousands) Prior service cost (credit) $ 24 $ 3 $ (366 ) $ (339 ) Net loss 2,716 1,282 (371 ) 3,627 Total $ 2,740 $ 1,285 $ (737 ) $ 3,288 |
Weighted Average Assumptions Used to Determine Net Periodic Benefit Cost of Plans | U.S. Plans Non-U.S. Plans 2017 2016 2015 2017 2016 2015 Discount rate 3.91 % 4.12 % 3.78 % 1.76 % 2.99 % 2.66 % Expected return on plan assets 5.50 % 6.50 % 6.50 % 3.20 % 4.58 % 5.19 % Rate of compensation increase 4.00 % 4.00 % 4.00 % 2.29 % 2.98 % 3.00 % |
Pension Plan Weighted Average Asset Allocations | The Company’s pension plan weighted average asset allocations at December 31, 2017 and 2016 , by asset category, were as follows: U.S. Plans Non-U.S. Plans 2017 2016 2017 2016 Equity securities 47 % 44 % 14 % 24 % Fixed income securities 51 % 43 % 30 % 26 % Cash/Commingled Funds/Other (1) 2 % 13 % 56 % 50 % Total 100 % 100 % 100 % 100 % |
Summary of Basis Used to Measure Defined Benefit Plans' Assets at Fair Value | The basis used to measure the defined benefit plans’ assets at fair value at December 31, 2017 and 2016 is summarized as follows: Basis of Fair Value Measurement Outstanding Balances Level 1 Level 2 Level 3 As of December 31, 2017 (In thousands) Equity U.S. Large Cap $ 16,402 $ 16,402 $ — $ — U.S. Small / Mid Cap 7,966 7,051 915 — International 16,844 13,205 3,639 — Fixed Income U.S. Intermediate 13,568 13,483 85 — U.S. Short Duration 13,362 13,362 — — U.S. High Yield 9,529 8,462 1,067 — International 13,311 3,767 9,544 — Other Commingled Funds (1) 16,059 — — 16,059 Cash and Equivalents 2,613 1,346 1,267 — Other 2,851 — 2,851 — $ 112,505 $ 77,078 $ 19,368 $ 16,059 (1) Other commingled funds represent pooled institutional investments in non-U.S. plans. Basis of Fair Value Measurement Outstanding Level 1 Level 2 Level 3 As of December 31, 2016 (In thousands) Equity U.S. Large Cap $ 15,345 $ 15,345 $ — $ — U.S. Small / Mid Cap 8,920 7,111 1,809 — International 16,282 10,647 5,635 — Fixed Income U.S. Intermediate 10,014 9,943 71 — U.S. Short Duration 10,160 10,160 — — U.S. High Yield 9,343 7,924 1,419 — International 10,310 3,627 6,683 — Other Commingled Funds (1) 14,180 — — 14,180 Cash and Equivalents 10,382 9,660 722 — Other 1,338 — 1,338 — $ 106,274 $ 74,417 $ 17,677 $ 14,180 |
Net Periodic Benefit Cost | |
Defined Benefit Plan Disclosure [Line Items] | |
Pretax Amounts Recognized in Accumulated Other Comprehensive Income (Loss) | The pretax change recognized in Accumulated other comprehensive income (loss) on the Consolidated Balance Sheet in 2017 is as follows: Pension Benefits Other U.S. Non-U.S. (In thousands) Net gain (loss) in current year $ (2,471 ) $ 318 $ (592 ) Amortization of prior service cost (credit) 24 3 (366 ) Amortization of net loss (gain) 2,542 2,040 (429 ) Exchange rate effect on amounts in OCI — (2,645 ) 35 Total $ 95 $ (284 ) $ (1,352 ) |
Pension Benefit Plan | |
Defined Benefit Plan Disclosure [Line Items] | |
Components of Net Periodic Benefit Cost for Defined Benefit Plans and Other Postretirement Plans | The components of, and the weighted average assumptions used to determine, the net periodic benefit cost for the plans in 2017 , 2016 and 2015 are as follows: Pension Benefits 2017 2016 2015 U.S. Non-U.S. U.S. Non-U.S. U.S. Non-U.S. (In thousands) Service cost $ 976 $ 1,975 $ 1,016 $ 1,627 $ 1,279 $ 1,506 Interest cost 2,677 1,283 3,043 1,429 3,770 1,734 Expected return on plan assets (3,832 ) (1,088 ) (4,777 ) (993 ) (4,910 ) (1,114 ) Settlement loss recognized — 234 3,339 215 — — Net amortization 2,566 1,809 3,226 1,008 3,422 1,931 Net periodic benefit cost $ 2,387 $ 4,213 $ 5,847 $ 3,286 $ 3,561 $ 4,057 |
Other Benefit Plans | |
Defined Benefit Plan Disclosure [Line Items] | |
Components of Net Periodic Benefit Cost for Defined Benefit Plans and Other Postretirement Plans | Other Benefits 2017 2016 2015 (In thousands) Service cost $ 610 $ 601 $ 673 Interest cost 818 811 833 Net amortization (795 ) (705 ) (414 ) Net periodic benefit cost $ 633 $ 707 $ 1,092 |
Quarterly Results of Operatio41
Quarterly Results of Operations (Unaudited) (Tables) | 12 Months Ended |
Dec. 31, 2017 | |
Quarterly Financial Information Disclosure [Abstract] | |
Summarized Quarterly Results of Operations | The unaudited quarterly results of operations for the years ended December 31, 2017 and 2016 are as follows: 2017 Quarters 2016 Quarters First Second Third Fourth First Second Third Fourth (In thousands, except per share amounts) Net sales $ 553,552 $ 573,366 $ 574,490 $ 585,904 $ 502,572 $ 549,696 $ 530,356 $ 530,419 Gross profit 250,941 256,925 257,930 260,882 223,335 244,058 230,889 232,485 Operating income 115,671 125,133 126,504 135,248 103,345 113,823 109,708 85,521 Net income 75,899 83,844 83,768 93,746 68,130 75,759 69,873 57,347 Basic EPS $ 0.99 $ 1.10 $ 1.09 $ 1.23 $ 0.90 $ 1.00 $ 0.92 $ 0.75 Diluted EPS $ 0.99 $ 1.08 $ 1.08 $ 1.21 $ 0.89 $ 0.99 $ 0.91 $ 0.75 Basic weighted average shares outstanding 76,115 76,220 76,309 76,283 75,749 75,690 75,819 75,955 Diluted weighted average shares outstanding 76,894 77,320 77,523 77,597 76,699 76,674 76,880 76,806 (1) Quarterly data includes acquisition of Akron Brass (March 2016), AWG Fittings (July 2016), SFC Koenig (September 2016) and thinXXS (December 2017) from the date of acquisition. Quarterly data also includes the gain/(loss) on the sale of Hydra-Stop (July 2016), CVI Japan (September 2016), IETG (October 2016), CVI Korea (December 2016) and Faure Herman (October 2017) and also the results of each divested business through the date of disposition. |
Significant Accounting Polici42
Significant Accounting Policies - Additional Information (Details) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017USD ($)unitsegmentshares | Dec. 31, 2016USD ($)shares | Dec. 31, 2015USD ($)shares | |
Accounting Policies [Abstract] | |||
Number of reportable segments | segment | 3 | ||
Advertising costs | $ 15,800 | $ 15,300 | $ 16,100 |
Asset impairments | $ 0 | $ 205 | $ 795 |
Number of reporting units | unit | 13 | ||
Option to purchase common stock shares not included in the computation of diluted EPS (in shares) | shares | 0 | 900,000 | 900,000 |
Engineering expense | $ 76,400 | $ 68,800 | $ 61,200 |
Research and development expense | 42,400 | 39,400 | 33,600 |
Business Combination, Separately Recognized Transactions [Line Items] | |||
Foreign currency transaction (gain) loss | $ 20,500 | (6,200) | (100) |
Percentage of concentration risk | 2.00% | ||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Other (income) expense - net | $ (2,394) | 1,731 | (3,009) |
Selling, general and administrative expenses | (524,940) | (492,398) | (474,156) |
SFC-Koenig | |||
Business Combination, Separately Recognized Transactions [Line Items] | |||
Foreign currency transaction (gain) loss | $ 20,200 | ||
Accounting Standards Update 2017-17 | New Accounting Pronouncement, Early Adoption, Effect | |||
New Accounting Pronouncements or Change in Accounting Principle [Line Items] | |||
Other (income) expense - net | 6,600 | 5,300 | |
Selling, general and administrative expenses | $ 6,600 | $ 5,300 |
Significant Accounting Polici43
Significant Accounting Policies - Schedule of Basic Weighted Average Shares Reconciles to Diluted Weighted Average Shares Outstanding (Details) - shares shares in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2017 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2016 | Mar. 31, 2016 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Accounting Policies [Abstract] | |||||||||||
Basic weighted average common shares outstanding | 76,283 | 76,309 | 76,220 | 76,115 | 75,955 | 75,819 | 75,690 | 75,749 | 76,232 | 75,803 | 77,126 |
Dilutive effect of stock options, restricted stock and performance share units | 1,101 | 955 | 846 | ||||||||
Diluted weighted average common shares outstanding | 77,597 | 77,523 | 77,320 | 76,894 | 76,806 | 76,880 | 76,674 | 76,699 | 77,333 | 76,758 | 77,972 |
Significant Accounting Polici44
Significant Accounting Policies - Property And Equipment at Cost Depreciation and Amortization Estimated Useful Lives (Details) | 12 Months Ended |
Dec. 31, 2017 | |
Land improvements | Minimum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 8 years |
Land improvements | Maximum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 12 years |
Buildings and improvements | Minimum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 8 years |
Buildings and improvements | Maximum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 30 years |
Machinery, equipment and other | Minimum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 3 years |
Machinery, equipment and other | Maximum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 12 years |
Office and transportation equipment | Minimum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 3 years |
Office and transportation equipment | Maximum | |
Property, Plant and Equipment [Line Items] | |
Estimated useful life | 10 years |
Significant Accounting Polici45
Significant Accounting Policies - Intangible Asset Depreciation and Amortization Estimated Useful Lives (Details) | 12 Months Ended |
Dec. 31, 2017 | |
Patents | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 11 years |
Patents | Minimum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 5 years |
Patents | Maximum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 17 years |
Trade Names | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 16 years |
Trade Names | Minimum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 10 years |
Trade Names | Maximum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 20 years |
Customer Relationships | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 13 years |
Customer Relationships | Minimum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 6 years |
Customer Relationships | Maximum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 20 years |
Unpatented technology and other | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 13 years |
Unpatented technology and other | Minimum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 6 years |
Unpatented technology and other | Maximum | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated useful life | 20 years |
Acquisitions and Divestitures -
Acquisitions and Divestitures - Additional Information (Details) $ in Thousands, € in Millions | Dec. 08, 2017USD ($) | Aug. 31, 2016EUR (€) | Aug. 31, 2016USD ($) | Jul. 01, 2016EUR (€) | Jul. 01, 2016USD ($) | Mar. 16, 2016USD ($) | Dec. 01, 2015USD ($) | Jul. 01, 2015USD ($) | Jun. 10, 2015EUR (€) | Jun. 10, 2015USD ($) | May 29, 2015EUR (€) | May 29, 2015USD ($) | Jun. 30, 2016USD ($) | Mar. 31, 2016USD ($) | Dec. 31, 2017USD ($) | Sep. 30, 2017USD ($) | Jun. 30, 2017USD ($) | Mar. 31, 2017USD ($) | Dec. 31, 2016USD ($) | Sep. 30, 2016USD ($) | Jun. 30, 2016USD ($) | Mar. 31, 2016USD ($) | Jun. 30, 2016USD ($) | Dec. 31, 2017USD ($) | Dec. 31, 2016USD ($) | Dec. 31, 2015USD ($) |
Business Acquisition [Line Items] | ||||||||||||||||||||||||||
Goodwill | $ 287,996 | $ 1,704,158 | $ 1,632,592 | $ 1,704,158 | $ 1,632,592 | $ 1,396,529 | ||||||||||||||||||||
Intangible assets | 217,677 | |||||||||||||||||||||||||
Indefinite-lived Intangible assets acquired | 28,800 | |||||||||||||||||||||||||
Contingent consideration for acquisition | 0 | 0 | 4,705 | |||||||||||||||||||||||
Revenues | $ 585,904 | $ 574,490 | $ 573,366 | $ 553,552 | $ 530,419 | $ 530,356 | $ 549,696 | $ 502,572 | 2,287,312 | 2,113,043 | 2,020,668 | |||||||||||||||
Selling, general and administrative expenses | ||||||||||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||||||||||
Acquisition related costs | 1,300 | $ 4,700 | 2,600 | |||||||||||||||||||||||
Cost of goods sold | ||||||||||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||||||||||
Fair value of inventory charges associated with acquisitions | $ 14,700 | $ 3,400 | ||||||||||||||||||||||||
thinXXS | ||||||||||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||||||||||
Business combination, cash consideration paid | $ 38,200 | |||||||||||||||||||||||||
Debt assumed | 1,200 | |||||||||||||||||||||||||
Goodwill | 23,900 | |||||||||||||||||||||||||
Intangible assets | $ 11,800 | |||||||||||||||||||||||||
Akron Brass | ||||||||||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||||||||||
Business combination, cash consideration paid | $ 221,400 | |||||||||||||||||||||||||
Goodwill | 124,643 | |||||||||||||||||||||||||
Intangible assets | $ 90,400 | |||||||||||||||||||||||||
AWG Fittings | ||||||||||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||||||||||
Business combination, cash consideration paid | € 42.8 | $ 47,500 | ||||||||||||||||||||||||
Goodwill | 22,055 | |||||||||||||||||||||||||
Intangible assets | $ 10,279 | |||||||||||||||||||||||||
SFC-Koenig | ||||||||||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||||||||||
Business combination, cash consideration paid | € 215.9 | 241,100 | ||||||||||||||||||||||||
Goodwill | 141,298 | |||||||||||||||||||||||||
Intangible assets | $ 116,998 | |||||||||||||||||||||||||
Novotema | ||||||||||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||||||||||
Business combination, cash consideration paid | € 56 | $ 61,100 | ||||||||||||||||||||||||
Goodwill | 34,316 | |||||||||||||||||||||||||
Intangible assets | $ 20,011 | |||||||||||||||||||||||||
Alfa Valvole | ||||||||||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||||||||||
Business combination, cash consideration paid | € 99.8 | $ 112,600 | ||||||||||||||||||||||||
Goodwill | 69,568 | |||||||||||||||||||||||||
Intangible assets | $ 32,058 | |||||||||||||||||||||||||
CPS | ||||||||||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||||||||||
Business combination, cash consideration paid | $ 19,500 | |||||||||||||||||||||||||
Goodwill | 9,739 | |||||||||||||||||||||||||
Intangible assets | 12,290 | |||||||||||||||||||||||||
Aggregate purchase price | 24,200 | |||||||||||||||||||||||||
Business combination, range of outcomes, value, high | 4,700 | |||||||||||||||||||||||||
CPS | Minimum | ||||||||||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||||||||||
Contingent consideration for acquisition | 0 | |||||||||||||||||||||||||
CPS | Maximum | ||||||||||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||||||||||
Contingent consideration for acquisition | $ 5,500 | |||||||||||||||||||||||||
CPS | Selling, general and administrative expenses | ||||||||||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||||||||||
Change in amount of contingent consideration, liability | $ (1,000) | $ (3,700) | $ (4,700) | |||||||||||||||||||||||
Complementary Product Line | ||||||||||||||||||||||||||
Business Acquisition [Line Items] | ||||||||||||||||||||||||||
Goodwill | $ 700 | |||||||||||||||||||||||||
Aggregate purchase price | $ 1,900 |
Acquisitions and Divestitures47
Acquisitions and Divestitures - Allocation of Acquisition Costs to Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands | Dec. 31, 2017 | Dec. 31, 2016 | Aug. 31, 2016 | Jul. 01, 2016 | Mar. 16, 2016 | Dec. 31, 2015 | Jul. 01, 2015 | Jun. 10, 2015 | May 29, 2015 |
Business Acquisition [Line Items] | |||||||||
Accounts receivable | $ 29,580 | ||||||||
Inventory | 61,562 | ||||||||
Other current assets, net of cash acquired | 5,512 | ||||||||
Property, plant and equipment | 23,427 | ||||||||
Goodwill | $ 1,704,158 | $ 1,632,592 | 287,996 | $ 1,396,529 | |||||
Intangible assets | 217,677 | ||||||||
Deferred income taxes | 3,928 | ||||||||
Total assets acquired | 629,682 | ||||||||
Current liabilities | (23,902) | ||||||||
Deferred income taxes | (72,607) | ||||||||
Other noncurrent liabilities | (23,172) | ||||||||
Net assets acquired | 510,001 | ||||||||
Akron Brass | |||||||||
Business Acquisition [Line Items] | |||||||||
Accounts receivable | $ 14,523 | ||||||||
Inventory | 29,157 | ||||||||
Other current assets, net of cash acquired | 446 | ||||||||
Property, plant and equipment | 12,195 | ||||||||
Goodwill | 124,643 | ||||||||
Intangible assets | 90,400 | ||||||||
Deferred income taxes | 0 | ||||||||
Total assets acquired | 271,364 | ||||||||
Current liabilities | (7,081) | ||||||||
Deferred income taxes | (36,439) | ||||||||
Other noncurrent liabilities | (6,445) | ||||||||
Net assets acquired | $ 221,399 | ||||||||
AWG Fittings | |||||||||
Business Acquisition [Line Items] | |||||||||
Accounts receivable | $ 5,867 | ||||||||
Inventory | 11,766 | ||||||||
Other current assets, net of cash acquired | 565 | ||||||||
Property, plant and equipment | 6,595 | ||||||||
Goodwill | 22,055 | ||||||||
Intangible assets | 10,279 | ||||||||
Deferred income taxes | 3,928 | ||||||||
Total assets acquired | 61,055 | ||||||||
Current liabilities | (5,117) | ||||||||
Deferred income taxes | 0 | ||||||||
Other noncurrent liabilities | (8,444) | ||||||||
Net assets acquired | $ 47,494 | ||||||||
SFC-Koenig | |||||||||
Business Acquisition [Line Items] | |||||||||
Accounts receivable | 9,190 | ||||||||
Inventory | 20,639 | ||||||||
Other current assets, net of cash acquired | 4,501 | ||||||||
Property, plant and equipment | 4,637 | ||||||||
Goodwill | 141,298 | ||||||||
Intangible assets | 116,998 | ||||||||
Deferred income taxes | 0 | ||||||||
Total assets acquired | 297,263 | ||||||||
Current liabilities | (11,704) | ||||||||
Deferred income taxes | (36,168) | ||||||||
Other noncurrent liabilities | (8,283) | ||||||||
Net assets acquired | $ 241,108 | ||||||||
Novotema | |||||||||
Business Acquisition [Line Items] | |||||||||
Accounts receivable | $ 8,029 | ||||||||
Inventory | 2,886 | ||||||||
Other current assets, net of cash acquired | 1,866 | ||||||||
Property, plant and equipment | 11,844 | ||||||||
Goodwill | 34,316 | ||||||||
Intangible assets | 20,011 | ||||||||
Total assets acquired | 78,952 | ||||||||
Current liabilities | (7,760) | ||||||||
Deferred income taxes | (7,803) | ||||||||
Other noncurrent liabilities | (2,291) | ||||||||
Net assets acquired | $ 61,098 | ||||||||
Alfa Valvole | |||||||||
Business Acquisition [Line Items] | |||||||||
Accounts receivable | $ 13,487 | ||||||||
Inventory | 11,036 | ||||||||
Other current assets, net of cash acquired | 3,367 | ||||||||
Property, plant and equipment | 8,395 | ||||||||
Goodwill | 69,568 | ||||||||
Intangible assets | 32,058 | ||||||||
Total assets acquired | 137,911 | ||||||||
Current liabilities | (11,279) | ||||||||
Deferred income taxes | (12,622) | ||||||||
Other noncurrent liabilities | (1,420) | ||||||||
Net assets acquired | $ 112,590 | ||||||||
CPS | |||||||||
Business Acquisition [Line Items] | |||||||||
Accounts receivable | $ 945 | ||||||||
Inventory | 442 | ||||||||
Other current assets, net of cash acquired | 79 | ||||||||
Property, plant and equipment | 1,105 | ||||||||
Goodwill | 9,739 | ||||||||
Intangible assets | 12,290 | ||||||||
Total assets acquired | 24,600 | ||||||||
Current liabilities | (420) | ||||||||
Deferred income taxes | 0 | ||||||||
Other noncurrent liabilities | 0 | ||||||||
Net assets acquired | $ 24,180 | ||||||||
Other | |||||||||
Business Acquisition [Line Items] | |||||||||
Accounts receivable | 0 | ||||||||
Inventory | 1,102 | ||||||||
Other current assets, net of cash acquired | 0 | ||||||||
Property, plant and equipment | 0 | ||||||||
Goodwill | 748 | ||||||||
Intangible assets | 0 | ||||||||
Total assets acquired | 1,850 | ||||||||
Current liabilities | 0 | ||||||||
Deferred income taxes | 0 | ||||||||
Other noncurrent liabilities | 0 | ||||||||
Net assets acquired | 1,850 | ||||||||
Acquisitions in 2015 | |||||||||
Business Acquisition [Line Items] | |||||||||
Accounts receivable | 22,461 | ||||||||
Inventory | 15,466 | ||||||||
Other current assets, net of cash acquired | 5,312 | ||||||||
Property, plant and equipment | 21,344 | ||||||||
Goodwill | 114,371 | ||||||||
Intangible assets | 64,359 | ||||||||
Total assets acquired | 243,313 | ||||||||
Current liabilities | (19,459) | ||||||||
Deferred income taxes | (20,425) | ||||||||
Other noncurrent liabilities | (3,711) | ||||||||
Net assets acquired | $ 199,718 |
Acquisitions and Divestitures48
Acquisitions and Divestitures - Acquired Intangible Assets and Weighted Average Amortization Periods (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2016 | Dec. 31, 2015 | |
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Amortized intangible assets | $ 188,877 | $ 64,359 |
Indefinite lived | 28,800 | |
Total acquired intangible assets | 217,677 | |
Trade Names | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Amortized intangible assets | $ 14,078 | $ 9,247 |
Weighted Average Life | 15 years | 15 years |
Customer Relationships | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Amortized intangible assets | $ 134,519 | $ 44,401 |
Weighted Average Life | 13 years | 12 years |
Unpatented technology | ||
Acquired Finite-Lived Intangible Assets [Line Items] | ||
Amortized intangible assets | $ 40,280 | $ 10,711 |
Weighted Average Life | 13 years | 8 years |
Acquisitions and Divestitures49
Acquisitions and Divestitures - Divestitures (Details) - USD ($) | Oct. 31, 2017 | Dec. 30, 2016 | Oct. 10, 2016 | Sep. 09, 2016 | Jul. 29, 2016 | Jul. 31, 2015 | Dec. 31, 2017 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2016 | Mar. 31, 2016 | Jul. 29, 2016 | Jul. 31, 2015 | Sep. 09, 2016 | Oct. 10, 2016 | Oct. 31, 2017 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 30, 2016 | Dec. 31, 2015 |
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||||||||||||||
Proceeds from sale of businesses, net of cash sold | $ 21,795,000 | $ 39,064,000 | $ 27,677,000 | ||||||||||||||||||||
Income tax expense (benefit) | 118,016,000 | 97,403,000 | 109,538,000 | ||||||||||||||||||||
Revenues | $ 585,904,000 | $ 574,490,000 | $ 573,366,000 | $ 553,552,000 | $ 530,419,000 | $ 530,356,000 | $ 549,696,000 | $ 502,572,000 | 2,287,312,000 | 2,113,043,000 | 2,020,668,000 | ||||||||||||
Disposed of by Sale | Faure Herman | |||||||||||||||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||||||||||||||
Proceeds from sale of businesses, net of cash sold | $ 21,800,000 | ||||||||||||||||||||||
Pre-tax gain (loss) on the sale | $ 9,300,000 | ||||||||||||||||||||||
Income tax expense (benefit) | $ 0 | ||||||||||||||||||||||
Revenues | $ 14,100,000 | ||||||||||||||||||||||
Disposed of by Sale | Hydra-Stop | |||||||||||||||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||||||||||||||
Proceeds from sale of businesses, net of cash sold | $ 15,000,000 | ||||||||||||||||||||||
Pre-tax gain (loss) on the sale | 5,800,000 | ||||||||||||||||||||||
Income tax expense (benefit) | 2,800,000 | ||||||||||||||||||||||
Additional proceeds from disposition of business | $ 1,000,000 | ||||||||||||||||||||||
Possible additions | 1,000,000 | ||||||||||||||||||||||
Revenues | $ 7,500,000 | ||||||||||||||||||||||
Disposed of by Sale | Melles Griot KK | |||||||||||||||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||||||||||||||
Proceeds from sale of businesses, net of cash sold | $ 17,500,000 | ||||||||||||||||||||||
Pre-tax gain (loss) on the sale | $ (7,900,000) | ||||||||||||||||||||||
Income tax expense (benefit) | (3,400,000) | ||||||||||||||||||||||
Revenues | $ 13,100,000 | ||||||||||||||||||||||
Disposed of by Sale | IETG and 40Seven | |||||||||||||||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||||||||||||||
Proceeds from sale of businesses, net of cash sold | $ 2,700,000 | ||||||||||||||||||||||
Pre-tax gain (loss) on the sale | $ (4,200,000) | ||||||||||||||||||||||
Revenues | $ 8,300,000 | ||||||||||||||||||||||
Disposed of by Sale | CVI Korea | |||||||||||||||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||||||||||||||
Proceeds from sale of businesses, net of cash sold | $ 3,800,000 | ||||||||||||||||||||||
Pre-tax gain (loss) on the sale | $ (16,000,000) | ||||||||||||||||||||||
Income tax expense (benefit) | $ (9,100,000) | ||||||||||||||||||||||
Revenues | $ 11,700,000 | ||||||||||||||||||||||
Disposed of by Sale | Ismatec Product Line | |||||||||||||||||||||||
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||||||||||||||
Proceeds from sale of businesses, net of cash sold | $ 27,700,000 | ||||||||||||||||||||||
Pre-tax gain (loss) on the sale | $ 18,100,000 | ||||||||||||||||||||||
Income tax expense (benefit) | $ 4,800,000 | ||||||||||||||||||||||
Revenues | $ 5,300,000 |
Balance Sheet Components - Comp
Balance Sheet Components - Components (Details) - USD ($) $ in Thousands | Dec. 31, 2017 | Dec. 31, 2016 |
RECEIVABLES | ||
Customers | $ 297,796 | $ 275,250 |
Other | 4,134 | 5,641 |
Total | 301,930 | 280,891 |
Less allowance for doubtful accounts | 7,764 | 8,078 |
Total receivables — net | 294,166 | 272,813 |
INVENTORIES | ||
Raw materials and components parts | 169,676 | 154,278 |
Work in process | 33,668 | 34,832 |
Finished goods | 56,380 | 63,749 |
Total | 259,724 | 252,859 |
PROPERTY, PLANT AND EQUIPMENT | ||
Land and improvements | 32,984 | 33,883 |
Buildings and improvements | 175,467 | 169,261 |
Machinery, equipment and other | 356,728 | 328,779 |
Office and transportation equipment | 96,541 | 98,355 |
Construction in progress | 14,715 | 10,373 |
Total | 676,435 | 640,651 |
Less accumulated depreciation and amortization | 418,085 | 392,835 |
Total property, plant and equipment — net | 258,350 | 247,816 |
ACCRUED EXPENSES | ||
Payroll and related items | 75,869 | 67,600 |
Management incentive compensation | 24,320 | 16,339 |
Income taxes payable | 28,033 | 8,808 |
Insurance | 9,424 | 9,416 |
Warranty | 6,281 | 5,628 |
Deferred revenue | 11,031 | 12,607 |
Restructuring | 4,180 | 3,893 |
Liability for uncertain tax positions | 1,745 | 1,366 |
Accrued interest | 1,759 | 1,663 |
Other | 22,063 | 25,532 |
Total accrued expenses | 184,705 | 152,852 |
OTHER NONCURRENT LIABILITIES | ||
Pension and retiree medical obligations | 99,646 | 93,604 |
Transition tax payable | 27,877 | 0 |
Liability for uncertain tax positions | 1,047 | 2,623 |
Deferred revenue | 3,297 | 2,442 |
Other | 23,818 | 22,561 |
Total other noncurrent liabilities | $ 155,685 | $ 121,230 |
Balance Sheet Components - Valu
Balance Sheet Components - Valuation And Qualifying Accounts (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Movement in Valuation Allowances and Reserves [Roll Forward] | |||
Beginning balance January 1 | $ 8,078 | $ 7,812 | $ 6,961 |
Charged to costs and expenses, net of recoveries | 720 | 1,425 | 1,556 |
Utilization | (1,418) | (1,585) | (1,009) |
Currency translation and other | 384 | 426 | 304 |
Ending balance December 31 | $ 7,764 | $ 8,078 | $ 7,812 |
Goodwill and Intangible Asset52
Goodwill and Intangible Assets - Additional Information (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Goodwill and Intangible Assets Disclosure [Abstract] | |||
Amortization of intangible assets | $ 45,902 | $ 49,038 | $ 42,426 |
Expected amortization expense, 2018 | 38,400 | ||
Expected amortization expense, 2019 | 35,300 | ||
Expected amortization expense, 2020 | 34,500 | ||
Expected amortization expense, 2021 | 33,200 | ||
Expected amortization expense, 2022 | $ 31,600 |
Goodwill and Intangible Asset53
Goodwill and Intangible Assets - Schedule of Changes in Carrying Amount of Goodwill (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Goodwill and Intangible Assets Disclosure [Line Items] | |||
Goodwill | $ 1,597,160 | ||
Accumulated goodwill impairment losses | (200,631) | ||
Goodwill | |||
Beginning Balance | $ 1,632,592 | $ 1,396,529 | |
Foreign currency translation | 53,179 | (37,482) | |
Acquisitions | 23,929 | 290,393 | |
Disposition of businesses | (3,121) | (15,772) | |
Acquisition adjustments | (2,421) | (1,076) | |
Ending Balance | 1,704,158 | 1,632,592 | |
Fluid & Metering Technologies | |||
Goodwill and Intangible Assets Disclosure [Line Items] | |||
Goodwill | 605,491 | ||
Accumulated goodwill impairment losses | (20,721) | ||
Goodwill | |||
Beginning Balance | 573,437 | 584,770 | |
Foreign currency translation | 15,748 | (5,951) | |
Acquisitions | 0 | 0 | |
Disposition of businesses | (3,121) | (3,759) | |
Acquisition adjustments | 0 | (1,623) | |
Ending Balance | 586,064 | 573,437 | |
Health & Science Technologies | |||
Goodwill and Intangible Assets Disclosure [Line Items] | |||
Goodwill | 740,425 | ||
Accumulated goodwill impairment losses | (149,820) | ||
Goodwill | |||
Beginning Balance | 699,299 | 590,605 | |
Foreign currency translation | 19,225 | (23,559) | |
Acquisitions | 23,929 | 143,719 | |
Disposition of businesses | 0 | (12,013) | |
Acquisition adjustments | (2,421) | 547 | |
Ending Balance | 740,032 | 699,299 | |
Fire & Safety/Diversified Products | |||
Goodwill and Intangible Assets Disclosure [Line Items] | |||
Goodwill | 251,244 | ||
Accumulated goodwill impairment losses | $ (30,090) | ||
Goodwill | |||
Beginning Balance | 359,856 | 221,154 | |
Foreign currency translation | 18,206 | (7,972) | |
Acquisitions | 0 | 146,674 | |
Disposition of businesses | 0 | 0 | |
Acquisition adjustments | 0 | 0 | |
Ending Balance | $ 378,062 | $ 359,856 |
Goodwill and Intangible Asset54
Goodwill and Intangible Assets - Schedule of Gross Carrying Value and Accumulated Amortization for Each Major Class of Intangible Asset (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Goodwill And Intangible Assets [Line Items] | ||
Amortized intangible assets - Gross Carrying Amount | $ 536,160 | $ 605,645 |
Intangible assets - Gross Carrying Amount | 627,060 | 696,545 |
Amortized intangible assets - Accumulated Amortization | (212,314) | (261,041) |
Amortized intangible assets - Net | 323,846 | 344,604 |
Intangible assets - Net | 414,746 | 435,504 |
Banjo Trade Name | ||
Goodwill And Intangible Assets [Line Items] | ||
Indefinite lived intangible assets - Gross Carrying Amount | 62,100 | 62,100 |
Indefinite lived intangible assets - Net | 62,100 | 62,100 |
Akron Brass trade name | ||
Goodwill And Intangible Assets [Line Items] | ||
Indefinite lived intangible assets - Gross Carrying Amount | 28,800 | 28,800 |
Indefinite lived intangible assets - Net | 28,800 | 28,800 |
Patents | ||
Goodwill And Intangible Assets [Line Items] | ||
Amortized intangible assets - Gross Carrying Amount | 9,633 | 9,856 |
Amortized intangible assets - Accumulated Amortization | (7,143) | (6,635) |
Amortized intangible assets - Net | $ 2,490 | 3,221 |
Amortized intangible assets - Weighted Average Life | 11 years | |
Trade Names | ||
Goodwill And Intangible Assets [Line Items] | ||
Amortized intangible assets - Gross Carrying Amount | $ 117,206 | 113,428 |
Amortized intangible assets - Accumulated Amortization | (50,604) | (42,653) |
Amortized intangible assets - Net | $ 66,602 | 70,775 |
Amortized intangible assets - Weighted Average Life | 16 years | |
Customer Relationships | ||
Goodwill And Intangible Assets [Line Items] | ||
Amortized intangible assets - Gross Carrying Amount | $ 317,316 | 369,087 |
Amortized intangible assets - Accumulated Amortization | (124,566) | (161,065) |
Amortized intangible assets - Net | $ 192,750 | 208,022 |
Amortized intangible assets - Weighted Average Life | 13 years | |
Unpatented technology and other | ||
Goodwill And Intangible Assets [Line Items] | ||
Amortized intangible assets - Gross Carrying Amount | $ 91,166 | 106,747 |
Amortized intangible assets - Accumulated Amortization | (29,428) | (44,516) |
Amortized intangible assets - Net | $ 61,738 | 62,231 |
Amortized intangible assets - Weighted Average Life | 13 years | |
Other Amortizable Intangible Assets | ||
Goodwill And Intangible Assets [Line Items] | ||
Amortized intangible assets - Gross Carrying Amount | $ 839 | 6,527 |
Amortized intangible assets - Accumulated Amortization | (573) | (6,172) |
Amortized intangible assets - Net | $ 266 | $ 355 |
Amortized intangible assets - Weighted Average Life | 10 years |
Borrowings - Additional Informa
Borrowings - Additional Information (Details) | Jun. 23, 2015USD ($) | Dec. 06, 2010USD ($) | Dec. 31, 2011USD ($) | Dec. 31, 2017USD ($) | Dec. 31, 2016USD ($) | Jun. 13, 2016USD ($) | Dec. 09, 2011USD ($) |
Line of Credit Facility [Line Items] | |||||||
Credit facility, term | 5 years | ||||||
Revolving facility expiration date | Jun. 23, 2020 | ||||||
Current borrowings under revolving facility | $ 10,740,000 | $ 169,579,000 | |||||
Minimum | |||||||
Line of Credit Facility [Line Items] | |||||||
Required percent for prepayment amount of aggregate principal amount | 5.00% | ||||||
Line of Credit | |||||||
Line of Credit Facility [Line Items] | |||||||
Current borrowing capacity | $ 700,000,000 | ||||||
Aggregate lending commitments | $ 350,000,000 | ||||||
Revolving facility, extension term | 1 year | ||||||
3.2% Senior Notes, due June 2023 | |||||||
Line of Credit Facility [Line Items] | |||||||
Stated interest rate | 3.20% | ||||||
3.37% Senior Notes, due June 2025 | |||||||
Line of Credit Facility [Line Items] | |||||||
Stated interest rate | 3.37% | ||||||
Revolving Credit Facility | |||||||
Line of Credit Facility [Line Items] | |||||||
Stated interest rate | 1.10% | ||||||
Applicable margin over LIBOR | 1.10% | ||||||
Basis spread on variable rate | 0.20% | ||||||
Outstanding letters of credit | $ 7,200,000 | ||||||
Revolving Facility, amount available to borrow | $ 682,100,000 | ||||||
Revolving Credit Facility | Minimum | |||||||
Line of Credit Facility [Line Items] | |||||||
Applicable margin over LIBOR | 0.005% | ||||||
Interest coverage ratio | 3 | ||||||
Revolving Credit Facility | Maximum | |||||||
Line of Credit Facility [Line Items] | |||||||
Applicable margin over LIBOR | 1.50% | ||||||
Leverage ratio | 3.50 | ||||||
4.2% Senior Notes, due December 2021 | |||||||
Line of Credit Facility [Line Items] | |||||||
Stated interest rate | 4.20% | 4.20% | |||||
Principal amount of private placement | $ 350,000,000 | ||||||
Debt instrument maturity period | Dec. 15, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | ||||
Net proceeds from debt offering | $ 346,200,000 | ||||||
Debt offering initial discount | $ 900,000 | ||||||
Debt offering underwriting commission | $ 2,300,000 | ||||||
Estimated offering expenses | 600,000 | ||||||
Contingent percentage of principal amount plus accrued and unpaid interest | 101.00% | ||||||
Outstanding repayment of indebtedness | $ 306,000,000 | ||||||
4.5% Senior Notes, due December 2020 | |||||||
Line of Credit Facility [Line Items] | |||||||
Debt instrument face amount | $ 300,000,000 | ||||||
Stated interest rate | 4.50% | 4.50% | |||||
Debt instrument maturity period | Dec. 15, 2020 | Dec. 31, 2020 | Dec. 31, 2020 | ||||
Net proceeds from debt offering | $ 295,700,000 | ||||||
Debt offering initial discount | 1,600,000 | ||||||
Debt offering underwriting commission | 1,900,000 | ||||||
Estimated offering expenses | $ 800,000 | ||||||
Contingent percentage of principal amount plus accrued and unpaid interest | 101.00% | ||||||
Outstanding repayment of indebtedness | $ 250,000,000 | ||||||
Senior Notes | Maximum | |||||||
Line of Credit Facility [Line Items] | |||||||
Limitation of outstanding principal of higher preference debt as percent of consolidated assets | 15.00% | ||||||
Senior Notes | 3.2% Senior Notes, due June 2023 | |||||||
Line of Credit Facility [Line Items] | |||||||
Debt instrument face amount | $ 100,000,000 | ||||||
Stated interest rate | 3.20% | ||||||
Senior Notes | 3.37% Senior Notes, due June 2025 | |||||||
Line of Credit Facility [Line Items] | |||||||
Debt instrument face amount | $ 100,000,000 | ||||||
Stated interest rate | 3.37% | ||||||
Letters Of Credit | Line of Credit | |||||||
Line of Credit Facility [Line Items] | |||||||
Current borrowing capacity | $ 75,000,000 | ||||||
Swing line Loans | Line of Credit | |||||||
Line of Credit Facility [Line Items] | |||||||
Current borrowing capacity | $ 50,000,000 |
Borrowings - Schedule of Borrow
Borrowings - Schedule of Borrowings (Details) - USD ($) $ in Thousands | Dec. 31, 2017 | Dec. 31, 2016 |
Debt Instrument [Line Items] | ||
Revolving Facility | $ 10,740 | $ 169,579 |
Total borrowings | 862,186 | 1,020,873 |
Less current portion | 258 | 1,046 |
Less deferred debt issuance costs | 2,204 | 4,399 |
Less unaccreted debt discount | 936 | 1,193 |
Long-term borrowings | 858,788 | 1,014,235 |
Senior Notes | 4.5% Senior Notes, due December 2020 | ||
Debt Instrument [Line Items] | ||
Total borrowings | 300,000 | 300,000 |
Senior Notes | 4.2% Senior Notes, due December 2021 | ||
Debt Instrument [Line Items] | ||
Total borrowings | 350,000 | 350,000 |
Senior Notes | 3.2% Senior Notes, due June 2023 | ||
Debt Instrument [Line Items] | ||
Total borrowings | 100,000 | 100,000 |
Senior Notes | 3.37% Senior Notes, due June 2025 | ||
Debt Instrument [Line Items] | ||
Total borrowings | 100,000 | 100,000 |
Other Borrowings | ||
Debt Instrument [Line Items] | ||
Other borrowings | $ 1,446 | $ 1,294 |
Borrowings - Schedule of Borr57
Borrowings - Schedule of Borrowings (Schedule of Debt, Narrative) (Details) | Dec. 06, 2010 | Dec. 31, 2011 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 09, 2011 |
4.2% Senior Notes, due December 2021 | |||||
Debt Instrument [Line Items] | |||||
Stated interest rate | 4.20% | 4.20% | |||
Senior Notes, maturity date | Dec. 15, 2021 | Dec. 31, 2021 | Dec. 31, 2021 | ||
4.5% Senior Notes, due December 2020 | |||||
Debt Instrument [Line Items] | |||||
Stated interest rate | 4.50% | 4.50% | |||
Senior Notes, maturity date | Dec. 15, 2020 | Dec. 31, 2020 | Dec. 31, 2020 |
Borrowings - Schedule of Maturi
Borrowings - Schedule of Maturities of Borrowings (Details) - USD ($) $ in Thousands | Dec. 31, 2017 | Dec. 31, 2016 |
Debt Disclosure [Abstract] | ||
2,018 | $ 1,436 | |
2,019 | 10 | |
2,020 | 310,740 | |
2,021 | 350,000 | |
2,022 | 0 | |
Thereafter | 200,000 | |
Total borrowings | $ 862,186 | $ 1,020,873 |
Derivative Instruments - Narrat
Derivative Instruments - Narrative (Details) $ in Thousands | Jan. 05, 2018USD ($) | Oct. 03, 2011USD ($) | Dec. 31, 2011USD ($) | Dec. 31, 2010USD ($) | Dec. 31, 2017USD ($) | Dec. 31, 2016USD ($) | Dec. 31, 2015USD ($) | Dec. 31, 2017EUR (€) | Dec. 09, 2011 | Sep. 29, 2011USD ($) | Jul. 12, 2011USD ($) | Dec. 06, 2010 | Apr. 15, 2010USD ($) |
Derivative [Line Items] | |||||||||||||
Notional amount | $ 350,000 | ||||||||||||
Amortization of interest expense | $ 1,320 | $ 1,295 | $ 1,612 | ||||||||||
Additional interest rate contract settlement | $ 4,000 | ||||||||||||
Expense reclassified into interest expense for interest rate contracts | 6,700 | $ 6,900 | $ 7,000 | ||||||||||
Amount to be recognized from hedged transactions within 12 months, approximate | 6,500 | ||||||||||||
Other (Income) Expense Net | |||||||||||||
Derivative [Line Items] | |||||||||||||
Foreign currency transaction loss | 20,200 | ||||||||||||
Four Point Five Percentage Senior Notes [Member] | |||||||||||||
Derivative [Line Items] | |||||||||||||
Interest rate on senior notes | 4.50% | 4.50% | |||||||||||
4.2% Senior Notes, due December 2021 | |||||||||||||
Derivative [Line Items] | |||||||||||||
Interest rate on senior notes | 4.20% | 4.20% | |||||||||||
Interest Rate Exchange Agreement Expiring 2010 | |||||||||||||
Derivative [Line Items] | |||||||||||||
Notional amount | $ 300,000 | ||||||||||||
Interest rate contract settlement amount | $ 31,000 | ||||||||||||
Amortization of interest expense | $ 31,000 | ||||||||||||
Term of amortized interest expense, years | 10 years | 10 years | |||||||||||
Interest rate | 5.80% | ||||||||||||
Interest Rate Exchange Agreement Expiring 2011 | |||||||||||||
Derivative [Line Items] | |||||||||||||
Notional amount | $ 350,000 | ||||||||||||
Interest rate contract settlement amount | $ 34,700 | ||||||||||||
Interest Rate Exchange Agreements Expiring 2011 And 2012 | |||||||||||||
Derivative [Line Items] | |||||||||||||
Amortization of interest expense | $ 37,900 | ||||||||||||
Interest rate | 5.30% | ||||||||||||
Settlement amount interest rate contract | 38,700 | ||||||||||||
Interest rate settlement recognized as other expense | $ 800 | ||||||||||||
Foreign currency exchange contracts | |||||||||||||
Derivative [Line Items] | |||||||||||||
Notional amount | € | € 180,000,000 | ||||||||||||
Cash received from settlement of contracts | 13,700 | ||||||||||||
Foreign currency exchange contracts | Subsequent Event | |||||||||||||
Derivative [Line Items] | |||||||||||||
Cash received from settlement of contracts | $ 6,600 | ||||||||||||
Foreign currency exchange contracts | Other (Income) Expense Net | |||||||||||||
Derivative [Line Items] | |||||||||||||
Gain on derivatives | $ 19,800 |
Derivative Instruments - Fair V
Derivative Instruments - Fair Value Amounts (Details) - USD ($) $ in Thousands | Dec. 31, 2017 | Dec. 31, 2016 |
Other current assets | Foreign currency exchange contracts | ||
Derivative [Line Items] | ||
Fair Value Assets (Liabilities) | $ 5,779 | $ 0 |
Fair Value Measurements - Addit
Fair Value Measurements - Additional Information (Details) - USD ($) $ in Millions | Dec. 31, 2017 | Dec. 09, 2011 | Dec. 06, 2010 |
Estimate of Fair Value Measurement | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Carrying value of our revolving facility and senior debt | $ 886.3 | ||
Reported Value Measurement | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Carrying value of our revolving facility and senior debt | $ 861 | ||
3.2% Senior Notes, due June 2023 | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Stated interest rate | 3.20% | ||
3.37% Senior Notes, due June 2025 | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Stated interest rate | 3.37% | ||
4.5% Senior Notes, due December 2020 | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Stated interest rate | 4.50% | 4.50% | |
4.2% Senior Notes, due December 2021 | |||
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] | |||
Stated interest rate | 4.20% | 4.20% |
Fair Value Measurements - Sched
Fair Value Measurements - Schedule of Company Financial Assets and Liabilities at Fair Value on Recurring Basis (Details) - Recurring Basis - USD ($) $ in Thousands | Dec. 31, 2017 | Dec. 31, 2016 |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available for sale securities | $ 6,742 | $ 5,369 |
Foreign currency exchange contracts | 5,779 | |
Level 1 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available for sale securities | 6,742 | 5,369 |
Foreign currency exchange contracts | 0 | |
Level 2 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available for sale securities | 0 | 0 |
Foreign currency exchange contracts | 5,779 | |
Level 3 | ||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
Available for sale securities | 0 | $ 0 |
Foreign currency exchange contracts | $ 0 |
Commitments and Contingencies -
Commitments and Contingencies - Additional Information (Details) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Commitments and Contingencies Disclosure [Abstract] | |||
Rental expense | $ 19 | $ 18.6 | $ 18.9 |
Commitments and Contingencies64
Commitments and Contingencies - Future Minimum Lease Payments For Operating And Capital Leases (Details) $ in Thousands | Dec. 31, 2017USD ($) |
Operating | |
2,018 | $ 15,992 |
2,019 | 12,064 |
2,020 | 9,465 |
2,021 | 6,904 |
2,022 | 4,999 |
2023 and thereafter | 15,435 |
Future minimum lease payments for operating lease total | 64,859 |
Capital | |
2,018 | 258 |
2,019 | 10 |
2,020 | 0 |
2,021 | 0 |
2,022 | 0 |
2023 and thereafter | 0 |
Future minimum lease payments for capital lease total | $ 268 |
Commitments and Contingencies65
Commitments and Contingencies - Roll Forward Of The Warranty Reserve (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward] | |||
Beginning balance January 1 | $ 5,628 | $ 7,936 | $ 7,196 |
Provision for warranties | 2,895 | 1,828 | 4,788 |
Claim settlements | (2,317) | (3,539) | (3,864) |
Other adjustments, including acquisitions, divestitures and currency translation | 75 | (597) | (184) |
Ending balance December 31 | $ 6,281 | $ 5,628 | $ 7,936 |
Common and Preferred Stock (Det
Common and Preferred Stock (Details) - USD ($) $ / shares in Units, $ in Thousands | Dec. 01, 2015 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 |
Equity [Abstract] | ||||
Increase in share repurchase authorized amount | $ 300,000 | |||
Purchase of common stock (in shares) | 266,000 | 738,593 | 2,811,002 | |
Purchase and accruals of common stock | $ 29,100 | $ 55,000 | ||
Purchase of common stock | 29,074 | $ 57,272 | $ 210,822 | |
Remaining authorized repurchase amount | $ 551,000 | |||
Common stock, shares authorized (in shares) | 150,000,000 | 150,000,000 | ||
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||
Preferred stock, shares authorized (in shares) | 5,000,000 | 5,000,000 | ||
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | ||
Preferred stock, shares issued (in shares) | 0 | 0 |
Income Taxes - Additional Infor
Income Taxes - Additional Information (Details) - USD ($) | 3 Months Ended | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Income Tax Disclosure [Line Items] | ||||
Tax Cuts and Jobs Act of 2017, income tax benefit | $ 100,000 | |||
Tax Cuts and Jobs Act of 2017, change in tax rate, income tax benefit | 40,600,000 | |||
Tax Cuts and Jobs Act of 2017, one time transition tax for accumulated foreign earnings, income tax expense | 30,300,000 | |||
Tax Cuts and Jobs Act of 2017,accumulated foreign earnings | 779,000,000 | $ 779,000,000 | ||
Tax Cuts and Jobs Act of 2017, tax planning strategies, income tax expense | 10,200,000 | |||
Permanently reinvested earnings of non-U.S. subsidiaries | 350,000,000 | 350,000,000 | $ 670,000,000 | |
Unrecognized deferred income tax liabilities on currently permanently reinvested earnings | $ 8,200,000 | 8,200,000 | ||
Foreign earnings repatriated | 3,300,000 | 28,800,000 | $ 14,300,000 | |
Incremental income tax expense (benefit) | (6,400,000) | 2,700,000 | 300,000 | |
Tax Cuts and Jobs Act of 2017, provisional increase, deferred tax liability | 9,200,000 | |||
Tax Cuts and Jobs Act of 2017, adjustment, deferred income tax expense | 9,200,000 | |||
Tax Cuts and Jobs Act of 2017, permanent reinvestment, deferred tax liability | $ 8,200,000 | |||
Tax Cuts and Jobs Act of 2017, global intangible low taxed income, benchmark, percent | 10.00% | 10.00% | ||
Tax Cuts and Jobs Act of 2017, provisional increase, income tax expense | $ 1,000,000 | |||
Accrued interest related to uncertain tax positions | $ 100,000 | 100,000 | 100,000 | 200,000 |
Accrued penalties related to uncertain tax positions | 0 | 0 | 100,000 | 300,000 |
Unrecognized tax benefits that would affect our effective tax rate | 900,000 | 900,000 | 1,800,000 | $ 3,000,000 |
Loss carry forwards for U.S. federal | 2,400,000 | 2,400,000 | 3,500,000 | |
Loss carry forwards for non-U.S. | 24,500,000 | 24,500,000 | 25,600,000 | |
Operating loss and credit carry forwards | 6,700,000 | 6,700,000 | 33,100,000 | |
Operating loss carryforwards, valuation allowance | 100,000 | 100,000 | 1,300,000 | |
Capital loss carryforwards | 12,853,000 | 12,853,000 | 18,668,000 | |
Federal | ||||
Income Tax Disclosure [Line Items] | ||||
Capital loss carryforwards | 46,000,000 | 46,000,000 | 70,100,000 | |
Capital loss carryforwards, valuation allowance | 9,700,000 | 9,700,000 | 18,700,000 | |
State and Local | ||||
Income Tax Disclosure [Line Items] | ||||
Capital loss carryforwards | 62,700,000 | 62,700,000 | 70,100,000 | |
Capital loss carryforwards, valuation allowance | 800,000 | 800,000 | 700,000 | |
Foreign | ||||
Income Tax Disclosure [Line Items] | ||||
Capital loss carryforwards | 14,200,000 | 14,200,000 | 700,000 | |
Minimum | ||||
Income Tax Disclosure [Line Items] | ||||
Unrecognized tax benefits possible change | 0 | 0 | ||
Maximum | ||||
Income Tax Disclosure [Line Items] | ||||
Unrecognized tax benefits possible change | 1,700,000 | 1,700,000 | ||
Other current assets | ||||
Income Tax Disclosure [Line Items] | ||||
Prepaid taxes | 40,900,000 | $ 40,900,000 | $ 42,200,000 | |
Accrued liabilities | ||||
Income Tax Disclosure [Line Items] | ||||
Tax Cuts and Jobs Act of 2017, one time transition tax for accumulated foreign earnings, income tax expense | 2,400,000 | |||
Other noncurrent liabilities | ||||
Income Tax Disclosure [Line Items] | ||||
Tax Cuts and Jobs Act of 2017, one time transition tax for accumulated foreign earnings, income tax expense | $ 27,900,000 |
Income Taxes - Schedule Of Inco
Income Taxes - Schedule Of Income Before Income Tax (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Income Tax Disclosure [Abstract] | |||
U.S. | $ 302,515 | $ 265,260 | $ 285,399 |
Foreign | 152,758 | 103,252 | 106,946 |
Income before income taxes | $ 455,273 | $ 368,512 | $ 392,345 |
Income Taxes - Provision Benefi
Income Taxes - Provision Benefit for Income Taxes (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Current | |||
U.S. | $ 91,641 | $ 67,668 | $ 73,059 |
State and local | 9,342 | 4,503 | 6,188 |
Foreign | 50,775 | 42,540 | 30,630 |
Total current | 151,758 | 114,711 | 109,877 |
Deferred | |||
U.S. | (36,390) | (6,249) | 7,125 |
State and local | 3,305 | (331) | (1,017) |
Foreign | (657) | (10,728) | (6,447) |
Total deferred | (33,742) | (17,308) | (339) |
Total provision for income taxes | $ 118,016 | $ 97,403 | $ 109,538 |
Income Taxes - Deferred Tax Ass
Income Taxes - Deferred Tax Assets Liabilities (Details) - USD ($) $ in Thousands | Dec. 31, 2017 | Dec. 31, 2016 |
Income Tax Disclosure [Abstract] | ||
Employee and retiree benefit plans | $ 31,804 | $ 42,950 |
Capital loss carryforwards | 12,853 | 18,668 |
Depreciation and amortization | (176,592) | (238,321) |
Inventories | 8,548 | 11,519 |
Allowances and accruals | 4,572 | 9,338 |
Interest rate exchange agreement | 5,007 | 10,442 |
Other | (8,019) | (90) |
Total gross deferred tax (liabilities) | (121,827) | (145,494) |
Capital loss valuation allowance | (12,853) | (18,668) |
Total deferred tax (liabilities), net of valuation allowances | $ (134,680) | $ (164,162) |
Income Taxes - Deferred Tax A71
Income Taxes - Deferred Tax Assets and Liabilities Recognized in Company's Consolidated Balance Sheets (Details) - USD ($) $ in Thousands | Dec. 31, 2017 | Dec. 31, 2016 |
Income Tax Disclosure [Abstract] | ||
Noncurrent deferred tax asset — Other noncurrent assets | $ 2,958 | $ 2,265 |
Noncurrent deferred tax liabilities — Deferred income taxes | (137,638) | (166,427) |
Total deferred tax (liabilities), net of valuation allowances | $ (134,680) | $ (164,162) |
Income Taxes - Computed Amount
Income Taxes - Computed Amount and Differences in Provision for Income Taxes (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Income Tax Disclosure [Abstract] | |||
Pretax income | $ 455,273 | $ 368,512 | $ 392,345 |
Computed amount at statutory rate of 35% | 159,346 | 128,979 | 137,321 |
State and local income tax (net of federal tax benefit) | 5,841 | 4,070 | 5,033 |
Taxes on non-U.S. earnings-net of foreign tax credits | (24,914) | (6,666) | (11,663) |
Effect of flow-through entities | 192 | (8,735) | (8,358) |
U.S. business tax credits | (1,928) | (1,665) | (1,273) |
Domestic activities production deduction | (8,516) | (9,043) | (6,521) |
Deferred tax effect of foreign tax rate change | 0 | 0 | (2,636) |
Capital loss on divestitures | (2,275) | (23,444) | 0 |
Share-based payments | (6,844) | (6,520) | 0 |
Valuation allowance | (361) | 17,973 | 0 |
Impact of Tax Act | (100) | 0 | 0 |
Other | (2,425) | 2,454 | (2,365) |
Total provision for income taxes | $ 118,016 | $ 97,403 | $ 109,538 |
Statutory tax rate | 35.00% | 35.00% | 35.00% |
Income Taxes - Reconciliation o
Income Taxes - Reconciliation of Beginning and Ending Amount of Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] | |||
Beginning balance January 1 | $ 3,775 | $ 7,228 | $ 3,619 |
Gross increase due to non-U.S. acquisitions | 0 | 0 | 3,772 |
Gross increases for tax positions of prior years | 537 | 201 | 1,256 |
Gross decreases for tax positions of prior years | (587) | (93) | 0 |
Settlements | (604) | (2,014) | (667) |
Lapse of statute of limitations | (399) | (1,547) | (752) |
Ending balance December 31 | $ 2,722 | $ 3,775 | $ 7,228 |
Business Segments and Geograp74
Business Segments and Geographic Information - Additional Information (Details) | 12 Months Ended |
Dec. 31, 2017segment | |
Segment Reporting [Abstract] | |
Number of reportable business segments | 3 |
Business Segments and Geograp75
Business Segments and Geographic Information - Schedule of Information on Company's Business Segments (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2017 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2016 | Mar. 31, 2016 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Segment Reporting Information [Line Items] | |||||||||||
Total net sales | $ 585,904 | $ 574,490 | $ 573,366 | $ 553,552 | $ 530,419 | $ 530,356 | $ 549,696 | $ 502,572 | $ 2,287,312 | $ 2,113,043 | $ 2,020,668 |
Total operating income | 135,248 | $ 126,504 | $ 125,133 | $ 115,671 | 85,521 | $ 109,708 | $ 113,823 | $ 103,345 | 502,556 | 412,397 | 436,990 |
Interest expense | 44,889 | 45,616 | 41,636 | ||||||||
Other (income) expense - net | 2,394 | (1,731) | 3,009 | ||||||||
Income before income taxes | 455,273 | 368,512 | 392,345 | ||||||||
Total assets | 3,399,628 | 3,154,944 | 3,399,628 | 3,154,944 | 2,805,443 | ||||||
Total depreciation and amortization | 84,216 | 86,892 | 78,120 | ||||||||
Total capital expenditures | 43,858 | 38,242 | 43,776 | ||||||||
Gain (loss) on sale of business | 9,273 | (22,298) | 18,070 | ||||||||
Intersegment Eliminations | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Total net sales | (1,309) | (876) | (3,035) | ||||||||
Corporate Office | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Total operating income | (65,069) | (82,399) | (45,139) | ||||||||
Total assets | 230,160 | 117,503 | 230,160 | 117,503 | 123,008 | ||||||
Total depreciation and amortization | 801 | 1,180 | 1,580 | ||||||||
Total capital expenditures | 2,937 | 243 | 2,022 | ||||||||
Fluid & Metering Technologies | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Total net sales | 880,957 | 849,101 | 860,792 | ||||||||
Total operating income | 241,030 | 217,500 | 206,419 | ||||||||
Total assets | 1,101,580 | 1,065,670 | 1,101,580 | 1,065,670 | 1,125,266 | ||||||
Total depreciation and amortization | 23,587 | 28,458 | 27,662 | ||||||||
Total capital expenditures | 18,218 | 16,389 | 22,846 | ||||||||
Fluid & Metering Technologies | External Customers | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Total net sales | 880,648 | 848,708 | 859,945 | ||||||||
Fluid & Metering Technologies | Intersegment Eliminations | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Total net sales | 309 | 393 | 847 | ||||||||
Health & Science Technologies | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Total net sales | 820,131 | 744,809 | 738,996 | ||||||||
Total operating income | 179,567 | 153,691 | 158,364 | ||||||||
Total assets | 1,323,373 | 1,266,036 | 1,323,373 | 1,266,036 | 1,108,302 | ||||||
Total depreciation and amortization | 45,287 | 45,298 | 42,827 | ||||||||
Total capital expenditures | 16,340 | 15,665 | 13,104 | ||||||||
Health & Science Technologies | External Customers | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Total net sales | 819,719 | 744,380 | 737,011 | ||||||||
Health & Science Technologies | Intersegment Eliminations | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Total net sales | 412 | 429 | 1,985 | ||||||||
Fire & Safety/Diversified Products | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Total net sales | 587,533 | 520,009 | 423,915 | ||||||||
Total operating income | 147,028 | 123,605 | 117,346 | ||||||||
Total assets | $ 744,515 | $ 705,735 | 744,515 | 705,735 | 448,867 | ||||||
Total depreciation and amortization | 14,541 | 11,956 | 6,051 | ||||||||
Total capital expenditures | 6,363 | 5,945 | 5,804 | ||||||||
Fire & Safety/Diversified Products | External Customers | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Total net sales | 586,945 | 519,955 | 423,712 | ||||||||
Fire & Safety/Diversified Products | Intersegment Eliminations | |||||||||||
Segment Reporting Information [Line Items] | |||||||||||
Total net sales | $ 588 | $ 54 | $ 203 |
Business Segments and Geograp76
Business Segments and Geographic Information - Schedule of Sales from External Customers and Long Lived Assets (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2017 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2016 | Mar. 31, 2016 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||||||||
Total net sales | $ 585,904 | $ 574,490 | $ 573,366 | $ 553,552 | $ 530,419 | $ 530,356 | $ 549,696 | $ 502,572 | $ 2,287,312 | $ 2,113,043 | $ 2,020,668 |
Total long-lived assets — net | 258,350 | 247,816 | 258,350 | 247,816 | 240,945 | ||||||
U.S. Plans | |||||||||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||||||||
Total net sales | 1,158,889 | 1,067,333 | 1,015,277 | ||||||||
Total long-lived assets — net | 145,808 | 152,504 | 145,808 | 152,504 | 144,508 | ||||||
North America, Excluding U.S. | |||||||||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||||||||
Total net sales | 93,419 | 84,836 | 85,852 | ||||||||
Total long-lived assets — net | 3,627 | 1,533 | 3,627 | 1,533 | 643 | ||||||
Europe | |||||||||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||||||||
Total net sales | 567,282 | 517,179 | 490,435 | ||||||||
Total long-lived assets — net | 85,932 | 71,681 | 85,932 | 71,681 | 69,082 | ||||||
Asia | |||||||||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||||||||
Total net sales | 366,577 | 340,624 | 325,507 | ||||||||
Total long-lived assets — net | 22,613 | 21,793 | 22,613 | 21,793 | 26,498 | ||||||
Other Countries | |||||||||||
Revenues from External Customers and Long-Lived Assets [Line Items] | |||||||||||
Total net sales | 101,145 | 103,071 | 103,597 | ||||||||
Total long-lived assets — net | $ 370 | $ 305 | $ 370 | $ 305 | $ 214 |
Restructuring - Additional Info
Restructuring - Additional Information (Details) $ in Thousands | 3 Months Ended | 12 Months Ended | ||||
Dec. 31, 2017USD ($) | Mar. 31, 2017USD ($) | Dec. 31, 2016USD ($) | Dec. 31, 2017USD ($)employee | Dec. 31, 2016USD ($)employee | Dec. 31, 2015USD ($)employee | |
Restructuring Cost and Reserve [Line Items] | ||||||
Pre-tax restructuring expenses related to restructuring initiative | $ 8,455 | $ 3,674 | $ 11,239 | |||
Restructuring liabilities | $ 4,180 | $ 3,893 | 4,180 | 3,893 | 6,636 | |
2017 Initiative | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Pre-tax restructuring expenses related to restructuring initiative | $ 3,658 | $ 3,658 | ||||
Number of employees | employee | 92 | |||||
2016 Initiative | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Pre-tax restructuring expenses related to restructuring initiative | $ 4,800 | $ 3,700 | $ 4,797 | $ 3,674 | ||
Number of employees | employee | 226 | |||||
2015 Initiative | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Pre-tax restructuring expenses related to restructuring initiative | $ 11,239 | |||||
Number of employees | employee | 208 |
Restructuring - Schedule of Pre
Restructuring - Schedule of Pre-Tax Restructuring Expenses by Segment (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | ||||
Dec. 31, 2017 | Mar. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Restructuring Cost and Reserve [Line Items] | ||||||
Total | $ 8,455 | $ 3,674 | $ 11,239 | |||
2017 Initiative | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Severance Costs | 3,067 | |||||
Exit Costs | 591 | |||||
Total | $ 3,658 | 3,658 | ||||
2017 Initiative | Fluid & Metering Technologies | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Severance Costs | 1,375 | |||||
Exit Costs | 433 | |||||
Total | 1,808 | |||||
2017 Initiative | Health & Science Technologies | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Severance Costs | 1,510 | |||||
Exit Costs | 158 | |||||
Total | 1,668 | |||||
2017 Initiative | Fire & Safety/Diversified Products | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Severance Costs | 182 | |||||
Exit Costs | 0 | |||||
Total | 182 | |||||
2017 Initiative | Corporate Office/Other | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Severance Costs | 0 | |||||
Exit Costs | 0 | |||||
Total | 0 | |||||
2016 Initiative | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Severance Costs | 4,239 | |||||
Exit Costs | 558 | |||||
Total | $ 4,800 | $ 3,700 | 4,797 | 3,674 | ||
2016 Initiative | Fluid & Metering Technologies | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Severance Costs | 1,566 | |||||
Exit Costs | 0 | |||||
Total | 1,566 | 932 | ||||
2016 Initiative | Health & Science Technologies | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Severance Costs | 2,470 | |||||
Exit Costs | 558 | |||||
Total | 3,028 | 1,117 | ||||
2016 Initiative | Fire & Safety/Diversified Products | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Severance Costs | 73 | |||||
Exit Costs | 0 | |||||
Total | 73 | 1,425 | ||||
2016 Initiative | Corporate Office/Other | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Severance Costs | 130 | |||||
Exit Costs | 0 | |||||
Total | $ 130 | $ 200 | ||||
2015 Initiative | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Total | 11,239 | |||||
2015 Initiative | Fluid & Metering Technologies | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Total | 7,090 | |||||
2015 Initiative | Health & Science Technologies | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Total | 3,408 | |||||
2015 Initiative | Fire & Safety/Diversified Products | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Total | 576 | |||||
2015 Initiative | Corporate Office/Other | ||||||
Restructuring Cost and Reserve [Line Items] | ||||||
Total | $ 165 |
Restructuring - Schedule of Res
Restructuring - Schedule of Restructuring Accruals Expenses (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Restructuring Reserve [Roll Forward] | |||
Beginning balance | $ 3,893 | $ 6,636 | |
Restructuring expenses | 8,455 | 3,674 | $ 11,239 |
Payments, utilization and other | (8,168) | (6,417) | |
Ending balance | $ 4,180 | $ 3,893 | $ 6,636 |
Share-Based Compensation - Addi
Share-Based Compensation - Additional Information (Details) $ in Thousands | 12 Months Ended | |||
Dec. 31, 2017USD ($)share-based_compensation_planshares | Dec. 31, 2016USD ($)shares | Dec. 31, 2015USD ($)shares | Dec. 31, 2018shares | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Number of share-based compensation plans | share-based_compensation_plan | 2 | |||
Number of shares authorized (in shares) | shares | 15,600,000 | |||
Number of shares available for future issuance (in shares) | shares | 4,900,000 | |||
Proceeds from stock option exercises | $ 22,935 | $ 30,240 | $ 19,217 | |
Forecast | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Shares issued (in shares) | shares | 143,897 | |||
Stock Option | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Stock option exercisable life | 10 years | |||
Total intrinsic value of options exercised | $ 26,100 | 26,500 | 16,900 | |
Proceeds from stock option exercises | 22,900 | 30,200 | 19,200 | |
Tax benefit realized for the tax deductions from stock options exercised | 9,500 | 9,600 | $ 6,100 | |
Total unrecognized compensation cost | $ 12,300 | |||
Weighted-average period of total unrecognized compensation cost, in years | 1 year 4 months 24 days | |||
Stock Option | Non-Employee Directors Cliff | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 1 year | |||
Restricted Stock | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 3 years | |||
Total unrecognized compensation cost | $ 4,900 | |||
Weighted-average period of total unrecognized compensation cost, in years | 1 year | |||
Unvested shares, granted (in shares) | shares | 59,315 | |||
Cash-settled Restricted Stock | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Vesting period | 3 years | |||
Share based compensation, accrued expenses | $ 4,500 | 3,000 | ||
Share based compensation, other noncurrent liabilities | $ 3,000 | $ 2,400 | ||
Unvested shares, granted (in shares) | shares | 34,530 | |||
Performance Shares Units | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Total unrecognized compensation cost | $ 6,600 | |||
Weighted-average period of total unrecognized compensation cost, in years | 10 months 24 days | |||
Award requisite service period | 3 years | |||
Unvested shares, granted (in shares) | shares | 65,530 | 100,000 | 100,000 | |
Performance Shares Units | Minimum | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Target award | 0.00% | |||
Performance Shares Units | Maximum | ||||
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
Target award | 250.00% | |||
Target payout | 100.00% |
Share-Based Compensation - Sche
Share-Based Compensation - Schedule of Weighted Average Option Fair Values and Assumptions (Details) - Stock Option - $ / shares | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Weighted average fair value of grants (in dollars per share) | $ 24.19 | $ 18.56 | $ 20.32 |
Dividend yield | 1.45% | 1.69% | 1.45% |
Volatility | 29.41% | 29.70% | 29.90% |
Risk-free interest rate, minimum | 0.83% | 0.53% | 0.24% |
Risk-free interest rate, maximum | 3.04% | 2.49% | 2.82% |
Expected life (in years) | 5 years 9 months 29 days | 5 years 10 months 28 days | 5 years 11 months 5 days |
Share-Based Compensation - Stoc
Share-Based Compensation - Stock Options Activity (Details) - Stock Option - USD ($) | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Shares | ||
Outstanding at January 1, 2017 (in shares) | 1,987,946 | |
Granted (in shares) | 441,990 | |
Exercised (in shares) | (448,189) | |
Forfeited (in shares) | (57,064) | |
Outstanding at December 31, 2017 (in shares) | 1,924,683 | 1,987,946 |
Vested and expected to vest at December 31, 2017 (in shares) | 1,823,279 | |
Exercisable at December 31, 2017 (in shares) | 898,003 | |
Weighted Average Price | ||
Outstanding at January 1, 2016 (in dollars per share) | $ 61.83 | |
Granted (in dollars per share) | 93.48 | |
Exercised (in dollars per share) | 51.17 | |
Forfeited (in dollars per share) | 79.14 | |
Outstanding at December 31, 2017 (in dollars per share) | 71.07 | $ 61.83 |
Vested and expected to vest at December 31, 2017 (in dollars per share) | 70.26 | |
Exercisable at December 31, 2017 (in dollars per share) | $ 57.21 | |
Weighted-Average Remaining Contractual Term | ||
Weighted-Average Remaining Contractual Term | 6 years 10 months 13 days | 6 years 10 months 2 days |
Vested and expected to vest at December 31, 2017 | 6 years 9 months 7 days | |
Exercisable at December 31, 2017 | 5 years 3 months 7 days | |
Aggregate Intrinsic Value | ||
Outstanding at January 1, 2017 | $ 56,144,876 | |
Outstanding at December 31, 2017 | 117,209,218 | $ 56,144,876 |
Vested and expected to vest at December 31, 2017 | 112,521,086 | |
Exercisable at December 31, 2017 | $ 67,130,223 |
Share-Based Compensation - Sc83
Share-Based Compensation - Schedule of Compensation Cost for Stock Options (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total expense before income taxes | $ 24,405 | $ 20,326 | $ 20,048 |
Stock Option | |||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total expense before income taxes | 7,775 | 6,988 | 7,031 |
Income tax benefit | (2,485) | (2,213) | (2,208) |
Total expense after income taxes | 5,290 | 4,775 | 4,823 |
Stock Option | Cost of goods sold | |||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total expense before income taxes | 428 | 427 | 543 |
Stock Option | Selling, general and administrative expenses | |||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total expense before income taxes | $ 7,347 | $ 6,561 | $ 6,488 |
Share-Based Compensation - Rest
Share-Based Compensation - Restricted Stock Units Activity (Details) - Restricted Stock | 12 Months Ended |
Dec. 31, 2017$ / sharesshares | |
Shares | |
Unvested at January 1, 2017 (in shares) | shares | 217,898 |
Granted (in shares) | shares | 59,315 |
Vested (in shares) | shares | (82,420) |
Forfeited (in shares) | shares | (12,770) |
Unvested at December 31, 2017 (in shares) | shares | 182,023 |
Weighted-Average Grant Date Fair Value | |
Unvested at January 1, 2017 (in dollars per share) | $ / shares | $ 76.19 |
Granted (in dollars per share) | $ / shares | 93.75 |
Vested (in dollars per share) | $ / shares | 72.42 |
Forfeited (in dollars per share) | $ / shares | 79.80 |
Unvested at December 31, 2017 (in dollars per share) | $ / shares | $ 83.37 |
Share-Based Compensation - Sc85
Share-Based Compensation - Schedule of Compensation Cost for Restricted Stock Units (Details) - Restricted Stock - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total expense before income taxes | $ 5,107 | $ 4,791 | $ 5,554 |
Income tax benefit | (1,654) | (1,410) | (1,604) |
Total expense after income taxes | 3,453 | 3,381 | 3,950 |
Cost of goods sold | |||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total expense before income taxes | 335 | 390 | 341 |
Selling, general and administrative expenses | |||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total expense before income taxes | $ 4,772 | $ 4,401 | $ 5,213 |
Share-Based Compensation Share-
Share-Based Compensation Share-Based Compensation - Cash-settled Restricted Stock Activity (Details) - Cash-settled Restricted Stock | 12 Months Ended |
Dec. 31, 2017$ / sharesshares | |
Shares | |
Unvested at January 1, 2017 (in shares) | shares | 103,790 |
Granted (in shares) | shares | 34,530 |
Vested (in shares) | shares | (27,050) |
Forfeited (in shares) | shares | (16,540) |
Unvested at December 31, 2017 (in shares) | shares | 94,730 |
Weighted-Average Grant Date Fair Value | |
Unvested at January 1, 2017 (in dollars per share) | $ / shares | $ 90.06 |
Granted (in dollars per share) | $ / shares | 93.92 |
Vested (in dollars per share) | $ / shares | 92.44 |
Forfeited (in dollars per share) | $ / shares | 122.31 |
Unvested at December 31, 2017 (in dollars per share) | $ / shares | $ 131.97 |
Share-Based Compensation - Sc87
Share-Based Compensation - Schedule of Compensation Cost for Cash-settled Restricted Stock (Details) - Cash-settled Restricted Stock - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total expense before income taxes | $ 4,598 | $ 2,988 | $ 2,518 |
Income tax benefit | (808) | (419) | (355) |
Total expense after income taxes | 3,790 | 2,569 | 2,163 |
Cost of goods sold | |||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total expense before income taxes | 1,357 | 764 | 753 |
Selling, general and administrative expenses | |||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total expense before income taxes | $ 3,241 | $ 2,224 | $ 1,765 |
Share-Based Compensation - Sc88
Share-Based Compensation - Schedule of Weighted Average Performance Share Units Fair Values and Assumptions (Details) - Performance Shares Units - $ / shares | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||
Weighted average fair value of grants (in dollars per share) | $ 115.74 | $ 111.42 | $ 95.07 |
Dividend yield | 0.00% | 0.00% | 0.00% |
Volatility | 17.36% | 17.99% | 19.14% |
Risk-free interest rate | 1.45% | 0.89% | 1.01% |
Expected life (in years) | 2 years 10 months 6 days | 2 years 10 months 10 days | 2 years 10 months 10 days |
Share-Based Compensation - Perf
Share-Based Compensation - Performance Share Unit Activity (Details) - Performance Shares Units - $ / shares | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Shares | |||
Unvested at January 1, 2017 (in shares) | 137,055 | ||
Granted (in shares) | 65,530 | 100,000 | 100,000 |
Vested (in shares) | (62,755) | ||
Forfeited (in shares) | (2,960) | ||
Unvested at December 31, 2017 (in shares) | 136,870 | 137,055 | |
Weighted-Average Grant Date Fair Value | |||
Unvested at January 1, 2017 (in dollars per share) | $ 104.18 | ||
Granted (in dollars per share) | 115.74 | ||
Vested (in dollars per share) | 95.81 | ||
Forfeited (in dollars per share) | 109.75 | ||
Unvested at December 31, 2017 (in dollars per share) | $ 113.81 | $ 104.18 |
Share-Based Compensation - Sc90
Share-Based Compensation - Schedule of Compensation Cost for Performance Share Units (Details) - Performance Shares Units - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total expense before income taxes | $ 6,925 | $ 5,559 | $ 4,946 |
Income tax benefit | (2,342) | (1,859) | (1,670) |
Total expense after income taxes | 4,583 | 3,700 | 3,276 |
Cost of goods sold | |||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total expense before income taxes | 0 | 0 | 0 |
Selling, general and administrative expenses | |||
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items] | |||
Total expense before income taxes | $ 6,925 | $ 5,559 | $ 4,946 |
Other Comprehensive Income (L91
Other Comprehensive Income (Loss) - (Components of Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Equity [Abstract] | |||
Cumulative translation adjustment, Pre-tax | $ 110,421 | $ (76,822) | $ (63,441) |
Cumulative translation adjustment, Tax | 0 | 0 | 0 |
Cumulative translation adjustment, Net of Tax | 110,421 | (76,822) | (63,441) |
Reclassification of foreign currency translation to earnings upon sale of business, Pre-tax | 2,749 | 14,257 | (4,725) |
Reclassification of foreign currency translation to earnings upon sale of business, Tax | 0 | 0 | 0 |
Reclassification of foreign currency translation to earnings upon sale of business, Net of Tax | 2,749 | 14,257 | (4,725) |
Tax effect of reversal of indefinite assertion on certain intercompany loans, Pre-tax | (3,932) | 0 | |
Tax effect of reversal of indefinite assertion on certain intercompany loans, Tax | 0 | 0 | |
Tax effect of reversal of indefinite assertion on certain intercompany loans, Net of Tax | (3,932) | 0 | 0 |
Foreign currency translation adjustments, Pre-tax | 109,238 | (62,565) | |
Foreign currency translation adjustments, Tax | 0 | 0 | |
Foreign currency translation adjustments, net of tax | 109,238 | (62,565) | |
Pension and other postretirement adjustments | |||
Net gain (loss) arising during the year, Pre-tax | (5,355) | (1,927) | 8,318 |
Net gain (loss) arising during the year, Tax | 828 | 789 | (2,411) |
Net gain (loss) arising during the year, Net of Tax | (4,527) | (1,138) | 5,907 |
Amortization/recognition of settlement loss, Pre-tax | 3,814 | 7,083 | 4,939 |
Amortization/recognition of settlement loss, Tax | (589) | (2,896) | (1,431) |
Amortization/recognition of settlement loss, Net of Tax | 3,225 | 4,187 | 3,508 |
Pension and other postretirement adjustments, Pre-tax | (1,541) | 5,156 | 13,257 |
Pension and other postretirement adjustments, Tax | 239 | (2,107) | (3,842) |
Pension and other postretirement adjustments, Net of Tax | (1,302) | 3,049 | 9,415 |
Reclassification adjustments for derivatives, Pre-tax | 6,655 | 6,851 | 7,030 |
Reclassification adjustments for derivatives, Tax | (2,445) | (2,490) | (2,499) |
Reclassification adjustments for derivatives, Net of tax | 4,210 | 4,361 | 4,531 |
Total other comprehensive income (loss), Pre-tax | 114,352 | (50,558) | (47,879) |
Total other comprehensive income (loss), Tax | (2,206) | (4,597) | (6,341) |
Other comprehensive income (loss) | $ 112,146 | $ (55,155) | $ (54,220) |
Other Comprehensive Income (L92
Other Comprehensive Income (Loss) - (Amounts Reclassified from Accumulated Other Comprehensive Income (Loss)) (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2017 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2016 | Mar. 31, 2016 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
Loss (gain) on sale of businesses - net | $ (9,273) | $ 22,298 | $ (18,070) | ||||||||
Other (income) expense - net | 2,394 | (1,731) | 3,009 | ||||||||
Interest expense | 44,889 | 45,616 | 41,636 | ||||||||
Total before tax | (455,273) | (368,512) | (392,345) | ||||||||
Provision for income taxes | 118,016 | 97,403 | 109,538 | ||||||||
Total net of tax | $ (93,746) | $ (83,768) | $ (83,844) | $ (75,899) | $ (57,347) | $ (69,873) | $ (75,759) | $ (68,130) | (337,257) | (271,109) | (282,807) |
Reclassification out of Accumulated Other Comprehensive Income | Foreign Currency Translation | |||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
Loss (gain) on sale of businesses - net | 2,749 | 14,257 | (4,725) | ||||||||
Total before tax | 2,749 | 14,257 | (4,725) | ||||||||
Provision for income taxes | 0 | 0 | 0 | ||||||||
Total net of tax | 2,749 | 14,257 | (4,725) | ||||||||
Reclassification out of Accumulated Other Comprehensive Income | Pension and Other Postretirement Plans | |||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
Total before tax | 3,814 | 7,083 | 4,939 | ||||||||
Provision for income taxes | (589) | (2,896) | (1,431) | ||||||||
Total net of tax | 3,225 | 4,187 | 3,508 | ||||||||
Reclassification out of Accumulated Other Comprehensive Income | Amortization of service cost | |||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
Other (income) expense - net | 3,580 | 3,529 | 4,939 | ||||||||
Reclassification out of Accumulated Other Comprehensive Income | Recognition of settlement loss | |||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
Other (income) expense - net | 234 | 3,554 | 0 | ||||||||
Reclassification out of Accumulated Other Comprehensive Income | Derivatives | |||||||||||
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
Interest expense | 6,655 | 6,851 | 7,030 | ||||||||
Total before tax | 6,655 | 6,851 | 7,030 | ||||||||
Provision for income taxes | (2,445) | (2,490) | (2,499) | ||||||||
Total net of tax | $ 4,210 | $ 4,361 | $ 4,531 |
Retirement Benefits - Additiona
Retirement Benefits - Additional Information (Details) $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Dec. 31, 2016USD ($) | Dec. 31, 2017USD ($)employee | Dec. 31, 2016USD ($) | Dec. 31, 2015USD ($) | |
Defined Benefit Plan Disclosure [Line Items] | ||||
Percentage of excess gains and losses over benefit obligation or market value of assets amortized | 10.00% | |||
Costs of defined contribution plans | $ 10,200 | $ 10,100 | $ 10,300 | |
Number of participants covering under multi employer pension plan | employee | 355 | |||
Costs of bargaining unit-sponsored multi-employer plans and defined contribution plans | $ 1,000 | 1,300 | 1,000 | |
Weighted average annual rate of increase in the per capita cost of covered health care benefits assumed | 6.21% | |||
Assumed decrease of weighted average health care cost trend rate | 4.50% | |||
Year that reaches assumed decrease of weighted average health care cost trend rate | 2,038 | |||
Increase in service and interest cost components of the net periodic benefit cost, as 1% increase in health care cost trend rates | $ 200 | |||
Increase in accumulated postretirement benefit obligation, as 1% increase in health care cost trend rates | 2,300 | |||
Decrease in service and interest cost components of the net periodic benefit cost, as 1% decrease in health care cost trend rates | 100 | |||
Decrease in accumulated postretirement benefit obligation, as 1% decrease in health care cost trend rates | 2,000 | |||
Future estimated benefit payments for year 2018 | 13,600 | |||
Future estimated benefit payments for year 2019 | 11,000 | |||
Future estimated benefit payments for year 2020 | 11,300 | |||
Future estimated benefit payments for year 2021 | 11,000 | |||
Future estimated benefit payments for year 2022 | 11,000 | |||
Future estimated benefit payments for years 2022 to 2026 | 54,700 | |||
Defined Contribution Plan | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Defined contribution plan, expected contribution for next fiscal year | 11,000 | |||
401k | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Defined contribution plan, expected contribution for next fiscal year | $ 8,500 | |||
Equity Securities | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target allocation of fund assets in equities | 44.00% | |||
Equity Securities | Minimum | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target allocation of fund assets in equities | 40.00% | |||
Equity Securities | Maximum | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target allocation of fund assets in equities | 60.00% | |||
Fixed Income Securities | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target allocation of fund assets in equities | 56.00% | |||
Fixed Income Securities | Minimum | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target allocation of fund assets in equities | 40.00% | |||
Fixed Income Securities | Maximum | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Target allocation of fund assets in equities | 60.00% | |||
Pension Benefit Plan | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Accumulated benefit obligation for all defined benefit pension plans | $ 176,700 | $ 182,700 | 176,700 | |
Defined benefit plan, expected contribution for next fiscal year | 5,500 | |||
Pension Benefit Plan | U.S. Plans | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Lump sum payment | 0 | 11,126 | ||
Settlement loss recognized | $ 3,500 | 0 | 3,339 | $ 0 |
Other Benefit Plans | ||||
Defined Benefit Plan Disclosure [Line Items] | ||||
Lump sum payment | 0 | $ 0 | ||
Defined benefit plan, expected contribution for next fiscal year | $ 100 |
Retirement Benefits - Reconcili
Retirement Benefits - Reconciliation Of Changes In Benefit Obligations And Fair Value Of Plan Assets (Details) - USD ($) $ in Thousands | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
CHANGE IN PLAN ASSETS | |||
Fair value of plan assets at January 1 | $ 106,274 | ||
Fair value of plan assets at December 31 | 112,505 | $ 106,274 | |
Other noncurrent liabilities | (99,646) | (93,604) | |
Pension Benefit Plan | |||
CHANGE IN BENEFIT OBLIGATION | |||
Other | 0 | ||
Pension Benefit Plan | U.S. Plans | |||
CHANGE IN BENEFIT OBLIGATION | |||
Obligation at January 1 | 90,256 | 98,476 | |
Service cost | 976 | 1,016 | $ 1,279 |
Interest cost | 2,677 | 3,043 | 3,770 |
Plan amendments | 0 | 0 | |
Benefits paid | (6,258) | (3,140) | |
Actuarial loss (gain) | 3,684 | 1,987 | |
Currency translation | 0 | 0 | |
Settlements | 0 | (11,126) | |
Acquisition/Divestiture | 0 | 0 | |
Other | 0 | ||
Obligation at December 31 | 91,335 | 90,256 | 98,476 |
CHANGE IN PLAN ASSETS | |||
Fair value of plan assets at January 1 | 73,688 | 77,575 | |
Actual return on plan assets | 5,046 | 6,740 | |
Employer contributions | 3,565 | 3,639 | |
Benefits paid | (6,258) | (3,140) | |
Currency translation | 0 | 0 | |
Settlements | 0 | (11,126) | |
Acquisition/Divestiture | 0 | 0 | |
Other | 0 | 0 | |
Fair value of plan assets at December 31 | 76,041 | 73,688 | 77,575 |
Funded status at December 31 | (15,294) | (16,568) | |
Current liabilities | (658) | (729) | |
Other noncurrent liabilities | (14,636) | (15,839) | |
Net liability at December 31 | (15,294) | (16,568) | |
Pension Benefit Plan | Non-U.S. Plans | |||
CHANGE IN BENEFIT OBLIGATION | |||
Obligation at January 1 | 87,764 | 58,063 | |
Service cost | 1,975 | 1,627 | 1,506 |
Interest cost | 1,283 | 1,429 | 1,734 |
Plan amendments | 0 | 0 | |
Benefits paid | (1,942) | (2,023) | |
Actuarial loss (gain) | (15) | 6,844 | |
Currency translation | 9,323 | (6,988) | |
Settlements | (2,452) | (819) | |
Acquisition/Divestiture | 29,491 | ||
Acquisition/Divestiture | (482) | ||
Other | 1,997 | 140 | |
Obligation at December 31 | 97,451 | 87,764 | 58,063 |
CHANGE IN PLAN ASSETS | |||
Fair value of plan assets at January 1 | 32,586 | 20,645 | |
Actual return on plan assets | 1,792 | 2,470 | |
Employer contributions | 2,702 | 1,974 | |
Benefits paid | (1,942) | (2,023) | |
Currency translation | 2,446 | (4,108) | |
Settlements | (2,452) | (819) | |
Acquisition/Divestiture | 0 | 14,307 | |
Other | 1,184 | 140 | |
Fair value of plan assets at December 31 | 36,316 | 32,586 | 20,645 |
Funded status at December 31 | (61,135) | (55,178) | |
Current liabilities | (1,159) | (1,005) | |
Other noncurrent liabilities | (59,976) | (54,173) | |
Net liability at December 31 | (61,135) | (55,178) | |
Other Benefit Plans | |||
CHANGE IN BENEFIT OBLIGATION | |||
Obligation at January 1 | 24,636 | 20,400 | |
Service cost | 610 | 601 | 673 |
Interest cost | 818 | 811 | 833 |
Plan amendments | 0 | 0 | |
Benefits paid | (738) | (718) | |
Actuarial loss (gain) | 592 | (1,990) | |
Currency translation | 150 | 52 | |
Settlements | 0 | 0 | |
Acquisition/Divestiture | 0 | 5,480 | |
Other | 0 | 0 | |
Obligation at December 31 | 26,068 | 24,636 | 20,400 |
CHANGE IN PLAN ASSETS | |||
Fair value of plan assets at January 1 | 0 | 0 | |
Actual return on plan assets | 0 | 0 | |
Employer contributions | 738 | 718 | |
Benefits paid | (738) | (718) | |
Currency translation | 0 | 0 | |
Settlements | 0 | 0 | |
Acquisition/Divestiture | 0 | 0 | |
Other | 0 | 0 | |
Fair value of plan assets at December 31 | 0 | 0 | $ 0 |
Funded status at December 31 | (26,068) | (24,636) | |
Current liabilities | (1,034) | (1,044) | |
Other noncurrent liabilities | (25,034) | (23,592) | |
Net liability at December 31 | $ (26,068) | $ (24,636) |
Retirement Benefits - Weighted
Retirement Benefits - Weighted Average Assumptions Used in the Measurement Of Benefit Obligation (Details) - Pension Benefit Plan | Dec. 31, 2017 | Dec. 31, 2016 |
U.S. Plans | ||
Schedule of Benefit Obligations Weighted Average Assumptions [Line Items] | ||
Discount rate | 3.46% | 3.91% |
Rate of compensation increase | 4.00% | 4.00% |
Non-U.S. Plans | ||
Schedule of Benefit Obligations Weighted Average Assumptions [Line Items] | ||
Discount rate | 1.82% | 1.76% |
Rate of compensation increase | 2.37% | 2.29% |
Retirement Benefits - Pretax Am
Retirement Benefits - Pretax Amounts Recognized in Accumulated Other Comprehensive Income Loss (Details) - USD ($) $ in Thousands | 12 Months Ended | |
Dec. 31, 2017 | Dec. 31, 2016 | |
Pension Benefit Plan | U.S. Plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Prior service cost (credit) | $ 86 | $ 110 |
Net loss | 27,789 | 27,860 |
Total | 27,875 | 27,970 |
Net gain (loss) in current year | (2,471) | |
Amortization of prior service cost (credit) | 24 | |
Amortization of net loss (gain) | 2,542 | |
Exchange rate effect on amounts in OCI | 0 | |
Total | 95 | |
Pension Benefit Plan | Non-U.S. Plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Prior service cost (credit) | 18 | 77 |
Net loss | 17,986 | 17,643 |
Total | 18,004 | 17,720 |
Net gain (loss) in current year | 318 | |
Amortization of prior service cost (credit) | 3 | |
Amortization of net loss (gain) | 2,040 | |
Exchange rate effect on amounts in OCI | (2,645) | |
Total | (284) | |
Other Benefit Plans | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Prior service cost (credit) | (483) | (849) |
Net loss | (2,866) | (3,852) |
Total | (3,349) | $ (4,701) |
Net gain (loss) in current year | (592) | |
Amortization of prior service cost (credit) | (366) | |
Amortization of net loss (gain) | (429) | |
Exchange rate effect on amounts in OCI | 35 | |
Total | $ (1,352) |
Retirement Benefits - Amounts i
Retirement Benefits - Amounts in Accumulated Other Comprehensive Income Loss Expected to be Recognized As Components of Net Periodic Benefit Cost During 2012 (Details) $ in Thousands | Dec. 31, 2017USD ($) |
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |
Prior service cost (credit) | $ (339) |
Net loss | 3,627 |
Total | 3,288 |
Pension Benefit Plan | U.S. Plans | |
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |
Prior service cost (credit) | 24 |
Net loss | 2,716 |
Total | 2,740 |
Pension Benefit Plan | Non-U.S. Plans | |
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |
Prior service cost (credit) | 3 |
Net loss | 1,282 |
Total | 1,285 |
Other Benefit Plans | |
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |
Prior service cost (credit) | (366) |
Net loss | (371) |
Total | $ (737) |
Retirement Benefits - Component
Retirement Benefits - Components of Net Periodic Benefit Cost for Defined Benefit Plans and Other Postretirement Plans (Details) - USD ($) $ in Thousands | 3 Months Ended | 12 Months Ended | ||
Dec. 31, 2016 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Pension Benefit Plan | U.S. Plans | ||||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||||
Service cost | $ 976 | $ 1,016 | $ 1,279 | |
Interest cost | 2,677 | 3,043 | 3,770 | |
Expected return on plan assets | (3,832) | (4,777) | (4,910) | |
Settlement loss recognized | $ 3,500 | 0 | 3,339 | 0 |
Net amortization | 2,566 | 3,226 | 3,422 | |
Net periodic benefit cost | 2,387 | 5,847 | 3,561 | |
Pension Benefit Plan | Non-U.S. Plans | ||||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||||
Service cost | 1,975 | 1,627 | 1,506 | |
Interest cost | 1,283 | 1,429 | 1,734 | |
Expected return on plan assets | (1,088) | (993) | (1,114) | |
Settlement loss recognized | 234 | 215 | 0 | |
Net amortization | 1,809 | 1,008 | 1,931 | |
Net periodic benefit cost | 4,213 | 3,286 | 4,057 | |
Other Benefit Plans | ||||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||||
Service cost | 610 | 601 | 673 | |
Interest cost | 818 | 811 | 833 | |
Net amortization | (795) | (705) | (414) | |
Net periodic benefit cost | $ 633 | $ 707 | $ 1,092 |
Retirement Benefits - Weighte99
Retirement Benefits - Weighted Average Assumptions Used to Determine Net Periodic Benefit Cost of Plans (Details) - Pension Benefit Plan | 12 Months Ended | ||
Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
U.S. Plans | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Discount rate | 3.91% | 4.12% | 3.78% |
Expected return on plan assets | 5.50% | 6.50% | 6.50% |
Rate of compensation increase | 4.00% | 4.00% | 4.00% |
Non-U.S. Plans | |||
Defined Benefit Plan Disclosure [Line Items] | |||
Discount rate | 1.76% | 2.99% | 2.66% |
Expected return on plan assets | 3.20% | 4.58% | 5.19% |
Rate of compensation increase | 2.29% | 2.98% | 3.00% |
Retirement Benefits - Pension P
Retirement Benefits - Pension Plan Weighted Average Asset Allocations (Details) - Pension Benefit Plan | Dec. 31, 2017 | Dec. 31, 2016 |
U.S. Plans | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Defined benefit plan securities | 100.00% | 100.00% |
U.S. Plans | Equity Securities | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Defined benefit plan securities | 47.00% | 44.00% |
U.S. Plans | Fixed Income Securities | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Defined benefit plan securities | 51.00% | 43.00% |
U.S. Plans | Cash/Commingled Funds/Other | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Defined benefit plan securities | 2.00% | 13.00% |
Non-U.S. Plans | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Defined benefit plan securities | 100.00% | 100.00% |
Non-U.S. Plans | Equity Securities | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Defined benefit plan securities | 14.00% | 24.00% |
Non-U.S. Plans | Fixed Income Securities | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Defined benefit plan securities | 30.00% | 26.00% |
Non-U.S. Plans | Cash/Commingled Funds/Other | ||
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
Defined benefit plan securities | 56.00% | 50.00% |
Retirement Benefits - Summary o
Retirement Benefits - Summary of Basis Used to Measure Defined Benefit Plans Assets at Fair Value (Details) - USD ($) $ in Thousands | Dec. 31, 2017 | Dec. 31, 2016 |
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | $ 112,505 | $ 106,274 |
U.S. Large Cap | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 16,402 | 15,345 |
U.S. Small / Mid Cap | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 7,966 | 8,920 |
International, Equity | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 16,844 | 16,282 |
U.S. Intermediate | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 13,568 | 10,014 |
U.S. Short Duration | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 13,362 | 10,160 |
U.S. High Yield | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 9,529 | 9,343 |
International, Fixed Income | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 13,311 | 10,310 |
Other Commingled Funds | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 16,059 | 14,180 |
Cash and Cash Equivalents | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 2,613 | 10,382 |
Other | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 2,851 | 1,338 |
Level 1 | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 77,078 | 74,417 |
Level 1 | U.S. Large Cap | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 16,402 | 15,345 |
Level 1 | U.S. Small / Mid Cap | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 7,051 | 7,111 |
Level 1 | International, Equity | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 13,205 | 10,647 |
Level 1 | U.S. Intermediate | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 13,483 | 9,943 |
Level 1 | U.S. Short Duration | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 13,362 | 10,160 |
Level 1 | U.S. High Yield | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 8,462 | 7,924 |
Level 1 | International, Fixed Income | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 3,767 | 3,627 |
Level 1 | Other Commingled Funds | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 1 | Cash and Cash Equivalents | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 1,346 | 9,660 |
Level 1 | Other | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 2 | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 19,368 | 17,677 |
Level 2 | U.S. Large Cap | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 2 | U.S. Small / Mid Cap | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 915 | 1,809 |
Level 2 | International, Equity | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 3,639 | 5,635 |
Level 2 | U.S. Intermediate | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 85 | 71 |
Level 2 | U.S. Short Duration | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 2 | U.S. High Yield | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 1,067 | 1,419 |
Level 2 | International, Fixed Income | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 9,544 | 6,683 |
Level 2 | Other Commingled Funds | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 2 | Cash and Cash Equivalents | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 1,267 | 722 |
Level 2 | Other | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 2,851 | 1,338 |
Level 3 | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 16,059 | 14,180 |
Level 3 | U.S. Large Cap | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 3 | U.S. Small / Mid Cap | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 3 | International, Equity | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 3 | U.S. Intermediate | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 3 | U.S. Short Duration | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 3 | U.S. High Yield | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 3 | International, Fixed Income | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 3 | Other Commingled Funds | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 16,059 | 14,180 |
Level 3 | Cash and Cash Equivalents | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | 0 | 0 |
Level 3 | Other | ||
Defined Benefit Plan Disclosure [Line Items] | ||
Defined benefit plan, fair value of plan assets | $ 0 | $ 0 |
Quarterly Results of Operati102
Quarterly Results of Operations (Unaudited) (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands | 3 Months Ended | 12 Months Ended | |||||||||
Dec. 31, 2017 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2016 | Mar. 31, 2016 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | |
Quarterly Financial Information Disclosure [Abstract] | |||||||||||
Net sales | $ 585,904 | $ 574,490 | $ 573,366 | $ 553,552 | $ 530,419 | $ 530,356 | $ 549,696 | $ 502,572 | $ 2,287,312 | $ 2,113,043 | $ 2,020,668 |
Gross profit | 260,882 | 257,930 | 256,925 | 250,941 | 232,485 | 230,889 | 244,058 | 223,335 | 1,026,678 | 930,767 | 904,315 |
Operating income | 135,248 | 126,504 | 125,133 | 115,671 | 85,521 | 109,708 | 113,823 | 103,345 | 502,556 | 412,397 | 436,990 |
Net income | $ 93,746 | $ 83,768 | $ 83,844 | $ 75,899 | $ 57,347 | $ 69,873 | $ 75,759 | $ 68,130 | $ 337,257 | $ 271,109 | $ 282,807 |
Basic EPS (in dollar per share) | $ 1.23 | $ 1.09 | $ 1.10 | $ 0.99 | $ 0.75 | $ 0.92 | $ 1 | $ 0.90 | $ 4.41 | $ 3.57 | $ 3.65 |
Diluted EPS (in dollar per share) | $ 1.21 | $ 1.08 | $ 1.08 | $ 0.99 | $ 0.75 | $ 0.91 | $ 0.99 | $ 0.89 | $ 4.36 | $ 3.53 | $ 3.62 |
Basic weighted average shares outstanding (in shares) | 76,283 | 76,309 | 76,220 | 76,115 | 75,955 | 75,819 | 75,690 | 75,749 | 76,232 | 75,803 | 77,126 |
Diluted weighted average shares outstanding (in shares) | 77,597 | 77,523 | 77,320 | 76,894 | 76,806 | 76,880 | 76,674 | 76,699 | 77,333 | 76,758 | 77,972 |